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Abstract 
Adipocytes store cell energy as triglycerides at times of sufficient nutritional 
supply and release free fatty acids during nutritional deprivation. Lines of evidence 
suggest that high fat diets increase adipose tissue mass, which requires differentiation 
of preadipocytes, and develop obesity in adult rodents. Saturated fats are more 
effective than polyunsaturated fats in inducing the expansion of adipose tissue mass. 
Fatty acids have been identified to control expression of genes implicated in lipid 
homeostasis via activation of nuclear receptors called peroxisome proliferator-
activated receptors (PPARs). The PPAR subfamily comprises of three distinct 
subtypes, PPARa, PPARy and PPARp/6. These receptors act as ligand-activated 
transcription factors. PPARa is expressed mainly in liver and mediates lipid 
catabolism. PPARy is predominantly expressed in adipose cells and is a key regulator 
of terminal stage of the adipocyte differentiation. PPARp is ubiquitously expressed 
and may also act as a regulator of adipocyte differentiation. However, the exact role 
of PPARp in the adipocyte differentiation and lipid homeostasis remains elusive. 
To gain further insight into the possible functions of PPARp in regulating lipid 
homeostasis and adipocyte differentiation, PPARp (-/-) mouse embryonic fibroblasts 
(MEFs) were prepared and examined its ability to undergo adipocyte differentiation in 
vitro, and the physiological responses of PPARp (-/-) mice to diets that are capable of 
inducing obesity were observed in vivo. 
For the in vitro studies, PPARp (-/-) MEFs and its wild-type controls were 
treated with common adipocyte differentiation inducers, together with a PPARP 
ligand (2-bromopalmitic acid), a PPARy ligand (troglitazone) or both. Visual 
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differences after Oil Red O staining, cellular triglyceride levels and mRNA expression 
patterns between PPARp (-/-) MEFs and its wild-type controls were compared. 
MEFs lacking PPARp receptors could be stimulated to differentiate into adipocytes, 
demonstrating that PPARp is not required in for this process. 
For the in vivo studies, PPARp (-/-) mice and its wild-type counterparts (male 
and female, 5-7 weeks old) were challenged with low fat lard (10% kcal fat as lard), 
high fat lard (45% kcal fat as lard), low fat safflower oil (10% kcal fat as safflower 
oil), or high fat safflower oil (45% kcal fat as safflower oil) diets for 5 months. 
Regular chow diet was used as a control. Comparisons between PPARp (-/-) and 
wild-type mice were carried out in body and organ weights, food intake, histological 
analyses of liver, white and brown adipose tissues, and the serum parameters 
including cholesterol, triglyceride, glucose, insulin and leptin. When feeding on a 
high fat diet, PPARp (-/-) mice resulted in a lean phenotype with reduced hepatic 
steatosis and lower serum cholesterol level, but not due to reduced adiposity. 
Adipocyte hypertrophy occurred in both PPARp (+/+) and PPARp (-/-) mice, 
indicating that no defect in adipocyte differentiation in PPARp (-/-) mice. 
Taken together, the above results demonstrated that PPARp is not an essential 
factor for adipocyte differentiation. Mice lacking PPARp receptor are less prone to 
high fat diet-induced obesity, suggesting PPARp plays an important role in 
developing obesity. 
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Chapter 1 General Introduction 
Adipocytes play a critical role in lipid homeostasis and energy balance by storing 
triglycerides or releasing free fatty acids in response to nutritional changes. Lines of 
evidence have illustrated that the effect of high fat diets on the development of obesity 
by accumulating adipose tissue mass, which requires the differentiation of adipocytes 
from preadipocytes in adult rodents (Shillabeer and Lau, 1994). Fatty acids regulate 
gene expressions implicated in fat cell differentiation via activation of peroxisome 
proliferators-activated receptors (PPARs) (Amri et al., 1994; Forman et al.’ 1997; 
Kliewer et al., 1997). There are three distinct subtypes of PPARs: PPARa 
(Issemann and Green, 1990), PPARy (Zhu et al” 1993; Kliewer et al., 1994) and 
PPARp (Kliewer et al., 1994). Among these three isoforms, PPARp is suggested to 
be a mediator of adipogenesis and regulate systemic lipid metabolism. A better 
understanding of the exact role of PPARp in mediating adipocyte differentiation, as 
well as lipid homeostasis, may provide clues for the prevention and treatment of 
obesity. 
1.1 PPARs 
The PPARs form a subfamily of the nuclear receptor superfamily, and three 
isoforms, encoded by separate genes, have been identified: PPARa, PPARy and 
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PPARp (Jones et al.，1995; Desvergne and Wahli, 1999). PPARs are 
ligand-dependent transcription factor that regulated target gene expression by binding 
to specific peroxisome proliferator response elements (PPREs) in enhancer sites of 
regulated genes. Each receptor binds to its PPRE as a heterodimer with a retinoid X 
receptor (RXR). Upon binding an agonist, the conformation of a PPAR is altered 
and stabilized such that a binding cleft is created and recruitment of transcriptional 
coactivators occurs, thus increasing in gene transcription (Desvergne and Wahli, 
1999). 
The first cloning of PPARa occurred in the course of searching for the molecular 
target of hepatic peroxisome proliferating agents in rodents (Issemann and Green, 
1990). Since then, numerous fatty acids and their derivatives, including a variety of 
eicosanoids and prostaglandins, have been shown to serve as natural ligands for 
PPARs, suggesting that these receptors play a central role in sensing nutrient levels 
and in modulating their metabolism (Yu et al, 1995; Forman et al, 1997; Kliewer et 
al” 1997; Krey et al., 1997). In addition, PPARs has been found as the primary 
targets of numerous synthetic compounds used in the successful treatment of diatbetes 
and dyslipidemia. As such, a significant understanding of the physiological 
characteristics of these factors has become extremely important to treat metabolic 
disorders, including obesity. 
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1.1.1 Receptor structure 
PPARs，like other nuclear receptors, possess a modular structure composed of 
functional domains. The DNA binding domain (DBD) and the ligand binding 
domain (LBD) are the most highly conserved regions across the receptor isoforms 
(Gottlicher, 1998; Berger and Moller, 2002). The DBD consists of two zinc fingers 
that specifically bind PPREs in the regulatory region of PPAR-responsive genes. 
The ligand binding “pocket” of PPARs appears to be quite large in comparison with 
that of other nuclear receptors. This difference may allow PPARs to interact with a 
broad range of structurally distinct natural and synthetic ligands. Located in the C 
terminus of the LBD is the ligand-dependent activation domain, AF-2. This region 
is intimately involved in the generation of the receptors' coactivator binding pocket. 
A ligand-independent activation function, AF-1, in found in close proximity to the N 
terminus of the receptor in the A/B domain (Gottlicher, 1998; Berger and Moller, 
2002). 
1.1.2 RXR and heterodimerization 
PPARs form heterodimers with the RXR. Like PPARs, RXR consists of three 
distinct isoforms, RXRa, RXRp and RXRy, which are activated by the endogenous 
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agonist 9-cis retinoic acid (Desvergne and Wahli, 1999; Berger and Mo Her, 2002). 
There is no specific role have yet been elaborated for these different RXR isoforms 
with PPARs to form PPAR:RXR heterodimers. 
1.1.3 PPRE 
PPREs are direct repeat (DR)-l elements consisting of two hexanucleotides with 
the consensus sequence AGGTCA separated by a single nucleotide spacer 
(Juge-Aubry et al., 1997; Berger and Moller, 2002). Cis elements adjacent to the 
PPRE core site (especially 5，）appear to play a role in defining the binding selectivity 
of these response elements. 
1.1.4 Natural ligands 
Eicosanoids as well as fatty acids derivatives are identified as ligands for PPARs 
(Yu et al., 1995; Forman et al., 1997; Kliewer et al.’ 1997; Krey et al” 1997; Berger 
and Moller, 2002). PPARy clearly prefers polyunsaturated fatty acids, including the 
essential linoleic acid, linolenic acid, arachidonic acid, and eicosapentaenoic acid. A 
prostaglandin derivative, 15-deoxy-Delta^^'^'^-prostaglandin J2, was demonstrated to 
be a relatively weak PPARy ligand. PPARa can be activated by a wide variety of 
saturated and unsaturated fatty acids, including palmitic acid, oleic acid, linoleic acid 
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and arachidonic acid. The lipoxygenase mtabolite 8(S)-hydroxyeicosatetraenoic 
acids were identified as ligand for PPARa. Like other PPARs, PPARp interacts with 
saturated and unsaturated fatty acids; its ligand selectivity is intermediate between 
that of PPARy and PPARa. The polyunsaturated fatty acids dihomo-y-linolenic acid 
and arachidonic acid had low affinities for PPARp. Palmitic acid and its 
metabolically stable analogue, 2-bromopalmic acid (2-BrP), were also identified as 
PPARp agonist (Amri et al., 1995). A number of eicosanoids, including 
prostaglandin Al and prostaglandin D2, have been shown to activate PPARp. 
1.1.5 Synthetic ligands 
Thiazolidinediones (TZDs), such as rosiglitazone, pioglitazone, englitazone, and 
ciglitzone were PPARy ligands as TZDs were found to induce adipocyte 
differentiation and increase expression of PPARy-dependent adipocyte genes, 
including fatty acid-binding protein (aP2) (Brun et al., 1996; Kubota et al” 1999; 
Berger and Moller, 2002; Miles et al., 2003). TZDs were developed primarily to 
improve antidiabetic actions of the fibrate hypolipidemic agents. Several TZDs, 
including troglitazone, rosiglitazone, and pioglitazone, have insulin-sensitizing and 
antidiabetic activity in humans with type 2 diabetes or impaired glucose tolerance 
(Berger and Moller, 2002). The flbrates, amphipathic carboxylic acids that have 
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been used in the treatment of hypertriglyceridemia, are PPARa ligands. Clofibrate, 
a prototype of fibrates, was found to induce peroxisome proliferation in rodents and 
activate PPARa (Issemann and Green, 1990). Wy-14643, the 2-arylthioacetic acid 
analogue of clofibrate, is a known potent murine PPARa agonist. Novel compounds 
that activate PPARp were developed. Among the a-substituted carboxylic acids, 
L-165041 was demonstrated its high affinity towards PPARp, but was weakly specific 
to PPARy and inactive on PPARa (Berger et al., 1999). Recently, GW501516 was 
reported as a potent, highly selective PPARp ligand (Oliver et al., 2001). These two 
compounds were able to improve serum lipid profiles in rodents and primates 
(Leibowitz et al, 2000; Oliver et al, 2001). 
1.1.6 PPARa 
Murine PPARa was the first member of this nuclear receptor subclass to be 
cloned (Issemann and Green, 1990). It is mapped to chromosome 15 in mouse and 
expressed mainly in liver, but is very low in white adipose tissue (Kliewer et al.’ 1994; 
Tontonoz et al, 1994; Jones et al., 1995). PPARa has been shown to play a critical 
role in the regulation of cellular uptake, binding, activation, and subsequent oxidation 
of fatty acids (both mitochondiral, peroxisomal and microsomal) (Lee et al” 1995; 
Berger and Moller, 2002; Kersten, 2002; Lee et al, 2002). 
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1.1.7 PPARy 
Three homologous PPARs, classified as PPARa, P and y, were cloned from a 
Xenopus complementary deoxyribonucleic acid (cDNA) library (Dreyer et al., 1992). 
PPARy was subsequently cloned from mouse (Zhu et al” 1993; Kliewer et al., 1994). 
Mouse PPARy gene is localized to chromosome 6 (Jones et al., 1995). Two PPARy 
isoforms are expressed at the protein level in mouse, PPARy 1 and PPARy2 (Zhu et al.， 
1995). PPARy2 has 30 more amino acids at its N terminus due to differential 
promoter usage within the same gene and subsequent alternative RNA splicing. 
PPARy is predominantly expressed in adipose cells and plays a key role in 
adipogenesis (Tontonoz et al., 1994; Jones et al, 1995; He et al., 2003; Jones et al.， 
2005). 
1.1.8 PPARP 
PPARP, also called NUCl (Schmidt et al., 1992), fatty acid-activated receptor 
(FAAR) (Amri et al., 1995) and PPAR5, was cloned in mouse (Kliewer et al., 1994). 
Murine PPARp has been localized to chromosome 17 (Jones et al., 1995). PPARp is 
expressed ubiquitously with a higher level in lipid-metabolizing tissue, such as 
adipose tissue, brain and skin (Kliewer et al, 1994; Tontonoz et al., 1994; Amri et al, 
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1995; Braissant et al., 1996). PPARp is thought to be a mediator of adipogenesis 
(Amri et al., 1995), and may regulate lipid metabolism (Peters et al., 2000), as the 
PPARP-deficient mice exhibit a reduction in fat mass. 
1.2 Adipocyte differentiation 
Adipocyte differentiation is a complex process involving dramatic changes in 
cell morphology and expression of genes involved in lipid transport and metabolism 
(Otto and Lane, 2005). When cultured in an appropriate condition, confluent 
fibroblasts convert into preadipocytes directed by transcriptional activation of early 
marker genes. Differentiation-competent preadipocytes were proliferated and lead to 
a clonal expansion. After these cells complete clonal expansion, they differentiate 
into lipid-containing adipocytes by expressing later markers of differentiation. The 
adipocyte differentiation program is regulated by several adipogenic transcription 
factors like CCAAT/enhancer binding proteins (C/EBPs) and PPARs (Yeh et al., 1995; 
Brun et al” 1996). These transcription factors coordinate the expression of these 
adipocyte differentiation related genes in creating and maintaining the adipocyte 
phenotype. 
1.2.1 Differentiation induction 
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External inducers are required for the induction of differentiation of fibroblasts 
in culture. Insulin, insulin-like growth factor-1, glucocorticoid, triiodothyronine and 
cAMP are often used in combination to induce adipocyte differentiation efficiently 
(Otto and Lane, 2005). Student and his colleagues had stimulated 3T3-L1 
preadipocytes proceeded to differentiation effectively by adding 
3-isobutyl-l-methylxanthine (IBMX), dexamethasone (DEX) and insulin in the 
presence of fetal bovine serum (Student et al., 1980). This cocktail of inducers, 
called MDI, includes a cAMP phosphodiesterase inhibitor IBMX to elevate cellular 
cAMP level and a synthetic glucocorticoid agonist DEX. 
1.2.2 Changes in morphology 
The isolated mouse embryonic fibroblasts (MEFs) are morphologically similar to 
those fibroblastic cells in the stroma of adipose tissue. During adipocyte 
differentiation, fibroblasts lose their fibroblastic character and appear in a ‘round-up’ 
in shape (MacDougald and Lane, 1995; Otto and Lane, 2005). They are 
morphologically and biochemically similar as normal adipocytes. The ‘round-up’ 
effect of differentiated cells may be due to changes in the cellular content of the 
cyotskeletal proteins, actin and tubulin, and collagen. Three to four days after 
induction of differentiation, many triglyceride-containing vacuoles accumulate in the 
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cytoplasm and combine to form a unilocular fat droplet finally, thus appearing the 
typical "signet ring” of mature adipocytes (MacDougald and Lane, 1995; Otto and 
Lane, 2005). 
1.2.3 Transcriptional regulation of adipocyte differentiation 
1.2.3.1 The C/EBP family 
The C/EBPs are unliganded transcription factors bearing a basic-leucine zipper 
domain at C-terminal that is able to bind DNA and form homo- or heterodimers with 
other C/EBP members (Grimaldi, 2001; Otto and Lane, 2005). Among the C/EBP 
family, C/EBPa, C/EBPp, C/EBP6 and a natural dominant-negative inhibitor of 
C/EBPs, called CHOP (or Gaddl53), are involved in regulating the transcription of 
genes implicated in adipocyte differentiation. C/EBPP and C/EBP6 are early 
regulators as they are expressed at the onset of the adipose differentiation program, 
but downregulated during terminal differentiation (Yeh et al., 1995). They were 
proposed to regulate the mitotic clonal expansion and activate the transcriptional 
activity of C/EBPa (Grimaldi, 2001). C/EBPP-expressing fibroblasts or 
preadipocytes promoted fat cell differentiation (Yeh et al., 1995). In C/EBPp (-/-) 
MEFs, mitosis of clonal expansion was blocked (Otto and Lane, 2005), and the 
differentiation frequency was reduced (Tanaka et al., 1997). Depletion of C/EBPp 
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and C/EBP5 in MEFs displayed an impaired fat cell conversion (Tanaka et al., 1997; 
Yamamoto et al., 2002); and C/EBPp and C/EBP5 double knockout mice exhibited a 
dramatic reduction of adipose tissue mass (Tanaka et al., 1997). C/EBPa regulates 
and cooperates with PPARy to control terminal adipocyte differentiation (Yeh et al., 
1995; Wu et al., 1999; Rosen et al., 2002). Fibroblasts lacking C/EBPa did not 
differentiate into fat cells properly, unless ectopic expression of PPARy (Wu et al” 
1999). Mice ablated of C/EBPa had defects in lipid accumulation (Wang et al., 
1995). These observations establish the importance of C/EBPs in adipocyte 
differentiation. 
1.2.3.2 PPARa 
The effect of PPARa in adipocyte differentiation is very limited because of the 
low expression level occurred in adipose tissue (Kliewer et al., 1994; Tontonoz et al., 
1994; Jones et al, 1995). PPARa-expressing fibroblasts required strong PPARa 
activators, such as Wy-14,643, to induce fat cell conversion (Brun et al., 1996). 
Furthermore, PPARa (-/-) mice were able to develop normal adipose mass (Lee et al， 
1995), implying that PPARa is not responsible for the gene regulation during 
adipocyte differentiation. 
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1.2.3.3 PPARy 
PPARy is induced at terminal stage of fat cell development (Dani et al., 1997; 
Bastie et al., 1999). In non-adipogenic fibroblasts that over-expressing PPARy, they 
stimulate adipogenesis upon treatment by 5,8,11,14-eicosatetraynoic acid (Tontonoz 
et al” 1994). PPARy promotes fat cell differentiation from embryonic fibroblasts as 
well as embryonic stem cells, and increases lipid storage in mature adipocytes by 
up-regulating adipocyte-specific genes, leptin, aP2 and adipsin (Kubota et al” 1999; 
Rosen et al., 1999). Moreover, PPARy can cooperate with C/EBPa to control the 
transcriptional pathway during fat cell formation (Tontonoz et al., 1994; Brun et al., 
1996; Wu et al., 1999). Recently, it was reported that adipose-specific 
PPARy-deficient mice have a significant reduction in the white adipose tissue (He et 
al” 2003; Jones et al., 2005). These findings indicate that PPARy is a key regulator 
of adipocyte differentiation. 
1.2.3.4 PPARP 
PPARp was cloned and identified from a preadipocyte culture treated with fatty 
acid (Amri et al., 1995), suggesting the role of PPARp in mediating adipocyte 
differentiaiton. PPARp is induced in the early stage of adipocyte differentiation 
(Amri et al” 1995; Dani et al., 1997). Activation and overexpression of PPARP in 
- 1 3 -
fibroblast cultures by long chain fatty acids or a selective PPARp agonist L-165041 
induced adipocyte lipid-binding protein (ALBP), fatty acid transporter (FAT), 
glycerol-3-phosphate dehydrogenase (GPDH) mRNA (Amri et al” 1995; Bastie et al.’ 
1999; Bastie et al., 2000; Hansen et al., 2001), along with a delayed activation of 
PPARy expression (Amri et al, 1995; Bastie et al., 1999). Mice in the ablation of 
PPARp showed an obvious reduction in adiposity relative to wild-type levels (Peters 
et al., 2000; Barak et al., 2002). The exact role of PPARp on fat cell differentiation 
remains elusive, as so far no genetic loss-of-function study on whether PPARp is 
essential for the fat cell differentiation. 
1.3 Obesity 
In the Western World, the prevalence of obesity continues to rise in alarm, and 
nearly one-third of the American population in now considered obese (Spiegelman 
and Flier, 2001). Obesity is defined medically as a state of body weight gain, more 
specifically adipose tissue, which is sufficient to produce adverse health consequences, 
including hypertension, insulin resistance, hypertriglyceridemia, low plasma 
high-density lipoprotein (HDL) and hyperuricemia. These metabolic abnormalities 
are collected in the term syndrome X (Spiegelman and Flier, 2001). 
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Obesity is caused by an imbalance between energy intake and energy 
expenditure, resulting in a positive energy balance and increased body weight 
(Spiegelman and Flier, 2001). It can be treated or prevented by reducing food intake 
and more energy expenditure. Theoretically, this method is supposed to be true, but 
it is difficult to change people's feeding habits. Therefore, pharmacological 
approach to treat obesity has become increasingly popular. 
PPARs have been proved as the therapeutical target for a number of drugs, 
fibrates and TZD, used in the treatment of such metabolic disorder (Berger and Moller, 
2002). In addition, high fat dietary challenge had been demonstrated to develop 
obesity in adult rodents (Shillabeer and Lau, 1994) and dietary fatty acids regulate 
gene expressions implicated in lipid and energy homeostasis via PPARs (Amri et al., 
1994; Forman et al., 1997; Kliewer et al, 1997). There is an increasing interest in 
the potential connection between PPARs and obesity. 
1.3.1.1 PPARa 
Mice lacking PPARa developed fatty liver (steatosis) in high fat diet-induced or 
spontaneous onset obesity (Costet et al., 1998; Kersten et al., 1999). Steatosis is 
probably due to excess release of fatty acids from the adipose tissue that accumulates 
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in the liver in the form of triglycerides. PPARa can influence fat storage in liver, 
suggesting its pharmacological activation in reducing steatosis. The PPARa agonist 
fibrate drugs lower serum triglycerides and slightly increase HDL cholesterol levels in 
patients with hyperlipidemia (Lee et al., 2003), most like due to induction of fatty 
acid oxidation through activation of PPARa. PPARa has also been shown to 
downregulate apolipoprotein C-III, a protein which inhibits triglyceride hydrolysis by 
lipoprotein lipase (LPL)，thus further contribute to lower serum triglyceride (Peters et 
al., 1997). 
1.3.1.2 PPARy 
As mention earlier, loss and gain of function experiments have exhibited that the 
activation of PPARy is both necessary and sufficient to induce an adipose phenotype, 
which is defined by lipid accumulation and the expression of fat-specific marker 
genes such as aP2, LPL and adipsin. PPARy mRNA levels in white adipose tissue 
were increased in obese animals (Kersten, 2002), demonstrating that PPARy plays a 
very important role in adipogenesis. Other than the actions of PPARy in adipose 
tissue, PPARy also regulates the expression of PPARy-responsive genes, either 
directly or indirectly, on other tissues. The administration of TZDs to fatless mice 
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activated PPARy and relieved hyperglycemia, hyperinsulinemia and hyperlipidemia 
(Lee et al., 2003). Adipose-specific PPARy knockout mice were more susceptible to 
high fat diet-induced steatosis (He et al.’ 2003). Furthermore, the expression of 
PPARy was upregulated in the liver of genetically obese mice, and TZDs induce 
several PPARy target genes involved in lipid uptake and storage in liver (Lee et al., 
2003). 
1.3.1.3 PPARP 
Activation of PPARp by synthetic PPARp ligands in genetically or diet-induced 
obese mice improves serum lipid profiles. Administration of a specific PPARp 
agonist L-165041 mice increased total plasma cholesterol levels that was primarily 
associated with HDL particles and decreased expression of LPL in white adipose 
tissue (Berger et al., 1999; Leibowitz et al.’ 2000). In skeletal muscle, fatty acid 
oxidation was enhanced, together with reduction in lipid content, by the activation of 
PPARP with GW501516 (Tanaka et al.’ 2003; Lee et al., 2006). Transgenic mice 
with an active form of PPARp in adipose tissue were resistant to obesity induced 
genetically or by a high fat diet (Wang et al, 2003). Adipose-specific 
PPARp-deficient mice displayed reduced energy uncoupling and are prone to 
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dramatic weight gain when challenging with the same high fat diet, however, 
displaying no defect on adipose differentiation (Barak et al., 2002; Wang et al, 2003). 
1.4 Objectives of the present study 
The recent development of PPARp (-/-) mice allows us to gain further insight the 
possible effects of PPARp deficiency in regulating adipocyte differentiation and lipid 
homeostasis (Peters et al., 2000). In the present study, the effect of PPARp 
deficiency on adipocyte differentiation was tested in vitro; and the physiological 
responses of PPARp (-/-) mice to diets that are capable of inducing obesity were 
examined in vivo. 
For the in vitro study, 
1. to prepare MEFs from PPARp (-/-) mice and its wild-type controls, 
2. to stimulate MEFs undergoing fat cell differentiation by the IB MX, DEX and 
insulin along with different PPARp and PPARy ligands, 
3. to observe any morphological difference between PPARp (+/+) and PPARp 
(-/-) MEFs by staining with Oil Red O, 
4. to measure cellular triglyceride level in PPARP (+/+) and PPARp (-/-) MEFs 
from all the treatment, 
5. to analyse the expression pattern of marker genes, acyl-CoA synthetase (ACS) 
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and GPDH, between PPARp (+/+) and PPARp (-/-) MEFs by reverse 
transcription-polymerase chain reaction (RT-PCR) and Northern blotting. 
For the in vivo study, 
1. to feed male and female PPARp (+/+) and PPARp (-/-) mice with low fat 
lard (10% kcal fat as lard), high fat lard (45% kcal fat as lard), low fat 
safflower oil (10% kcal fat as safflower oil) and high fat safflower oil (45% 
kcal fat as safflower oil) and regular chow diets for 5 months, 
2. to monitor body weight and food intake throughout the 5-month feeding, 
3. to examine the morphological differences in liver, white and brown adipose 
tissues by hematoxylin and eosin (H&E) staining, 
4. to measure serum cholesterol, triglyceride, glucose, insulin and leptin 
levels, 
5. to analyse fecal lipid content by extracting lipids and weighing their 
amount. 
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Chapter 2 
Role of PPARp in adipocyte 
differentiation - an in vitro study 
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Chapter 2.1 Introduction 
PPARp is suggested to be a mediator of adipocyte differentiation. It 
ubiquitously expressed with a higher level in lipid-metabolizing tissues, such as 
adipose tissue (Kliewer et al” 1994; Tontonoz et al., 1994; Amri et al., 1995). Fatty 
acids and fibrate drugs were originally identified as PPARp activators, although these 
compounds are non-specific (Kliewer et al., 1994; Yu et al, 1995; Brun et al., 1996; 
Forman et al., 1997; Krey et al” 1997). Selective agonists for PPARp, e.g. 
L-165041 (Berger et al., 1999)，were discovered in the past few years. PPARp is 
suggested to be a regulator of adipocyte differentiation. PPARp is induced in the 
early stage of adipocyte differentiation (Amri et al, 1995; Dani et al., 1997). 
Fibroblasts, which ectopically expressed PPARp, respond to long chain fatty acids or 
synthetic specific activator by induction of ALBP, FAT, GPDH mRNA (Amri et al., 
1995; Bastie et al., 1999; Bastie et al., 2000; Hansen et al., 2001), follow by a delayed 
activation of PPARy expression (Amri et al.’ 1995; Bastie et al” 1999). Exposure of 
these cells to a combination of PPARp and PPARy activators, e.g. 2-BrP and 
BRL49653 (also termed as rosiglitazone), could promote fat cell differentiation 
(Bastie et al., 1999). The effects of forced expression of wild-type or 
dominant-negative mutant PPARp on gene induction and adipose differentiation of 
preadipocytes have been studied (Bastie et al., 2000). The transactivation-deficient 
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form of PPARp mutant severely reduced long-chain fatty acid (LCFA) induction of 
the adipose related genes, e.g. ALBP, FAT, and PPARy, and decreased fatty acid 
effects on terminal differentiation. PPARp may control post-confluent cell 
proliferation in response to LCFAs (Jehl-Pietri et al., 2000). Ectopic expression of 
PPARp in fibroblasts caused the initiation of clonal expansion mitoses inducing by 
LCFAs. However, the exact role of PPARp on fat cell differentiation remains 
elusive, as there has been no genetic loss-of-function study on whether PPARp is 
essential for the fat cell differentiation. 
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Chapter 2.2 Materials and Methods 
2.2.1 Preparation of PPARP (+/+) and PPARP (-/-) MEFs 
MEFs were isolated from the mouse embryos of 13.5 days post coitus pregnant 
mouse of PPARp (-/-) and their wild-type counterparts, which are on a mixed 
C57BL/6 and SV/129 genetic background. They were the offspring of breeder mice 
obtained from the National Cancer Institute (National Institutes of Health, Bethesda, 
MD, USA) (Peters et al., 2000). MEFs were isolated according to the method 
modified from Hogan et al. (Hogan et al., 1994). 
2.2.1.1 Materials 
Dulbecco's phosphate-buffered saline (PBS), Dulbecco's modified Eagle's 
medium (DMEM)，trypsin, fetal bovine serum (FBS), pyruvate, penicillin and 
streptomycin were purchased from Invitrogen (Carlsbad, CA，USA). Tissue culture 
wares and pipettes were obtained from Coming (Coming, NY, USA), Falcon (Franklin 
Lakes, NJ, USA) or Iwaki (Tokyo, Japan). 
2.2.1.2 Methods 
2.2.1.2.1 Isolation of MEFs 
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Pregnant PPARp (+/+) and PPARp (-/-) mice were sacrificed at 13.5 days post 
coitus by cervical dislocation. The whole uterus including embryos was isolated from 
the mother carcass by pairs of sterile forceps and scissors. The uterus was washed 
with 10 ml of IX Dulbecco's PBS in a sterile 100 mm tissue culture dish twice, 
followed by placing in the culture dish containing 10 ml of DMEM only. Working 
under a primary culture hood (NuAire, Class II Type A/B3 biological safety cabinet, 
Plymouth, MN, USA), embryos were isolated from the uterus by a pair of sterile 
scissors and the embryonic sac of the embryos was removed. The heads and livers of 
embryos were cut and carcasses were washed with 5 ml of DMEM in a 60 mm tissue 
culture dish. After the DMEM solution was aspirated off, the carcasses were minced 
by another pair of sterile scissors and 5 ml of 0.05% trypsin was added to the minced 
carcasses. The whole contents in the culture dish were transferred into a sterile 50 ml 
Falcon tube containing 5 ml of 0.05% trypsin (Tube 1). The tube was incubated in a 
37°C water bath for 10 min and the tube was inverted several times during the 
incubation. Five milliliters of the incubated suspension was removed and inactivated 
by 5 ml of fresh standard growth medium (DMEM plus 10% FBS, 1 mM sodium 
pyruvate, 100 units/ml penicillin and 100 g/ml streptomycin) in a new sterile Falcon 
tube (Tube 2). Incubation of the minced carcasses was repeated by adding 5 ml of 
fresh 0.05% trypsin into the first incubation tube (Tube 1). Another 5 ml-aliquot of 
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the carcasses' suspension was pipetted into Tube 2 and the inactivated suspension was 
further diluted with 5 ml of fresh standard growth medium. The whole contents were 
then seeded onto a 150 cm^ tissue culture flask (approximately 4-6 embryos per flask) 
and incubated at 37�C with 5% CO2. 
2.2.1.2.2 Passage ofMEF culture 
About 4 days after seeding, MEF cells were splitted into a ratio of 1:5. The cells 
in the culture flask were washed with 10 ml of IX Dulbecco's PBS and then trypsinized 
with 4 ml of 0.05% trypsin at 37°C for 5 min. The trypsin was inactivated by the 
addition of 22 ml of fresh standard growth medium and the trypsinized MEFs were 
resuspended for at least 10 times by pipetting up and down. The cell suspension (5 ml 
per flask) was transferred into 5 new 150 cm^ tissue culture flasks and then further 
diluted with 15 ml of fresh standard growth medium for each flask. The MEF cultures 
were incubated at 3TC with 5% CO2. Passage of MEF cells was continued until 
enough MEF cells were obtained for studies. 
2.2.2 Genotyping of PPARp (+/+) and PPARp (-/-) MEFs 
As there are no external morphological differences between PPARp (+/+) and 
PPARp (-/-) MEFs, their genotypes were confirmed by polymerase chain reaction 
(PCR). In the PGR genotyping, a pair of primers was designed, which flanks the 
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Xba I site in exon 8 of the mouse PPARp gene and the PGR products amplified from 
the genomic DNA of PPARp (+/+) and PPARp (-/-) MEFs were analyzed by agarose 
gel electrophoresis. 
2.2.2.1 Materials 
Isopropanol and concentrated hydrochloric acid (HCl, 37%) were purchased 
from BDH (Poole, Dorset, England). The nucleotide mix dNTP (1:1:1:1) and 
proteinase K were obtained from Roche (Mannheim， Germany). 
Ethylenediaminetetraacetic acid (EDTA) was supplied from Riedel-de Haen (Seelze, 
Germany). DNA markers and gene-specific PCR primers were provided from 
Invitrogen (Carlsbad, CA, USA). Ethidium bromide (EB) and sodium dodecyl 
sulfate (SDS) were purchased from Sigma Aldrich (St. Louis, MO, USA). Agarose, 
boric acid, sodium chloride (NaCl) and Tris (hydroxymethyl)aminomethane (Tris) 
base were purchased from USB (Cleveland, OH, USA). Magnesium chloride 
(MgCli), Taq polymerase and PCR buffer were purchased from GenSys Limited 
(Camberley, Surrey, UK). 
2.2.2.2 Methods 
2.2.2.2.1 Primer design 
A 18-bp forward (FP4459, 5'-TGAATGTGCCCCAGGTAG-3') corresponding to 
the nucleotide numbers 4459-4476 of the published sequence of NCBI accession 
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number AJ420922 and a 18-bp reverse (RP4758, 5'-TGGCTGGTCCTCTGAACA-3') 
primers corresponding to the nucleotide numbers 4741-4758 of the published 
sequence of NCBI accession number AJ420922) were designed for the PCR 
genotyping using primer analysis software (OLIGO® version 6.55, Molecular Biology 
Insights, Casade, CO, USA). The pair of primers flanks the Xba I site of exon 8 of 
the mouse PPARp gene of PPARp (+/+) MEFs (Figure 2.1 and Appendix A). The 
expected size of PCR products of PPARp (+/+) MEFs is 300 bp. On the other hand, 
the exon 8 of PPARp (-/-) MEFs was disrupted by inserting a NEO cassette (1146 bp) 
into the Xba I site (Peters et al, 2000). Therefore, the expected size of PCR 
products amplified from PPARp (-/-) MEFs, including the neomycin (NEO) fragment, 
is about 1446 bp. 
2.2.2.2.2 Genomic DNA extraction 
Genomic DNA was extracted based on the protocols modified from Laird et al. 
(Laird et al, 1991). Complete lysis buffer was prepared by freshly dissolving 100 
|Lig/ml proteinase K in 100 mM Tris-HCl (pH 8.5), 5 mM EDTA (pH 8.0), 0.2% SDS 
and 200 mM NaCl. A flask (150 cm�）of MEFs, which would be proceeded to 
adipocyte differentiation, was incubated at 37°C overnight in 7 ml of complete lysis 
buffer. The lysate was mixed by pipetting up and down for 10 times, and then 
transferred into a 15 ml Falcon tube. Genomic DNA was precipitated by equal 










































































































































































































































































































































































































volume of isopropanol and tube was shaken laterally until a white mass of DNA 
thread was observed. DNA pellet was transferred into another sterile 1.5 ml tube and 
air-dried. The DNA mass was dissolved in 1 ml of TE buffer [10 mM Tris-HCl (pH 
7.5) and 0.1 mM EDTA (pH 7.5)] and incubated at 55®C for overnight. The next day, 
the DNA solution was resuspended until all solution viscosity had gone by adding 
more TE buffer. DNA sample was stored at 4°C until further use and its 
concentration was determined by measuring the optical density (OD) at wavelength of 
260 nm with a spectrophotometer (DU® 640, Beckman Coulter, Fullerton, CA, USA). 
2.2.2.2.3 PCR reaction 
The PCR reaction mixture (13 |LI1) was made of 0.2 mM dNTP mix, 0.2 \iM 
forward primer (FP4459), 0.2 |LIM reverse primer (RP4758), 0.05 Tag 
polymerase and 100 ng genomic DNA in IX PCR buffer containing 1.5 mM MgCl�. 
PCR was performed in a thermal cycler (GeneAmp® PCR system 9700, Applied 
Biosystems, Foster City, CA, USA) with the procedure included initial denaturation at 
94°C for 5 min，followed by 34 cycles of 94�C for 1 min, 62�C for 1 min [or 65�C for 
1 min for DNA samples from PPARp (-/-) MEFs] and 72°C for 1 min, incubated at 
72°C for 7 min and a hold at 4°C. The entire PCR products of PPARp (+/+) MEFs 
were electrophoresed on 2% agarose, 0.5X TBE gels with EB staining, while those of 
PPARp (-/-) MEFs were resolved on 1% agarose, 0.5X TBE gels with EB staining. 
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2.2.3 Western blotting of PPARP (+/+) and PPAR|3 (-/-) MEFs 
The genotypes of PPARp (+/+) and PPARp (-/-) MEFs were further confirmed 
by Western blot analysis. Nuclear extracts from PPARp (+/+) and PPARp (-/-) MEF 
cell lines were prepared and subjected to sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE). Polyclonal antibody was used to identify mouse 
PPARp on the membrane. 
2.2.3.1 Materials 
NE-PER® nuclear and cytoplasmic extraction reagents and BCA™ protein assay 
kit were purchased from Pierce (Rockford, IL, USA). Complete protease inhibitor 
cocktail, nitro blue tetrazolium chloride (NBT) and 
5-bromo-4chloro-3-indolyl-phosphate (BCIP) were obtained from Roche (Mannheim, 
Germany). B e n c h M a r k ™ pre-stained protein ladder was supplied from Invitrogen 
(Carlsbad, CA, USA). Acrylamide, N，N,-methylenebisacrylamide, ammonium 
persulphate (APS), SDS and N,N,N',N'- tetramethylethylenediamine (TEMED) were 
purchased from Sigma Aldrich (St Louis, MO, USA). Tris base, NaCl and glycine 
were obtained from USB Corporation (Cleveland, OH, USA). Concentrated HCl 
was supplied from BDH (Poole, Dorset, England). BioTrace丁乂 PVDF transfer 
membrane was purchased from Pall (East Hills, NY, USA). Polyclonal antibody to 
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mouse PPARP was obtained from ALEXIS® Biochemicals (San Diego, CA, USA). 
Alkaline phosphatase (AP) conjugated-goat anti-rabbit antibody was supplied from 
ZYMED® Laboratories (San Francisco, CA, USA). Methanol was purchased from 
Lab scan Asia Co. Ltd (Bangkok, Thailand). Non fat milk powder was obtained from 
Nestle Hong Kong Ltd. (Hong Kong, China). 
2.2.3.2 Methods 
2.2.3.2.1 Preparation of nuclear extracts 
The nuclear extracts from PPARp (+/+) and PPARp (-/-) MEF cell lines were 
prepared by NE-PER nuclear and cytoplasmic extraction reagents according to the 
manufacturer's instructions. Ice-cold cytoplasmic extraction reagent I (CER I) was 
added to the cell pellet in a 1.5 ml Eppendorf tube (100 |LI1 CER 1/20 mg cells). The 
cell pellet was fully resuspended by vortexing on the highest setting for 15 sec and 
then chilled on ice for 10 min. Ice-cold cytoplasmic reagent II (CER II) was added 
to the tube (5.5 CER 11/20 mg cells). The tube was vortexed for 5 sec on the 
highest setting and then incubated on ice for 1 min. The tube was vortexed again for 
5 sec vigorously and then centrifuged at 14,000 rpm, 4°C for 5 min. The supernatant 
(cytoplasmic extract) was transferred to a clean pre-chilled 1.5 ml Eppendorf tube 
immediately. The pellet, which contains nuclei, was resuspended in ice-cold nuclear 
extraction reagent (NER, 50 \i\ NER/20 mg cells). The tube was vortexed on the 
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highest setting for 15 sec and then returned on ice. The sample was continued 
vortexing for 15 sec every 10 min for a total of 40 min. The tube was centrifuged at 
14,000 rpm, 4®C for 10 min. The supernatant (nuclear extract) was transferred to a 
clean pre-chilled 1.5 ml Eppendorf tube immediately. All extracts were stored 
at -80°C until use. Protein concentration was measured by BCA™ protein assay kit 
according to the manufacturer's guidelines. 
2.2.3.2.2 Western blot 
About 80 1^1 of nuclear extract from each PPARp (+/+) and PPARp (-/-) MEFs 
was mixed with 20 i^l of 5X sample buffer. The mixtures were boiled for 10 min. 
The boiled samples and 15 \x\ of BenchMark^'^ pre-stained protein ladder were loaded 
into a SDS-PAGE gel. The stacking gel was made of 4% acrylamide, 125 mM 
Tris-HCl (pH 6.8), 0.1% SDS，0.05% APS and 0.1% TEMED, and the separating gel 
was made of 12% acrylamide, 375 mM Tris-HCl (pH 8.8), 0.1% SDS, 0.05% APS 
and 0.05% TEMED. The gel was electrophoresed at 60 V for 16 hr using a Hoefer 
SE 600 Ruby vertical electrophoresis unit (Amersham Pharmacia Biotech AB, San 
Francisco, CA, USA). Proteins were blotted onto a 0.45 i^m BioTrace™ PVDF 
transfer membrane in transfer buffer (25 mM Tris, 192 mM glycine and 20% 
methanol) at 70 V for 3 hr using a Transphor +4 cassettes and cooler system 
(Amersham Biosciences Corporation, Piscataway, NJ, USA). The membrane was 
- 3 2 -
incubated at IX blocking reagent (4% non fat milk powder) for 2 hr at room 
temperature with shaking. The blocked membrane was incubated at 4°C with 
primary antibody [polyclonal antibody to mouse PPARp IgG (H+L), 1:1000] in IX 
blocking reagent overnight with shaking. The membrane was washed with 
autoclaved deionized distilled water by 3 times and then incubated with secondary 
antibody [AP conjugated-goat anti-rabbit IgG (H+L), 1:2000] in IX blocking reagent 
at 4°C for 2 hr with shaking. After washing with autoclaved deionized distilled 
water by 3 times, the membrane was developed colorimetrically using NBT (100 
mg/ml) and BCIP (50 mg/ml) in 20 ml detection buffer [0.1 M Tris-HCl (pH 9.5) and 
0.1 M NaCl] and captured with a scanner. 
2.2.4 Induction of adipocyte differentiation of PPARP (+/+) and 
PPARP (-/-) MEFs 
The MEFs isolated from above were induced and converted into adipocytes 
when DEX, IBMX and insulin were added (Miki et al., 2001; Ge et al., 2002; 
Matsusue et al., 2004). In addition, PPARp and PPARy ligands were used, in which 
2-bromopalmitic acid (also named as 2-bromohexadecanoic acid, 2-BrP) (Amri et al” 
1995; Bastie et al., 1999; Bastie et al, 2000; Jehl-Pietri et al�2000; Hansen et al., 
2001) and troglitazone (Miles et al., 2003) were chosen, to stimulate PPARp and 
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PPARy activities, respectively. Six different lines each of PPARp (+/+) and PPARp 
(-/-) MEFs were cultured for studying the role of PPARp in adipoycte differentiation. 
2.2.4.1 Materials 
Dulbecco's PBS, DMEM, 0.05% trypsin, FBS, sodium pyruvate, penicillin and 
streptomycin were purchased from Invitrogen (Carlsbad, CA, USA). DEX，IB MX, 
insulin, dimethyl sulfoxide (DMSO), 2-BrP and troglitazone were obtained from 
Sigma Aldrich (St. Louis, MO, USA). 
2.2.4.2 Methods 
2.2.4.2.1 Seeding of MEFs 
The passage of MEFs used was within second to third passage. MEFs in a 150 
cm^ flask were rinsed with 10 ml of IX Dulbecco's PBS. MEFs were trypsinized by 
4 ml of 0.05% trypsin and incubated at 37°C until MEFs were detached from the wall 
of flask. The trypsin reaction was stopped by pipetting 9 ml of fresh standard 
growth medium into the cell suspension and the trypsinized suspension was 
resuspended for at least 10 times by pipetting up and down. The concentration of 
MEF suspension was determined in triplicate with a hemacytometer (Bright-Line™, 
Sigma, St. Louis, MO, USA) and calculated according to the manufacturer's 
instructions [Concentration of cells (cells/ml) 二 the average cell number x dilution 
factor X 104]. Cell suspension that was too concentrated for counting was further 
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diluted with more fresh standard growth medium until 100-150 cells were marked in 
one count. MEFs were seeded at a confluent density of 0.9-1.0 x 10^ cells per well 
of 6-well plates and then maintained in 3 ml of standard growth medium per well. 
For a 100-mm tissue culture dish, 7 x 10^ MEFs were seeded and cultured in 10 ml 
standard growth medium. All plates and dishes were incubated at 37°C with 5% 
CO2. 
2.2.4.2.2 Adipocyte differentiation 
Forty-eight hour post-confluent MEF cultures were stimulated with 3 ml of 
differentiation medium (standard growth medium containing 1 jiiM DEX, 0.5 mM 
IBMX, and 5 |Lig/ml of insulin) in each well, or 10 ml for each 100-mm tissue culture 
dish. 2-BrP (30 )aM) and troglitazone (10 i^M) were also added according to their 
corresponding groups. As stock solutions of 2-BrP (120 mM) and troglitazone (40 
mM) were prepared in DMSO, MEFs receiving equal volume of DMSO were used as 
controls. Each MEF cell line was divided into 4 treatment groups: DMSO (control), 
troglitazone, 2-BrP and troglitazone plus 2-BrP and triplicate wells were preformed 
for each treatment. The day of induction was regarded as Day 0. On Day 3，the 
differentiation medium was completely replaced by similar volume of maintenance 
medium (standard growth medium with 5 jag/ml of insulin，with or without PPAR 
ligands for the corresponding groups). Care was taken to avoid bursting or floating 
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of differentiated adipocytes. The maintenance medium was renewed on Day 6 and 
Day 8. Half of the medium was aspirated off and replaced by 1.5 ml of fresh 
maintenance medium per well of 6-well plate (or 5 ml per 100-mm dish). If the 
colour of culture medium was yellowish-orange or intense yellow, more than half of 
the medium was removed and replenished with more fresh maintenance medium. 
The differentiation of MEFs was terminated on Days 9-11 and the differentiated 
adipocytes were subjected to morphological examination by Oil Red O staining, 
biochemical measurement of triglyceride/protein levels and RNA extraction for 
RT-PCR and Northern blot analysis for adipocyte differentiation marker genes. 
2.2.5 Oil Red O staining of differentiated PPARP (+/+) and PPARp 
(-/-) MEFs 
The morphological differences between differentiated PPARp (+/+) and PPARp 
(-/-) MEFs among all treatment groups were examined by staining the neutral lipids 
inside the adipocytes with Oil Red O. 
2.2.5.1 Materials 
Oil Red O was purchased from Sigma Aldrich (St. Louis, MO, USA). 
Isopropanol was purchased from BDH (Poole, Dorset, UK). Formaldehyde (37%) 
was purchased from Riedel-de Haen (Seelze, Hannover, Germany). Whatman® no. 1 
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filter paper was purchased from Whatman® (Brantford, Middlesex, UK). 
2.2.5.2 Method 
2.2.5.2.1 Oil Red O staining 
Oil Red O working solution was freshly prepared by diluting the stock solution 
(0.5 g of Oil Red O in 100 ml of isopropanol) with water in a ratio of 6:4 and filtered 
through a Whatman no. 1 filter paper (Hansen et al., 1999; Miki et al., 2001). On 
Days 10-11 after induction, all of the culture medium was aspirated off slowly to 
avoid floating of adipocytes and the cells in each well of 6-well plates were washed 
with 3 ml of IX PBS, whereas 15 ml was used for the 100-mm dish. After removal 
of PBS, MEFs were fixed with similar volume of 3.7% formaldehyde (10% formalin) 
for 1 hr at room temperature. Fixed cells were rinsed with IX PBS, followed by 
staining with 1 ml of Oil Red O working solution in each well (or 5 ml of staining 
solution in 100-mm dish) for 1 hr at room temperature. After staining, cells were 
washed with IX PBS extensively three times and the stained cells were photographed 
under a microscope (Leica, Wetzler, Germany) with a digital camera attachment 
(DlOO Nikon™, USA) at 20X magnification. 
2.2.6 Determination of triglyceride-protein levels in differentiated 
PPARP (+/+) and PPARP (-/-) MEFs 
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The degree of adipocyte differentiation between PPARp (+/+) and PPARp (-/-) 
MEFs of all treatment groups wase compared by measuring their intracellular 
triglyceride contents. The triglyceride level of MEFs was determined based on a 
modification of the enzymatic method described by Bucolo and David (Bucolo and 
David, 1973), and Fossati and Prencipe (Fossati and Prencipe, 1982). Triglyceride 
in cell lysate is first hydrolyzed by lipase into glycerol and fatty acids. The glycerol 
is phosphorylated by adenosine triphosphate (ATP) into glycerol-3-phosphate, which 
is catalyzed by glycerolkinase. Glycerol-3-phosphate is then oxidized by 
glycerol-3 -phosphate oxidase to produce hydrogen peroxide (H2O2). Finally, H2O2 
is coupled with 4-aminoantipyrine and 4-chlorophenol in the presence of peroxidase 
to generate quinoneimine, which is a colored complex that can be measured at the 
wavelength of 500 nm. The intensity of the color is directly proportional to the 
triglyceride concentration in the sample. The intracellular triglyceride level of each 
sample is normalized with the number of cells in term of the protein concentration. 
The protein concentration of the same homogenate solution was determined by the 
method described by Smith and his colleagues in 1985 (Smith et al., 1985). The 
assay depends on bicinchoninic acid (BCA) to form color product and quantify total 
protein. Protein in the cell lysate reduces the copper (II) ion (Cu^^) into copper (I) 
ion (CV.) in an alkaline medium. The Cu'^ ion chelates with 2 molecules of BCA 
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selectively and sensitively to form purple-colored product. This water-soluble 
complex exhibits a strong absorbance at 562 nm that is nearly linear with increasing 
protein concentration. 
2.2.6.1 Materials 
Tris base and NaCl were obtained from USB Corporation (Cleveland, OH, USA). 
Concentrated HCl (37%) was supplied from BDH (Poole, Dorset, England). Triton 
X-100 was purchased from Sigma Aldrich (St. Louis, MO, USA). Triglyceride 
determination enzyme kit was obtained from BioSystems, S.A. (Barcelona, Spain). 
BCA™ protein assay kit was supplied from Pierce (Rockford, IL, USA). Plastic 
curvets were purchased from Sarstedt (Ntimbrecht, Germany). 
2.2.6.2 Methods 
2.2.6.2.1 Lysis of differentiated MEFs 
On Day 10 after induction, differentiated PPARp (+/+) and PPARp (-/-) MEFs 
from each well were washed gently with 1 ml of IX PBS twice. Five hundred 
microliters of lysis buffer [150 mM NaCl, 10 mM Tris-HCl (pH 8.0) and 0.1% Triton 
X-100 in IX PBS] was added to each well of the 6-well plates and the plates were 
shaken until cells were detached. The entire content of the well was transferred into 
a 2 ml Eppendorf tube. The cell lysate was homogenized with a tissue tearor 
(Dremel®, BioSpec Products, Racine, WI, USA) and then centrifUged at 14,000 rpm 
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for 15 min at room temperature. The supernatant was collected in a 1.5 ml 
Eppendorf tube and then frozen at -80 °C until use. 
2.2.6.2.2 Measurement of triglyceride levels in cell lysate 
The triglyceride content of MEF lysate was measured by using the BioSystems 
triglyceride kit. The original triglyceride standard that is equivalent to 2000 j^g/ml 
of triolein was diluted to a final concentration of 80 |Lig/ml with lysis buffer. A 
125-)al aliquot of the supernatant from each sample or the diluted standard was mixed 
with 500 jil of the reagent from the kit in a 1.5 ml Eppendorf tube. Triplicate 
measurements were done for each of the samples or the diluted standard. A blank 
containing 500 |LI1 of the reagent only was used as a baseline control. The tubes were 
incubated in a 37°C water bath for 5 min and then allowed to cool to room 
temperature. The entire content was vortexed and transferred into a 1 ml plastic 
curvet. The absorbance of each sample or standard against that of the blank was 
measured at 500 nm with a spectrophotometer (DU® 640，Beckman Coulter, Fullerton, 
California, USA). The triglyceride levels in each sample was calculated according 
to the manufacturer's instructions as following, 
Triglyceride concentration of sample (|Lig/ml) = (OD500 nm of sample / OD500 nm of the 
diluted standard) x triglyceride concentration of the diluted standard (jag/ml) 
-40 -
2.2.6.2.3 Measurement of protein concentent in cell lysate 
The protein concentration of the MEF supernatant was measured with a BCA™ 
protein assay kit. Serial dilutions (1500, 1000，750, 500，250, 125 and 25 |Lig/ml) of 
the bovine serum albumin (BSA) standards were prepared by diluting the BSA stock 
concentration (2 mg/ml) from the kit with lysis buffer. Forty microliters of the 
sample lysate was diluted 5-fold with 160 of lysis buffer. The BCA working 
reagent (WR) was made up of 50 parts of BCA Reagent A from the kit and 1 part of 
BCA Reagent B. The WR was mixed thoroughly until a clear green solution was 
seen. A 25-jal aliquot of each diluted sample or standard was mixed with 500 jul of 
WR in a 1.5 ml Eppendorf tube by vortexing and triplicate determinations were 
performed for each sample and standard. The tubes were incubated in a 37°C water 
bath for 30 min and cooled to room temperature. The entire content was mixed and 
poured into a 1 ml plastic curvet. A BSA standard curve was plotted by measuring 
the absorbance at 562 nm against the concentrations of BSA standards. The protein 
concentration of each diluted sample was determined by measuring their absorbances 
at 562 nm. 
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2.2.7 Preparation of PPAR|3 (+/+) and PPARP (-/-) MEF RNA for 
RT-PCR and Northern blot analysis 
RNA samples from the differentiated PPARp (+/+) and PPARp (-/-) MEFs of all 
treatment groups were isolated by TRIzol® reagentand used for RT-PCR and Northern 
blot analyses. The TRIzol® reagent is a mono-phasic solution of phenol and 
guanidine isothiocyanate, which disrupts the cells and dissolves the cell components, 
while the integrity of the RNA is unaffected. 
2.2.7.1 Materials 
TRIzol® reagent were purchased from Invitrogen (Carlsbad, CA, USA). 
Chloroform was obtained from Merck & Co, Inc (Whitehouse Station, NJ, USA). 
Ethanol and isopropanol were supplied from BDH (Poole, Dorset, England). 
Formamide was purchased from USB Corporation (Cleveland, OH, USA). 
2.2.7.2 Method 
2.2.7.2.1 RNA isolation 
On Day 9 or Day 10 after induction, MEFs were washed with 1 ml of IX PBS 
twice for each well of 6-well plates and 500 \x\ of TRIzol® reagent was added to each 
well. For the 100-mm tissue culture dish, the MEF cells were washed with 5 ml of 
IX PBS twice and then followed by 2 ml of TRIzol® reagent. The plates or dishes 
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were shaken until the whole cell cake detached. The entire content in the well or 
dish was transferred into new sterile 2 ml Eppendorf tubes, and then homogenized 
with a tissue tearor (Dremel®, BioSpec Products, Racine, WI, USA) at room 
temperature for 30 sec twice. In addition, RNA was also extracted from a 150 cm^ 
tissue culture flask of untreated MEFs to confirm their genotypes by Northern blotting. 
After washing the flask with 10 ml of IX PBS, 6 ml of TRIzol® reagent was added to 
the flask and cells were lysed by resuspending the lysate up and down until the 
solution viscosity had gone. The cell lysate was transferred into sterile 2 ml 
Eppendorf tubes in 0.5 or 1 ml aliquots. One hundred microliters of chloroform was 
added per 500 |LI1 of the cell lysate and the mixture was vortexed thoroughly. The 
tubes were allowed to stand at room temperature for 10 min, and then centrifuged at 
14,000 rpm at 4°C for 20 min. After centrifugation, the aqueous (colorless) phase 
containing RNA was pipetted into new sterile 1.5 ml Eppendorf tubes and mixed with 
equal volume of isopropanol for precipitating RNA. The mixture was vortexed 
vigorously and incubated at room temperature for another 10 min. The samples 
were then centrifuged at 14,000 rpm at 4°C for 20 min and the supernatant was 
discarded. The RNA pellet was washed with 1 ml of 70% ethanol followed by 
centrifuging at 14,000 rpm at 4°C for 20 min and the washing steps were repeated 
twice. The RNA pellet was air-dried and dissolved in 100% form amide at 4°C 
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overnight. The concentration of RNA solution was measured at 260 nm with a 
spectrophotometer (DU® 640, Beckman Coulter, Fullerton, CA, USA). 
2.2.8 RT-PCR analysis of differentiated PPARP (+/+) and PPARP (-/-) 
MEFs 
In order to support the morphological appearance of these PPARp (+/+) and 
PPARp (-/-) adipocytes with the pattern of gene expression, mRNA was isolated at 10 
days post-confluence induction and subjected to RT-PCR. Four each of 
differentiated PPARp (+/+) and PPARp (-/-) MEF cell lines were used. By 
performing RT-PCR, the differences in the expression of adipocyte differentiation 
maker genes were compared between PPARp (+/+) and PPARp (-/-) MEFs. The 
effect of PPARp deficiency on terminating fat cell conversion was investigated by 
examining the expression of ACS and GPDH, in which these gene are responsible for 
triacylglycerol synthesis and act as the indicators of terminal adipocyte differentiation 
(Amri et al., 1994). The housekeeping gene, P-actin, was used for normalization of 
the mRNA expression. Respective cDNA sequences of mouse long-chain ACS, 
GPDH and P-actin were amplified with the primers designed by OLIGO® primer 
analysis software. The expected sizes of PCR products for ACS, GPDH and P-actin 
were 1791，942 and 852 bp, respectively. 
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2.2.8.1 Materials 
Agarose, formamide, Tris base and boric acid were purchased from USB 
Corporation (Cleveland, OH, USA). Nuclease-free (NF) water was obtained from 
Promega (Madison, WI, USA). Oligo dT (15) primer, Dithiothreitol (DTT), 
Superscript™ II Rnase H" reverse transcriptase, strand buffer and gene-specific 
primers were supplied from Invitrogen (Carlsbad, CA, USA). dNTP mix (1:1:1:1) 
was purchased from Roche (Mannheim, Germany). MgCl�，PCR buffer and Taq 
Polymerase were obtained from GeneSys Limited (Camberley, Surrey, UK). EDTA 
was supplied from Riedel-de Haen (Seelze, Hannover, Germany). EB was 
purchased from Sigma Aldrich (St. Louis, MO, USA). 
2.2.8.2 Methods 
2.2.8.2.1 Primer design 
The cDNA sequences of adipocyte differentiation marker genes were amplified 
by using the following pairs of primers designed by OLIGO® primer analysis 
software (version 6.55, Molecular Biology Insights Inc, Cascade, CO, USA). The 
primers for ACS were a 18-bp forward (ACS_FP378, 
5 '-GGGGGATTC AGGTGTCAA-3') and a 19-bp reverse (ACS-RP2168, 
5'-TGGCGTACAGTTCATCTAT-3') primers corresponding to the nucleotide 
numbers from 517-2307 of the published sequence of NCBI accession number 
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NM_007981. The primers for GPDH were a 18-bp forward (GPDH-FP16, 
5 ‘ - ATGGCTGGC AAGAAAGTC-3') and a 18-bp reverse (GPDH_RP957, 
5 ‘-GCCCTTGTGTTGGAGAAT-3 ‘) primers corresponding to the nucleotide numbers 
from 16-957 of the published sequence of NCBI accession number NM_010271. 
The primers for P-actin were a 18-bp forward (BETA-ACTIN-FP2, 
5'-CCCAGAGCAAGAGAGGTA-3') and a 18-bp reverse (BETA-ACTIN-RP2, 
5'-CCGATCCACACAGAGTAC-3') primers corresponding to the nucleotide 
numbers from 253-1105 of the published sequence of NCBI accession number 
NM—007393. The expected sizes of PGR products for ACS, GPDH and p-actin were 
1791, 942 and 852 bp, respectively. The locations of primers on the respective gene 
sequences were shown in Appendix B. 
2.2.8.2.2 RT-PCR 
RNA sample (0.4 )ag) was denatured at 65°C for 5 min and the RT reaction was 
carried out by mixing denatured RNA with NF water in a final volume of 20 i^l 
mixture containing 0.5 mM Oligo dT (15) primer, 0.5 mM dNTP mix, 10 mM DTT, 
10 U/|al S u p e r s c r i p t ™ n RNase H' reverse transcriptase and IX strand buffer. RT 
was performed in a thermal cycler (GeneAmp® PCR system 9700, Applied 
Biosystems, Foster City, CA, USA) with the PCR profile as: 42°C for 50 min; 70°C 
for 15 min and hold at 4°C. Two microliters of the cDNA products from the above 
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reverse transcription were expanded in a mixture (25 |LI1 in total) of 0.2 jiM forward 
and 0.2 [iM reverse primers of the respective gene, 0.2 mM dNTP mix, 1.5 mM 
MgClz and 0.1 U / | L I 1 of Tag polymerase in IX PCR buffer at 94°C for 2 min followed 
by 30 cycles at 94�C for 1 min, 58�C for 30 sec, 72°C for 90 sec; 72�C for 7 min; and 
hold at 4°C. The entire RT-PCR products were electrophoresed through 0.8% or 
1.0% agarose, 0.5X TBE gels with EB staining. 
2.2.9 Northern blot analysis of differentiated PPARP (+/+) and 
PPARP (-/-) MEFs 
In addition to the RT-PCR, the expression of adipocyte differentiation marker 
genes in differentiated PPARp (+/+) and PPARp (-/-) MEFs were anaylzed by 
Northern blot analysis. Two each of the differentiated PPARp (+/+) and PPARp (-/-) 
MEF cell lines were used in the Northern blot analysis. The cDNAs of mouse ACS, 
GPDH, glyceraldehydes-3-phosphate dehydrogenase (GAPDH) and P-actin were 
amplified by RT-PCR and subcloned into TOPO TA vector. In addition, the partial 
cDNA of PPARP was amplified by RT-PCR and subcloned into pDIRECT vector for 
confirming the genotypes of MEF cell lines by Northern blotting. The cDNAs were 
digoxigenin (DIG)-labeled and used as probes for Northern blot analyses. 
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2.2.9.1 Materials 
TRIzol® reagent, TOPO TA cloning kit, phenol: chloroform: isoamyl alcohol 
(25:24:1) and gene-specific primers were purchased from Invitrogen (Carlsbad, CA, 
USA). Trypton peptone, yeast extract and bacto agar were obtained from Becton 
Dickinson (Sparks, MD, USA). Ampicillin, EB, maleic acid and sodium citrate 
were supplied from Sigma Aldrich (St. Louis, MO, USA). Agarose, 
5-bromo-4-chloro-3-indolyl-D-thiogalactoside (X-gal), 3 -(N-morpholino)propane-
sulfonic acid (MOPS), Tris base, boric acid, formamide, NF water and NaCl were 
purchased from USB Corporation (Cleveland, OH, USA). DIG-labeled RNA 
molecular weight marker I (0.39-6.9 kb), DIG Easy Hyb, Tween 20, block reagent, 
anti-DIG-AP antibody, PCR-DIG labeling mix, NET and BCIP were obtained from 
Roche (Mannheim, Germany). PCR buffer, MgCh and Taq polymerase were 
supplied from GeneSys Limited (Camberley, Surrey, UK). Formaldehyde (37%) and 
EDTA were purchased from Riedel-de Haen (Seelze, Hannover, Germany). 
Biodyne® IST nylon membrane was obtained from Pall (East Hills, NY, USA). Gel 
blotting paper was supplied from Schleicher & Schuell (Dassel, Germany). Three 
MM filter paper was purchased from Whatman® (Brantford, Middlesex, UK). 
Kapak SealPAK pouches were obtained form KAPAK® (Minneapolis, MN, USA). 
Restriction enzymes and their buffers were supplied from New England Biolabs 
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(Herts, UK). QIAGEN® Spin Miniprep kit was purchased from QIAGEN® (Hilden, 
Germany). 
2.2.9.2 Methods 
2.2.9.2.1 Preparation of cDNA probes for Northern blot analysis 
2.2.9.2.1.1 RNA extraction 
Total RNA was extracted from the epididymal white fat (WF) pads of a 2 
month-old male C57BL/6 mouse by TRIzol® reagent. Frozen WF samples were 
mixed with TRIzol® reagent (10 ml/g) and homogenized with a tissue tearor (Dremel®, 
Bio Spec Products, Racine, WI, USA). The homogenate was allowed to stand for 5 
min and then transferred into new 2 ml Eppendorf tubes as 1 ml aliquots. The other 
steps of RNA isolation were the same as described in section 2.2.7.2.1. 
2.2.9.2.1.2 Primer design 
The primers for preparing the cDNA probes of ACS and GPDH were the same as 
those used in RT-PCR (section 2.2.7.2.1), while the primers for GAPDH and P-actin 
were designed using OLIGO® primer analysis software (version 6.55, Molecular 
Biology Insights, Casade, CO, USA). The pair of primers for GAPDH were a 22-bp 
forward (GAPDH-FP191, 5'-TCCACTCACGGCAAATTCAACG-3') and a 20-bp 
reverse (GAPDH-RP1017, 5 '-TCCACCACCCTGTTGCTGTA-3') primers 
corresponding to the nucleotide numbers from 175-1001 of the published sequence of 
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NCBI accession number BC093508. The primers for p-actin include a 18-bp 
forward (BETA-ACTIN-FP2, 5,-CCCAGAGCAAGAGAGGTA-3,) and a 18-bp 
reverse (BETA-ACTIN-RP1, 5 ,-GGCCGGACTC ATCGTACT-3,) primers 
corresponding to nucleotide numbers from 253-1179 of the published sequence of 
NCBI accession number NM—007393. The expected sizes of PCR products for 
GAPDH and p-actin were 827 and 927 bp, respectively. The locations of primers on 
the corresponding gene sequences were shown in Appendix B. 
2.2.9.2.1.3 RT-PCR of extracted mRNA 
RT-PCR was performed as described in section 2.2.8.2.2，in which 5 jig of RNA 
extracted from adipose tissue from above was used for one reaction. 
2.2.9.2.1.4 Subcloning of amplified cDNA products 
Subcloning of amplified cDNA fragments was performed by TOPO TA cloning 
kit. Three microliters of amplified cDNA products from above were ligated into 
0.33 ng/|il of pCR®II-TOPO® vector in 0.2 M NaCl and 10 mM MgCl�. The 
mixture was then incubated at room temperature for 30 min. The entire ligation 
products (6 |al) were transformed into 100 i^l of TOP 10 Escherichia coli {E. coli) 
competent cells by the following steps: chilled on ice for 30 min, heat shocked in 
42°C water bath for 90 sec and chilled on ice for 2 min. The mixture was diluted to 
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1 ml by Luria-Bertani (LB) medium and then incubated at 37°C for 1 hr. The culture 
was centrifuged at 2500 rpm at 4®C for 8 min. Nine hundred microliters of 
supernatant was discarded and the cell pellet was resuspended in 100 jiil of the 
remaining LB medium. The transformed cells were spreaded onto LB agar plates 
containing 100 |Lig/ml ampicillin and 40 jLil of 40 mg/ml X-gal. The plate was 
cultured in a 3TC incubator for 16 hr. 
In addition, partial PPARp cDNA fragment was subcloned into the pDIRECT 
vector and transformed into E.coli as described previously (Peters et al., 2000). The 
length of the PPARp insert is 900 bp, which corresponds to nucleotide numbers 
140-1039 of the published sequence of NCBI accession number L28116. The insert 
sequence was listed in Appendix C. 
2.2.9.2.1.5 Screening of recombinant clones by phenol-chloroform extraction 
As a first step to screen for positive recombinant clones, each single colony was 
incubated in 3 ml of fresh LB medium containing 100 jug/ml ampicillin at 37°C for 16 
hr with shaking. Thirty microliters of bacterial culture were mixed with equal 
volume of phenol: chloroform: isoamyl alcohol (25:24:1) for extracting the plasmid 
DNA. The mixture was vortexed vigorously and then centrifuged at 14,000 rpm for 
1 min. The supernatant (16 i^l) was resolved on 0.6% agarose, 0.5X TBE gels with 
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EB staining. After agarose gel electrophoresis, the positive recombinant clones were 
identified by comparing their sizes to that of the pCR®II-TOPO® vector alone. 
2.2.9.2.1.6 Confirmation of the recombinant clones by restriction enzyme 
mapping 
After preliminary screening for the recombinant clones that showed positive 
results in the phenol-chloroform extraction, the positive recombinant clones were 
subjected to restriction enzyme digestion for confirming their insert sizes and 
orientations. A 1-ml aliquot of overnight bacterial culture was centrifuged at 14,000 
rpm for 1 min twice. The supernatant was discarded. The cell pellet was 
resuspended in 17 pi of autoclaved distilled water containing 250 |Lig/ml of RNase A. 
The bacterial suspension was boiled for 1 min in order to extract DNA and then 
centrifuged at 14,000 rpm for 1 min. Ten microliters of supernatant, which 
containing the recombinant DNA, were digested with 1 of different restriction 
enzymes. The restriction enzyme digest was resolved on 1% or 2% agarose, 0.5X 
TBE gels with EB staining. 
2.2.9.2.1.7 Confirmation of the recombinant clones by PCR method 
Recombinant clones were further confirmed by PCR. A 20-|LI1 aliquot of the 
overnight culture was centrifuged at 14,000 rpm for 1 min. Ten microliters of 
supernatant were discarded and the bacterial pellet was resuspended in the remaining 
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culture. The resuspended culture (2 |al) was added to IX PCR buffer containing 0.2 
| L I M forward primer, 0.2 | L I M reverse primer, 0.2 mM dNTP mix ( 1 : 1 : 1 : 1 ) and 0 . 1 U / | L I 1 
Taq polymerase. The pair of primers used for checking the clones of PPARp were 
full-length T7 promoter 22-mer forward (5'-GTAATACGACTCACTATAGGGC-3') 
and full-length Ml 3 reverse (-48) 24-mer 
(5'-AGCGGATAACAATTTCACACAGGA-3') primers which amplified the PCR 
products with the expected size of 1140 bp. The PCR was performed with 
denaturing temperature at 94°C for 2 min, followed by 20 cycles of 94°C for 1 min, 
58®C for 30 sec, 72°C for 90 sec, and a hold at finally. The PCR products were 
then resolved on 0.8%, 1% or 2% agarose, 0.5X TBE gels with EB staining. For 
accurate identification of the correct insert, the corresponding reamplifled PCR 
products from the RT-PCR above were also included on the agarose gel as a size 
standard. 
Alternatively, the PCR screening was also carried out on single colony. A 
single clone was picked with a toothpick and then streaked onto a new LB agar plate 
containing 100 ^g/ml ampicillin as master plate. The bacterial culture remained on 
the toothpick was dipped into the PCR core mix as mentioned above and subjected to 
PCR reaction. 
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2.2.9.2.1.8 Mini-preparation of plasmid DNA from the selected recombinant 
clones 
The plasmid DNA from the confirmed, positive recombinant clones was 
prepared using QIAGEN® Spin Miniprep kit according to the manufacturer's 
guidelines. Ten milliliters of bacterial culture were centrifliged at 2,500 rpm at 4°C 
for 10 min. The supernatant was discarded and cell pellet was resuspended in 250 /xl 
of buffer PI containing 100 [ig/m\ RNase A. The resuspended cells were then mixed 
with 250 jLtl of buffer P2 by inverting several times. The mixture was incubated at 
room temperature for about 5 min. Three hundred and fifty microliters of buffer P3 
were added to the mixture and mixed by inverting several times. The mixture was 
centrifuged at 14,000 rpm at room temperature for 15 min. The supernatant was 
transferred to QIAprep spin columns in 2 ml collection tubes and centrifuged at 
14,000 rpm for 1 min. The flow-through was discarded and the columns were 
washed with 750 fil buffer PE. The columns were transferred to new 1.5 ml 
Eppendorf tubes. The plasmid DNA was eluted by adding 50 /xl of NF water and 
centrifuged at 14,000 rpm at room temperature for 1 min twice. The samples were 
diluted to 6 \x\ with sterile water and stored at 4°C. 
2.2.9.2.1.9 Preparation of cDNA probes 
The recombinant plasmid DNA extracted from above was used as the template 
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and the corresponding cDNA was amplified by PCR in the presence of DIG-dUTP to 
generate the DIG-labeled probe. Two nanograms of plasmid DNA were mixed in IX 
PCR buffer with 200 |aM PCR DIG labeling mix (1:1:1:1), 1 |LIM forward primer, 1 
jiM reverse primer, 1.5 mM MgCb and 0.04 U/|LI1 of Taq polymerase. A control 
PCR reaction was set simultaneously using non-labled dNTP mix instead of PCR DIG 
labeling mix. PCR was run in the thermal cycler (GeneAmp® PCR system 9700， 
Applied Biosystems, Foster City, CA, USA) starting at 95°C for 7 min, followed by 
30 cycles at 95°C for 45 sec, 60°C for 1 min, 72°C for 2 min, 72°C for 7 min and hold 
at 4°C. One microliter of PCR-DIG labeled cDNA probes was resolved on 1% or 
2% agarose, 0.5X TBE gels with EB staining. The DIG-labeled probe showed a 
shift up in size when comparing to that of their corresponding non DIG-labeled PCR 
products. The DIG-labeled probe was stored at -20°C or used immediately. 
2.2.9.2.1.10 Formaldehyde-agarose gel electrophoresis of RNA 
Twenty micrograms of RNA samples and 10 /xl DIG-labeled RNA molecular 
weight marker I (100 ng) were mixed with 2 pX of lOX MOPS, 3 jitl of 37% 
formaldehyde, 2 "1 loading dye and 5 "1 NF water. RNA samples were then 
denatured by heating at 68°C for 15 min and then chilled on ice for 10 min 
immediately. RNA samples were then separated on a 1% formaldehyde-agarose gel 
in IX MOPS buffer at 30 V for about 15 hr. The RNA gel was post-stained with 0.5 
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|Ag/|Lil EB for 1 hr and washed with distilled water for 20 min 3 times. After taking 
photos, RNA gel was washed in lOX SSC [3 M sodium chloride and 0.3 M sodium 
citrate (pH 7.0)] for 45 min with gently shaking. The gel was then transferred to a 
N+ nylon membrane in lOX SSC buffer by upward capillary action for 24 hr. Then 
the membrane was washed in 5X SSC for 10 min, air-dried and then baked at 80®C 
for 2 hr for fixing the RNA onto the membrane. 
2.2.9.2.1.11 Hybridization and color development 
The membrane was pre-hybridized in 20 ml of DIG Easy Hyb buffer at 42 °C for 
2 hr. The PCR DIG-labeled probe was first denatured by boiling for 10 min and then 
chilled on ice immediately. The denatured probe was mixed with the pre-hybridized 
buffer and then added to the membrane. The membrane was hybridized at 42°C for 
overnight. The hybridized membrane was washed in 2X SSC and 0.1% SDS at 
room temperature for 10 min twice, followed by washing in 0.5X SSC and 0.1% SDS 
at 68°C for 10 min twice. The membrane was further washed in washing buffer 
[0.3% Tween 20 in maleic acid buffer (pH 7.5)] for 5 min and then incubated in IX 
blocking solution in maleic acid buffer at pH 7.5 for 1 hr. Afterwards, the membrane 
was incubated in anti-DIG-AP antibody at a final concentration of 0.075 U/ml in IX 
blocking solution for the next 1 hr. The membrane was washed in washing buffer 
for 10 min twice and then equilibrated in detection buffer [0.1 M Tris-HCl (pH 9.5) 
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and 0.1 M NaCl] for 5 min. The membrane was allowed to develop color in 25 ml 
of detection buffer containing NBT (100 mg/ml) and BCIP (50 mg/ml). Color 
development was terminated with autoclaved distilled water. The membrane image 
was captured with a scanner. 
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Chapter 2.3 Results 
2.3.1 Confirmation of PPARP (+/+) and PPARP (-/-) MEF genotypes 
As there was no obvious morphological difference between the wild-type PPARp 
(+/+) and PPARP (-/-) fibroblasts, genomic DNA and RNA were extracted from cells 
and subjected to PCR-genotyping and Northern blot analysis. In Figure 2.2, the 
genotypes of both PPARp (+/+) and PPARp (-/-) fibroblast cell lines were confirmed 
by PCR method. The sizes of PCR product amplified in PPARp (+/+) and PPARp 
(-/-) MEFs were about 300 and 1446 bp, respectively, which matched with the 
expected sizes. Northern blot analysis demonstrated that PPARp mRNA was 
expressed in wild-type fibroblasts, but was not detectable in PPARp (-/-) fibroblasts 
(Figure 2.3). However, a larger mRNA fragment was detected in PPARP (-/-) MEF 
cell lines and the increase in size of the mRNA transcript appeared due to the insertion 
of the Neo DNA fragment. These results indicate that PPARp (-/-) fibroblasts do not 
express normal PPARp mRNA transcripts. 
In addition, the expression levels of PPARp protein in PPARp (+/+) and PPARp 
(-/-) MEFs were analyzed by Western blot. The expected size of PPARp protein is 
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Figure 2.3. Confirmation of PPARP (+/+) and PPARP (-/-) MEF genotypes by 
Northern blot analysis. Twenty micrograms of RNA from untreated PPARp (+/+) 
(n=6) and PPARp (-/-) (n=6) MEFs were separated on a 1.0% agarose-fomialdehyde 
gel and transferred to a N+ nylon membrane. The partial PPARP cDNA fragment 
(-900 bp) was DIG-labeled and used as a probe for hybridization. The signal was 
detected by colorimetric method using reagents NBT and BCIP. Ethidium bromide 
stained RNA gel was used for normalization. M, DIG-labeled RNA molecular 
weiaht marker 1. 
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corresponds to the target PPARp receptor protein (Appendix D). The decision that 
PPARp (-/-) fibroblasts do not produce a normal PPARp protein could not be 
concluded. 
2.3.2 PPARP (-/-) MEFs differentiated similarly to PPARP (+/+) MEF 
as measured by Oil Red O staining 
As a first step to assess whether PPARp receptor is required in adipocyte 
differentiation in vitro, PPARp (+/+) and PPARp (-/-) MEFs were treated with the 
standard MDI inducers and the amount of lipid accumulated in their differentiated 
adipocytes were examined with the Oil Red O staining. Our results inducated that 
PPARp (-/-) MEFs were differentiated similarly as the wild-type MEF cells in all 
treatment combinations (Figures 2.4.1 and 2.4.2). Lipid droplets were observed in 
both PPARP (+/+) and PPARp (-/-) MEFs exposed to DMSO (control). In the 
presence of troglitazone, more adipocytes were differentiated as reflected by the 
increase in lipid staining in both PPARp (+/+) and PPARp (-/-) MEFs. Omission of 
this PPARy ligand compromised adipocyte differentiation dramatically in both PPARp 
(+/+) and PPARp (-/-) MEFs. Treatment of PPARp (+/+) and PPARp (-/-) MEFs 
with the PPARp ligand, 2-BrP resulted to the formation of very tiny lipid droplets in 
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Figure 2.4.1. Adipocyte differentiation induced by various treatments in 
PPARP (+/+) MEFs. Post-confluent PPARP (+/+) MEFs (n=6) were exposed to 
IBMX, DEX, insulin and together with (1) DMSO, (2) troglitazone (Tro), (3) 2-
bromopalmitic acid (2-BrP) and (4) troglitazone plus 2-BrP (Tro+2-BrP). At days 
10-11 after induction, MEFs were fixed and stained for fat accumulation in cells with 
Oil Red O. Magnification, 20X. Bar, 100 jam. 
- 6 2 -
P P A R p ( - / - ) 
Tro 
MEF 
cell line D M S O T f o 2-BrP +2-BrP 
-31_國漏 
K � • 釅 圓 1 1 
鹏 _ _ _ _ 
1 2 3 4 
Figure 2.4.2. Adipocyte differentiation stimulated by various treatments in 
PPARP (-/-) MEFs. Post-confluent PPARp (-/-) MEFs (n=6) were treated with 
IBMX, DEX, insulin and in addition to (1) DMSO, (2) troglitazone (Tro), (3) 2-
bromopalmitic acid (2-BrP) and (4) troglitazone plus 2-BrP (Tro+2-BrP). At days 
10-11 after induction, MEFs were fixed and stained for lipid accumulation in cells 
with Oil Red O. Magnification, 20X. Bar, 100 nm. 
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could not be counteracted by the addition of troglitazone. Taken together, these 
results suggest that PPARp is not required in the process of adipocyte differentiation 
from embryonic fibroblasts upon MDI induction in vitro and 2-BrP acts as an 
antagonist in the induction of adipocyte differentiation by the conventional inducers. 
2.3.3 PPARP (-/-) MEF differentiated similarly to PPARP (+/+) MEF 
as reflected by their intracellular triglyceride contents 
To quantitatively assess the lipid accumulated in the differentiated adipocytes in 
both PPARp (+/+) and PPARp (-/-) MEFs, their intracellular triglyceride contents 
were extracted and compared. In parallel to the findings in the Oil Red O staining, 
no significant difference in the intracellular triglyceride level was found between 
PPARp (+/+) and PPARp (-/-) MEFs treated with troglitazone, 2-BrP, and 2-BrP plus 
troglitazone (Figure 2.5). Significant increase in the intracellular triglyceride level 
was observed in both PPARp (+/+) and PPARp (-/-) differentiated MEFs treated with 
troglitazone when compared to their respective DMSO controls. This data suggest 
troglitazone promotes the conversion into lipid-filled adipocytes effectively in the 
absence of PPARp. In PPARp (+/+) MEFs, treatment with 2-BrP did not result in 
significant increase in intracellular triglyceride level, whereas a small but significant 
decrease in intracellular triglyceride was observed in PPARp (-/-) receiving the same 
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Figure 2.5. Intracellular triglyceride contents in PPARP (+/+) and PPARP (-/-) 
adipocytes following stimulation by different inducers. Post-confluent PPARp 
(+/+) and PPARp (-/-) MEFs were cultured in medium including IBMX, DEX, 
insulin, together with DMSO, troglitazone (Tro), 2-bromopalmitic acid (2-BrP) and 
troglitazone plus 2-BrP (Tro+2-BrP). Intracellular triglyceride level was determined 
at day 10 after induction. Data are expressed as mean 二 SD (n=4) from three 
replicates per treatment. ANOVA on ranks was used to compare the differences in 
median values within each treatment and also between treatments using SigmaStat 
Program. No significant difference in the intracellular triglyceride level was found 
between PPARP (+/+) and PPARP (-/-) adipocytes in the same treatment. *,p< 0.05, 
< 0.01, indicate significant different from the control group (DMSO) within the 
same genotype; NS, no significant different from the control treatment of the same 
genotype. 
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treatment. The inhibitory effects of 2-BrP on the ability of PPARp (+/+) and PPARp 
(-/-) MEFs differentiated into adipocytes could not restored by troglitazone. Thus, it 
is strongly evident that PPARp receptor does not play a significant role in adipocyte 
differentiation in vitro. 
2.3.4 PPARp (-/-) MEFs expressed the adipocyte differentiation 
marker genes similarly to PPARp (+/+) MEFs 
It is known that the levels of ACS and GPDH mRNA increase during adipocyte 
differentiation. To further support the Oil Red O staining and intracellular 
triglyceride findings that PPARp (-/-) MEFs could be differentiated into adipocytes 
despite the lack of a PPAR(3 receptor, the levels of ACS and GPDH mRNAs in both 
PPARp (+/+) and PPARp (-/-) MEFs were measured by both RT-PCR and Northern 
blot analyses. In RT-PCR, there was constitutive expression of ACS and GPDH 
mRNAs in both PPARp (+/+) and PPARp (-/-) MEFs in the DMSO control (Figures 
2.6.1’ 2.6.2, 2.7.1 and 2.7.2). The levels of ACS and GPDH expression in both 
genotypes were abundantly increased upon troglitazone treatment. This result was 
consistent to their lipid-filled phenotypes and higher intracellular triglyceride 
accumulation in their adipocytes. When comparing to the DMSO control, similar 
expression level in ACS and reduction in GPDH expressions were found in 
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Figure 2.6.1. Effect of different treatments on acyl-CoA synthetase (ACS) 
expression in adipocyte-differentiated PPARp (+/+) MEFs. Post-confluent 
PPARP (+/+) MEFs (11=4) were exposed to IBMX, DEX, insulin, and together with 
DMSO, troglitazone (Tro), 2-bromopalmitic acid (2-BrP) and troglitazone plus 2-
BrP (Tro+2-BrP). At days 9-10 after induction, RNA was isolated and 0.4 |ag each 
of RNA sample was reverse transcribed using Oligo dT (15) primer. The cDNA was 
amplified by PCR using ACS-FP378 and ACS-RP2168 primers. The PCR products 
were resolved on 0.8% agarose, 0.5X TBE gels with EB staining. The expected size 
of PCR product amplified was 1791 bp. M, 1 kb DNA molecular weight marker. 
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Figure 2.6.2. Effect of different treatments on acyl-CoA synthetase (ACS) 
expression in adipocyte-differentiated PPARP (-/-) MEFs. Post-confluent PPARp 
(-/-) MEFs (n=4) were exposed to IBMX, DEX, insulin, and together with DMSO, 
troglitazone (Tro), 2-bromopalmitic acid (2-BrP) and troglitazone plus 2-BrP 
(Tro+2-BrP). At days 9-10 after induction, RNA was extracted and 0.4 |ag each of 
RNA sample was reverse transcribed using Oligo dT (15) primer. The cDNA was 
amplified by PCR using ACS-FP378 and ACS-RP2168 primers. The PCR products 
were resolved on 0.8% agarose, 0.5X TBE gels with EB staining. The expected size 
of PCR product amplified was 1791 bp. M, 1 kb DNA molecular weight marker. 
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Figure 2.7.1. Effect of different treatments on glycerol-3-phosphate 
dehydrogenase (GPDH) expression in adipocyte-differentiated PPARP (+/+) 
MEFs. Post-confluent PPARp (+/+) MEFs (n=4) were exposed to IBMX, DEX, 
insulin, and together with DMSO, troglitazone (Tro), 2-bromopalmitic acid (2-BrP) 
and troglitazone plus 2-BrP (Tro+2-BrP). At days 9-10 after induction, RNA was 
isolated and 0.4 jag each of RNA sample was reverse transcribed using Oligo dT (15) 
primer. The cDNA was amplified by PCR using GPDH-FP16 and GPDH-RP957 
primers. The PCR products were resolved on 1.0% agarose, 0.5X TBE gels with EB 
staining. The expected size of PCR product amplified was 942 bp. M, 100 bp DNA 
molecular weight marker. 
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Figure 2.7.2. Effect of different treatments on gIycerol-3-phosphate 
dehydrogenase (GPDH) expression in adipocyte-differentiated PPARP (-/-) 
MEFs. Post-confluent PPARP (-/-) MEFs (n=4) were exposed to IBMX, DEX, 
insulin, and together with DMSO, troglitazone (Tro), 2-bromopalmitic acid (2-BrP) 
and troglitazone plus 2-BrP (Tro+2-BrP). At days 9-10 after induction, RNA was 
isolated and 0.4 pig each of RNA sample was reverse transcribed using Oligo dT (15) 
primer. The cDNA was amplified by PCR using GPDH-FP16 and GPDH-RP957 
primers. The PCR products were resolved on 1.0% agarose, 0.5X TBE gels with EB 
staining. The expected size of PCR product amplified was 942 bp. M, 100 bp DNA 
molecular weight marker. 
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2-BrP-treated cells. The ACS and GPDH expressions were slightly induced in 
PPARP (+/+) and PPARp (-/-) MEFs upon 2-BrP and troglitazone co-treatment. The 
expression levels of P-actin were similar in all treatments in both genotypes (Figures 
2.8.1 and 2.8.2). Therefore, our data suggest that activation of PPARy by 
troglitazone regulated the expression of PPAR-dependent genes during adipocyte 
differentiation and this event was independent of the loss of PPARp. 
In Northern blot analyses, the expression patterns of ACS and GPDH mRNA 
were consistent with those in RT-PCR. Activation by troglitazone resulted in an 
induction of ACS and GPDH mRNA in PPARp (+/+) and PPARp (-/-) MEFs as 
compared with the DMSO control in both genotypes (Figures 2.9.1 and 2.9.2). 
Treatment with 2-BrP did not noticeably increase the expressions of ACS and GPDH 
as compared with the DMSO group. When the cells were exposed to co-treatment of 
troglitazone and 2-BrP, the ACS and GPDH expressions were induced slightly, but not 
to the same level as those of the troglitazone treatment. GAPDH was chosen for 
normalizing the expression of mRNA at first. However, this gene was induced 
slightly in the groups of troglitazone and troglitazone plus 2-BrP in these two 
genotypes. Then another housekeeping gene, P-actin, was selected. The P-actin 
expression was more or less the same in either treatment of PPARp (+/+) and PPARP 




DMSO Tro 2-BrP +2-BrP 
MEF 
bp M 1 2 3 1 2 3 1 2 3 1 2 3 cell line 
B V i P M m a i i i B i i 
甜g WT 7 
=騰W ！’••• 
Figure 2.8.1. Expression of beta-actin (p-actin) in adipocyte-differentiated 
PPARp (+/+) MEFs. Post-confluent PPARP (+/+) MEFs (n二4) were exposed to 
IBMX, DEX, insulin, and together with DMSO, troglitazone (Tro), 2-bromopalmitic 
acid (2-BrP) and troglitazone plus 2-BrP (Tro+2-BrP). At days 9-10 after induction, 
RNA was isolated and 0.4 |ag each of RNA sample was reverse transcribed using 
Oligo dT (15) primer. The cDNA was amplified by PCR using P-ACTIN-FP2 and 
I3-ACTIN-RP2 primers. The PCR products were resolved on 1.0% agarose, 0.5X 
TBE gels with EB staining. The expected size of PCR product amplified was 852 bp. 
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Figure 2.8.2. Expression of beta-actin (p-actin) in adipocyte-differentiated 
PPARP (-/-) MEFs. Post-conflucnt PPARp (-/-) MEFs (n=4) were exposed to 
IBMX, DEX, insulin, and together with DMSO, troglitazone (Tro), 2-bromopalmitic 
acid (2-BrP) and troglitazone plus 2-BrP (Tro+2-BrP). At days 9-10 after induction, 
RNA was isolated and 0.4 |ag each of RNA sample was reverse transcribed using 
Oligo dT (15) primer. The cDNA was amplified by PCR using |3-ACTIN-FP2 and 
P-ACTIN-RP2 primers. The PCR products were resolved on 1.0% agarose, 0.5X 
TBE gels with EB staining. The expected size of PCR product amplified was 852 bp. 




DMSQ Tro 2-BrP +2-BrP 
p e p c p c c p 
b f i M 金 金 金 金 金 金 金 金 
4742- - i j j l^ l j l l l l I ^ ^ • � -
2661 - 条 . - ^ ^ ^ K K W t r ^ ^ ^ ^ ^ W i (2848 bp) 
16.77 35.19 22.74 34.21 
4742- • „ 一 
266卜 一 一 mmrnrnm ~ •麵一 G P D H 
10.09 18.64 ‘~8^54‘ 14.65 (2809 bp) 
2661-
nil： _ 麵 _ _ 麵 華 睡 縫 
9.50 15.54 12.54 16.71 (l二* 印） 
溫 : 替 禱 • 禱 循 _ _ 歡 二 L 
23.52 23.68 26.81 23.95 
Figure 2.9.1. Northern blot analysis of adipocyte gene marker expressions in 
differentiated PPARP (+/+) MEFs. PPARP (+/+) MEFs (n=2) were stimulated by 
IBMX, DEX, insulin, and together with DMSO, troglitazone (Tro), 2-bromopalmitic 
acid (2-BrP) and troglitazone plus 2-BrP (Tro+2-BrP). At days 9-10 after induction, 
RNA was isolated. Twenty micrograms of RNA from each treatment group were 
separated on a 1.0% agarose-formaldehydc gel and transferred to a N+ nylon 
membrane. The cDNA probes of ACS, GPDH, GAPDH and P-actin were DIG-
labeled for hybridization. The signal was detected by colorimetric method using 
reagents NBT and BCIP. The intensity of signals was quantified using MultiAnalyst 
software and the values are represented as mean. M, DIG-labeled RNA molecular 
weight marker I. 
- 7 4 -
PPARp (-/_) 
Tro 
DMSO Tro 2-BrP +2-BrP 
o o o o o o o o 
4742 > f m ^ l l l l ^ ^ M M ^ H ^ ^ H I f — ACS 
2661 ^ - ^ . . (2848 bp) 
‘ 6 . 0 2 28.89 17.05 24.26 
4742 —一 
2661 > r^nmrnm ‘ * 機 一-—GPDH 
(2809 bp) 
4.62 18.74 5.63 7.81 
2661> — 
1821 - mmm mmrn mmm mmm 一GAPDH 
‘ ^ ^ s i B ‘ 11.98 ‘ 8 3 3 ” ‘ 10.31 (1228 bp) 
’ 2 7 . 9 5 ‘ • 26.26 _ _ 29.58 ‘ ‘ 29.20 ‘ ( 辦 2 bp) 
Figure 2.9.2. Northern blot analysis of adipocyte gene marker expressions in 
differentiated PPARP (-/-) MEFs. PPAR(3 (-/-) MEFs (n=2) were stimulated by 
IBMX, DEX, insulin, and together with DMSO, troglitazone (Tro), 2-bromopalmitic 
acid (2-BrP) and troglitazone plus 2-BrP (Tro+2-BrP). At days 9-10 after induction, 
RNA was isolated. Twenty micrograms of RNA from each treatment group were 
separated on a 1.0% agarose-formaldehyde gel and transferred to a N+ nylon 
membrane. The cDNA probes of ACS, GPDH, GAPDH and P-actin were DIG-
labeled for hybridization. The signal was detected by colorimetric method using 
reagents NBT and BCIP. The intensity of signals was quantified using MultiAnalyst 
software and the values are represented as mean. M, DIG-labeled RNA molecular 
weight marker 1. 
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adipocyte marker genes in Northern blot analysis, as well as RT-PCR, were correlated 
to their differentiated morphology and intracellular triglyceride levels at different 
treatments in PPARp (+/+) and PPARp (-/-) MEFs. These implicated that cells 
without PPARp did not influence the expression of ACS, GPDH, GAPDH and P-actin 
at the differentiation of adipocytes. 
Taken together, these data supported that PPARP is not required for adipocyte 
differentiation in vitro. PPARp (-/-) MEFs were capable to differentiate into 
adipocytes, in which its adipocyte differentiation was effective with troglitazone and 
suppressive with 2-BrP. Cells were differentiated into adipocyte in a manner of 
ligand-dependent, but not PPARp-dependent. In the ablation of PPARp receptor, the 
expression of terminal adipocyte differentiation marker genes was not influenced. 
Therefore, the decision that PPARp does not involve in the conversion of fibroblasts 
into adipocytes is suggested. 
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Chapter 2.4 Discussion 
Recently, PPARp has been reported to potentiate adipocyte differentiation under 
the stimulation of PPARy in preadipocytes isolated from brown adipose tissues in 
wild-type and PPARp-null mice (Matsusue et al., 2004). Adipocytes in the absence 
of PPARp expression exhibited less lipid accumulation and lower expression level of 
adipocyte differentiation marker mRNAs than wild-type adipocytes. In contrast with 
the above findings in brown fat adipocytes, our present findings suggested that 
PPARp does not require in adipocyte differentiation in MEFs in vitro. PPARp (-/-) 
MEFs could differentiate into fat cells and appear with a differentiated morphology 
that was comparable to those of the wild-type counterparts. Fibroblasts from PPARp 
(+/+) and PPARP (-/-) genotypes developed into lipid-containing cells and their 
intracellular triglyceride content increased dramatically in the presence of troglitazone, 
but was refractory in the presence of 2-BrR In PPARP (+/+) and PPARp (-/-) cells, 
terminal differentiation-related genes, ACS and GPDH, were induced in a 
troglitazone-dependent, but genotype-independent manner. This result was 
consistent with the Matsusue's studies that differentiation of embryonic fibroblasts 
from PPARp (+/+) and PPARp (-/-) mice did not result in any difference in expressing 
adipocyte differentiation-related genes, aP2 and PPARy (Matsusue et al., 2004). In 
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parallel with other in vivo studies, reduced adipose stores were found in 
PPARp-deficient mice relative to those wild-type mice (Peters et al., 2000; Barak et 
al., 2002). However, this effect was not reproduced in mice harboring an adipose 
tissue-specific deletion of PPARp (Barak et al., 2002). Comparison of the gonadal 
white and interscapular brown fat pads from mice without PPARp in its adipose tissue 
specifically to those controls revealed no obvious difference. These observations 
suggested that the absence of PPARp in cells or animals does not show any defect in 
adipocyte conversion. 
Microarray analysis of the gene expression profiles at fat cell differentiation 
revealed that several transcription factors, such as PPARy, C/EBPa, C/EBPp and 
C/EBP5, were induced (Soukas et al., 2001; Burton et al, 2004). Null-embryonic 
fibroblast cells of these transcription factors were less prone to undergo adipocyte 
differentiation. PPARy-null fibroblasts or stem cells did not form any fat cells with 
undetectable expression levels of fat cell-specific markers, C/EBPa, leptin, aP2 and 
adipsin (Kubota et al, 1999; Rosen et al., 1999; Rosen et al., 2002). In parallel, 
adipose-specific PPARy knockout mice resulted in impaired fat formation and 
lessened in expressing PPARy target genes, C/EBPa, aP2, LPL, phosphoenolpyruvate 
carboxykinase (PEPCK), CD36 and fatty acid transporters (He et al., 2003; Jones et 
al., 2005). Heterozygous PPARy-deflcient mice also displayed a smaller size of fat 
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cells and decreased in fat mass (Kubota et al., 1999). C/EBPa was found to 
cooperate with PPARy to control the termination of fat cell development (Tontonoz et 
al., 1994; Brun et al” 1996; Wu et al” 1999; Rosen et al., 2002). Fibroblasts lacking 
C/EBPa did not induce endogenous PPARy (Wu et al., 1999). They were able to 
differentiate into fat cells with less lipid accumulation, through ectopic expression of 
PPARy only. Mice ablated of C/EBPa suffer from significant decrease in adipose 
tissues (Wang et al, 1995). C/EBPp and C/EBPS, which are similar to PPARp, are 
induced in the early period of adipocyte differentiation (Soukas et al., 2001). 
Depletion of either the C/EBPp or 6 gene causes a mild perturbation of adipogenic 
differentiation of MEFs and a slightly loss in gonadal white adipose tissue in mice 
(Tanaka et al.’ 1997; Yamamoto et al., 2002). Moreover, the C/EBPp and C/EBP5 
double knockout mice ceased adipocyte differentiation completely and reduced white 
adipose tissues severely due to a greatly diminished number of adipocytes (Tanaka et 
al., 1997). Expressions of aP2，PEPCK, C/EBPa and PPARy in these cells were 
dropped markly in addition. These findings revealed that PPARy, C/EBPa, C/EBPp 
and C/EBP5 are important for controlling adipocyte differentiation and the absence of 
either one of these genes in cells can repress the fat cell development. In contrast, 
adipocyte differentiation is unaffected in the PPARP deficiency, implicating that 
PPARp is not required and does not take a significant part in this process. On the 
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other hand, it is possible that PPARy, C/EBPa, C/EBPp and C/EBP6 may mimic and 
function as PPARp to regulate gene expression during adipocyte differentiation and 
compensate for the loss of PPARp in fibroblasts. 
The PPARp ligand，2-BrP, could stimulate PPARp-expressing fibroblasts or 
preadipocytes to form fat cells effectively in the previous studies (Bastie et al., 1999; 
Bastie et al., 2000; Hansen et al, 2001). However, no adipogenic effect occurred in 
these cells upon activation of endogenous PPARp by the combination of 
differentiation media and 2-BrP (Hansen et al., 2001), suggesting that the 
commitment of fibroblasts to adipocytes was mainly due to the over-expressed 
PPARp, but not the endogenous one. Moreover, these preadipocyte or fibroblast cell 
lines exposed to 2-BrP for 4 or 5 days post-confluence only, but not throughout the 
whole period of 8 or 14-day adipocyte differentiation (Bastie et al., 1999; Bastie et al., 
2000). Other factors in the medium, such as hormones or ligands, could be 
responsible for promoting fat cell differentiation after withdrawal of 2-BrP. 
Similarly, smaller and less lipid droplets were accumulated in PPARp (+/+) and 
PPARp (-/-) cells exposed to 2-BrP as observed in our studies suggesting that 2-BrP 
might inhibit the adipocyte differentiation by repressing expression of some adipocyte 
related genes, such as GPDH in our case. Furthermore, co-treatment of troglitazone 
and 2-BrP did not restore the inhibitory effect of 2-BrP in adipocyte differentiation 
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completely. It is also known that 2-BrP is also a very weak ligand of PPARy (Brun 
et al., 1996), and therefore, both 2-BrP and troglitazone, act as competitors for the 
binding to PPARy, and the effect of troglitazone on fat cell conversion is diminished. 
Our findings indicated that 2-BrP is an inhibitor for adipocyte differentiation. 
Taken together, the present study indicated that PPARp is not necessary for 
adipocyte differentiation in PPARp (-/-) MEFs. We concluded that PPARp does not 
involve in the fat cell formation in vitro. Alternatively, the possibility of other 
transcription factors regulated in the conversion of fibroblasts into adipocytes may 
replace the loss of PPARp cannot be excluded. Work is needed to better understand 
the possible function that PPARp may mediate in the lipid homeostasis in vivo. 
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Chapter 3 
Role of PPARP in 
adipocyte differentiation 
and lipid homeostasis 
- a n in vivo study 
- 8 2 -
Chapter 3.1 Introduction 
Several studies revealed that PPARp regulates lipid transport through 
lipoproteins. Administration of a synthetic PPARp agonist L-165041 to obese and 
diabetic db/db mice increased total plasma cholesterol levels that was primarily 
associated with HDL particles and decreased expression of LPL in white adipose 
tissue (Berger et al., 1999; Leibowitz et al., 2000). In obese rhesus monkeys, a 
4-week treatment with another specific PPARp agonist GW501516 resulted in 
improving lipid profiles by normalizing plasma glucose and insulin, raising HDL 
cholesterol and reducing low-density lipoprotein (LDL) cholesterol (Oliver et al” 
2001). When does to genetically or dietary-induced obese mice, GW501516 
reduced adiposity and improved insulin sensitivity (Tanaka et al., 2003; Wang et al., 
2003). PPARp-null mice exhibited hypertriglyceridemia under high-fat feeding, due 
to increased hepatic production of very low-density lipoprotein (VLDL) and 
decreased LPL-mediated catabolism of VLDL-triglycerides (Akiyama et al., 2004). 
Experimental observations in muscle and adipose tissue have begun to uncover 
the metabolic functions of PPARp. In skeletal muscle, agonist of PPARp is capable 
for regulating genes important for fatty acid catabolism such as malonyl-CoA 
decarboxylase, carnitine palmitoyltransferase 1 and uncoupling protein 3 (Muoio et 
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al., 2002; Lee et al” 2006). Administration of GW501516 to genetically or 
dietary-induced obese mice enhanced fatty acid oxidation and reduction in lipid 
content in skeletal muscle (Tanaka et al., 2003; Lee et al., 2006). Transgenic mice, 
which selectively express a constitutive active form of PPARp in adipose tissue, 
produced a lean phenotype and were resistant to obesity induced genetically or by a 
high fat diet (Wang et al., 2003). In parallel, adipose-specific PPARp-deficient mice 
displayed reduced energy uncoupling and are prone to dramatic weight gain when 
challenging with the same high fat diet. However, an other model of PPARP-null 
mice exhibited reduced adipose stores (Peters et al., 2000; Barak et al., 2002). The 
exact role of PPARp in regulating adipocyte differentiation and lipid metabolism 
remains unclear. 
In this chapter, the possible roles of PPARp in regulating lipid homeostasis were 
investigated. Age-matched (5-7 weeks old) PPARP (-/-) males and females, and the 
wild-type littermates, were challenged with low fat lard, high fat lard, low fat 
safflower oil and high fat safflower oil diets for 5 months. Regular chow diet was 
used as a control. The physiological responses of PPARp (-/-) mice withstanding 
high fat diet-induced obesity were monitored. It was shown here that PPARp (-/-) 
mice under high fat diet had a leaner phenotype along with reduced serum cholesterol 
level, relieved hepatic steatosis and improved insulin resistance. 
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Chapter 3.2 Materials and Methods 
In the second part of my research, PPARp (-/-) mice and their control wild-type 
littermates were challenged with high fat diets that are known to induce obesity in 
wild-type mice for 5 months. The physiological responses of PPARp in regulating 
lipid homeostasis, as well as adipocyte differentiation, were examined in vivo. 
3.2.1 Animals and high-fat diet treatment 
Male and female PPARp (+/+) and PPARp (-/-) mice on C57BL/6 and Sv/129 
genetic backgrounds were used for the high-fat diet treatment and they were the 
offspring of breeder mice from the National Cancer Institute (Peters et al., 2000). 
The diet study was begun at the age of 4-7 week-old to ensure that the mice were 
weaned and continued up to 22 weeks (5 months) after high-fat diet feeding. 
3.2.1.1 Materials 
Low fat lard diet (10% kcal fat as lard, D12450B), high fat lard diet (45% kcal 
fat as lard, D12451), low fat safflower oil diet (10% kcal fat as safflower oil, 
D02062101), and high-fat safflower oil diets (45% kcal fat as safflower oil, 
D02062102) were custom made from Research Diets, Inc (New Brunswick, NJ, USA). 
Formaldehyde was purchased from Riedel-de Haen (Seelze, Germany). 
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3.2.1.2 Method 
3.2.1.2.1 Animal treatment 
Male and female PPARp (+/+) and PPARp (-/-) mice were randomly selected 
from different litters and housed in a pathogen-free facility of the Laboratory Animal 
Services Center in the Chinese University of Hong Kong under the standard 12 hr 
light/ 12 hr dark cycle (light, 06:00-18:00) and allowed with ozonated water ad 
libitum. When the mice were 4-7 weeks old, they were kept in groups of 1-6 mice 
per cage and maintained on low fat lard, high fat lard, low fat safflower oil or high fat 
safflower oil diet. A control group was also established by feeding the mice with 
regular chow (Prolab® RMH 2500 5P14, LabDiet®, St. Louis, MO, USA). The 
nutrient composition of different diets is listed in Appendix E. The body weight and 
food intake of each mouse were recorded weekly by an electronic balance. After 22 
weeks (approximately 5 months), mice were sacrificed by decapitation with a pair of 
clean scissors and blood was collected for biochemical analyses. Brain, heart, 
kidneys, liver, lungs, skeletal muscle, small intestine, spleen, testes (or uterus for 
female mouse), gonadal white adipose tissues and scapular brown adipose tissues 
were dissected and weighed. Pieces (about 1 cm^) of liver, WF and brown fat (BF) 
samples were fixed in 10% phosphate-buffered formalin (3.7% formaldehyde with IX 
PBS) for further histological studies. The remaining organs were wrapped in 
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aluminum foil and stored in liquid nitrogen. 
3.2.2 Tail-genotyping of PPARP (+/+) and PPARp (-/-) mice 
The genotypes of PPARp (+/+) and PPARp (-/-) mice were confirmed by PCR 
tail-genotyping before feeding of the animals, as there is no external phenotypic 
difference between PPARp (+/+) and PPARp (-/-) mice. In PCR tail-genotyping, 
genomic DNA was extracted from mouse's tail with the method modified from Laird 
et al. (Laird et al., 1991). A pair of forward (FP4459, 
5'-TGAATGTGCCCCAGGTAG-3') and reverse primers (RP4758, 
5'-TGGCTGGTCCTCTGAACA-3') were used, which flanks the Xba I site ofexon 8 
of the mouse PPARp gene (Figure 2.1). The expected size of PCR products 
amplified from genomic tail DNA of PPARp (+/+) mice was 300 bp. Due to the 
insertion of a NEO cassette (1146 bp) into the Xba I site of exon 8 of the mouse 
PPARp gene, the expected size of PCR products amplified from genomice tail DNA 
of PPARp (-/-) mice, including the NEO fragment, was about 1446 bp. 
3.2.2.1 Materials 
Isopropanol and concentrated HCl were purchased from BDH (Poole, Dorset， 
England). The nucleotide mix dNTP (1:1:1:1) and proteinase K were purchased 
from Roche (Mannheim, Germany). EDTA was purchased from Riedel-de Haen 
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(Seelze, Germany). DNA markers and primers were purchased from Invitrogen 
(Carlsbad, CA, USA). EB and SDS were purchased from Sigma Aldrich (St. Louis, 
MO, USA). Agarose, boric acid, NaCl and Tris base were purchased from USB 
Corporation (Cleveland, OH, USA). MgCli, Taq polymerase and PCR buffer were 
purchased from GenSys Limited (Camberley, Surrey, UK). 
3.2.2.2 Methods 
3.2.2.2.1 DNA extraction from tail 
Complete lysis buffer was prepared by freshly dissolving 100 /xg/ml of 
proteinase Kin 0.1 M Tris-HCl (pH 8.5), 5 mM EDTA(pH 8.0), 0.2% SDS and 0.2 M 
NaCl. About 1 cm tail tip of each mouse was excised and incubated in 500 |LI1 of 
complete lysis buffer in a 15 ml Falcon tube. The piece of tail tip was digested at 
55°C overnight with shaking. After overnight incubation, the lysates were vortexed 
and incubated at 55°C for an additional 2 hr. The samples were centrifuged at 3,000 
rpm for 10 min and the supernatant was then transferred into a new 1.5 ml Eppendorf 
tube. The supernatant was centrifuged at 14,000 rpm for 10 min and then pipetted to 
a new 1.5 ml Eppendorf tube containing same volume of isopropanol. The genomic 
DNA was precipitated by shaking laterally until the appearance of a white mass of 
DNA. The DNA was transferred to a sterile tube with the help of a yellow pipette tip 
and air-dried. The pellet was dissolved in 150 of TE buffer [10 mM Tris-HCl and 
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0.1 mM EDTA (pH 7.5)] at 55°C overnight. The DNA solution was resuspended by 
pipetting up and down until the solution viscosity was eliminated and stored at 4®C 
until further use. The DNA concentration was determined by measuring OD at 
wavelength of 260 nm with a spectrophotometer (DU® 640, Beckman Coulter, 
Fullerton, CA, USA). 
3.2.2.2.2 PCR tail-genotyping 
The PCR reaction mixture and PCR profile were set up as mentioned in section 
2.2.2.2.3 with a modification. One hundred nanograms of genomic DNA extracted 
from MEFs was replaced by 150 ng of genomic DNA extracted from mouse's tail. 
3.2.3 Measurement of serum triglyceride, cholesterol and glucose 
levels by enzymatic and spectrophotometric methods 
In order to characterize the physiological differences between PPARp (+/+) and 
PPARp (-/-) mice challenged with high-fat diets, the serum triglycerides, cholesterol 
and glucose levels were assayed by standard enzymatic colormetric assays, while 
insulin and leptin levels were determined by enzyme-linked immunosorbent assay 
(ELISA). 
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The working principle of determining serum triglyceride concentration was 
described earlier in section 2.2.6. 
The method for serum cholesterol determination was developed by Allain (Allain 
et al., 1974) and Meiattini (Meiattini et al” 1978) in 1970’s. The cholesterol esters 
in the serum sample are deesterificated into cholesterols and fatty acids in the 
presence of cholesterol esterase. When cholesterol oxidase catalyzes the conversion 
of cholesterol to cholestenone, H2O2 is produced. H2O2 reacts with 
4-aminoantipyrine and phenol to form red-colored quinoneimine under the influence 
of peroxidase. The color complex exhibits a strong absorbance at 500 nm that is 
directly proportional to the cholesterol concentration in the serum sample. 
Measurement of blood glucose levels for diagnostic purpose was firstly 
described by Folin et al. (Folin and Wu, 1920). The present method followed the 
technique based on Trinder's description (Trinder, 1969). In brief, this assay 
involves the oxidization of glucose in serum by glucose oxidase to generate H2O2. 
Then H2O2 reacts with p-hydroxybenzene sulfonate and 4-aminoantipyrine to form a 
red-violet quinone complex under the influence of peroxidase. The intensity of color 
is proportional to the glucose concentration in the serum sample. 
3.2.3.1 Materials 
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The triglyceride and cholesterol enzyme determination kits were purchased from 
BioSystems, S.A. (Barcelona, Spain). The glucose enzymatic determination kit was 
purchased from Stanbio Laboratory, Inc (San Antonio, TX, USA). Plastic curvets 
were purchased from Sarstedt (Niimbrecht, Germany). 
3.2.3.2 Methods 
3.2.3.2.1 Serum preparation 
The blood was collected by dripping from the neck of the mouse carcass into a 
1.5 ml Eppendorf tube after decapitation immediately. The blood samples were 
allowed to clot at room temperature for 30 min and the tubes were centrifuged at 
2,400 rpm for 20 min at room temperature. The supernatant was transferred to a 
new 1.5 ml Eppendorf tube and centrifuged again at 2,400 rpm for 20 min. The 
clear serum samples were then transferred to another 1.5 ml Eppendorf tube and 
stored at -20°C until further use. 
3.2.3.2.2 Measurement of serum triglycerides 
The triglyceride concentration of each serum sample was measured by using the 
BioSystems triglyceride kit. Triglycerides standard (200 mg/dl of triolein) and the 
reagent from kit were wanned to room temperature. Five microliters of the serum 
sample from each mouse or the standard were mixed with 500 )LI1 of reagent in a 1.5 
ml Eppendorf tube. A blank containing 500 reagent only was set. The tubes 
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were incubated in a 37°C water bath for 5 min and then allowed to cool to room 
temperature. The entire content of each tube was vortexed and transferred to a 1 ml 
plastic curvet. The absorbance at 500 nm of each sample or standard against that of 
the blank was measured with the spectrophotometer (DU® 640, Beckman Coulter, 
Fullerton, CA, USA). Duplicate determinations were done for each sample and the 
standard. The serum triglyceride concentration of each mouse was calculated 
following the manufacturer's instruction: 
Triglyceride concentration of sample (mg/dl) = (OD500 nm of sample / OD500 nm of 
standard) x the standard concentration (mg/dl) 
3.2.3.2.3 Measurement of serum cholesterol 
The cholesterol concentration of each serum sample was measured using the 
BioSystems cholesterol kit. Cholesterol standard (200 mg/dl) and the reagent were 
warmed to room temperature. A 5 |LX1 aliquot of each serum sample or the standard 
was mixed with 500 pi reagent in a 1.5 ml Eppendorf tube. A blank contained 500 
)Lil reagent only. The tubes were incubated in a 37°C water bath for 5 min and then 
allowed to cool to room temperature. The entire content of each tube was mixed and 
transferred to a 1 ml plastic curvet. The absorbance at 500 nm of each sample or 
standard against that of the blank was measured with the same spectrophotometer. 
Duplicate determinations were done for each sample and the standard. The serum 
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cholestrol concentration of each mouse was calculated following the manufacturer's 
instruction: 
Cholesterol concentration of sample (mg/dl) = (OD500 nm of sample / OD500 nm of 
standard) x the standard concentration (mg/dl) 
3.2.3.2.4 Measurement of serum glucose 
The glucose concentration of serum samples was measured by using the Stanbio 
enzymatic glucose kit. Glucose standard (100 mg/dl) and reagent powder were 
warmed to room temperature. The reagent solution was reconstituted by dissolving 
a bottle of the reagent powder in 10 ml deionized water, then transferred to a 75 cm^ 
culture flask and made up to a final volume of 200 ml with deionized water. The 
glucose reagent solution was mixed thoroughly. Five microliters of each serum 
sample or the standard was mixed with 500 jal reagent in a 1.5 ml Eppendorf tube. A 
blank with 500 jj,l reagent was prepared. The tubes were incubated in a 37°C water 
bath for 10 min and then allowed to cool to room temperature. The entire content of 
each tube was vortexed and transferred into a 1 ml plastic curvet. The absorbance at 
500 nm of each sample or standard against that of the blank was measured with the 
same spectrophotometer. The serum glucose concentration of each mouse was 
calculated following the manufacturer's guide: 
Glucose concentration of sample (mg/dl) = (OD500 腦 of sample / OD500 nm of standard) 
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X the standard concentration (mg/dl) 
3.2.4 Measurement of serum insulin and leptin levels by ELISA 
Serum insulin and leptin levels in high-fat feeding mice are determined by 
ELISA. The rat/mouse insulin ELISA kit is used for the non-radioactive 
quantification of serum insulin in mouse and is a Sandwich ELISA. First of all, the 
mouse monoclonal anti-rat insulin antibodies fix on the wells of the microtiter plate 
capture insulin molecules from the serum sample. Secondly, the biotinylated 
polyclonal anti-insulin antibodies bind to those captured insulin molecules and then 
streptavidin-linked horseradish peroxidase (HP) binds to the immobilized biotinylated 
antibody. Finally, the antibody-enzyme conjugates are quantified by monitoring the 
HP activity in the presence of its substrate, 3，3’，5, 5'- tetramethylbenzidine. The 
enzyme activity is measured spectrophotometrically by the increased absorbance at 
450 nm, corrected from that at 595 nm, after the acidification of the products 
generated. The increase in absorbance is directly proportional to the amount of 
captured insulin in the sample. 
The mouse leptin TiterZyme® Enzyme Immunometric Assay (EIA) kit was 
chosen for the quantitative determination of mouse leptin in serum non-radioactively. 
The kit uses a rabbit polyclonal antibody specific to mouse leptin attached on the 
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microtiter plate to bind the leptin in serum samples. Leptin captured on the plate is 
bound by another rabbit antibody to mouse leptin labeled with HR The substrate is 
added and reacts with the immobilized HP. The enzyme reaction is stopped after 
acidification and the color product formed is read at the wavelength of 450 nm. The 
measured OD is directly proportional to the concentration of mouse leptin in serum. 
3.2.4.1 Materials 
The rat/mouse insulin ELISA kit was purchased from Linco Research Inc (St. 
Charles, MO, USA). The mouse leptin TiterZyme® EI A kit was purchased from 
Assay Designs, Inc (Ann Arbor, MI, USA). NF water was purchased from USB 
corporation (Cleveland, OH, USA). 
3.2.4.2 Methods 
3.2.4.2.1 Measurement of serum insulin 
The concentration of insulin in each serum sample was determined by the 
rat/mouse insulin ELISA kit. All the reagents were warmed to room temperature. 
The serum samples from mice were diluted with assay buffer by 1 -5 fold, depending 
on their diet group. Each well of the microtiter assay plate was washed with 200 jiil 
of IX wash buffer 5 times. The wash buffer was decanted and the residue was 
removed by inverting the plate and tapping it smartly onto absorbent towels several 
times. The wells should be prevented from drying before proceeding to the next step. 
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Sixty microliters of detection antibody solution (biotinylated anti-insulin antibody) 
was added to each of the wells. As the serum samples were used, an extra 20 \x\ of 
matrix solution was added into each well of the blank, standards and controls, and the 
remaining wells of samples were made up for the same volume of assay buffer. 
Twenty microliters of each rat insulin standard or serum sample were added to the 
appropriate well. For the blank, another 20 j^ l of assay buffer was added. The step 
of sample loading should be completed within 1 hr. The plate was covered with a 
plate sealer and incubated at room temperature for 2 hr on an orbital microtiter plate 
shaker at 450 rpm. After the first incubation, the plate sealer was discarded and the 
entire fluid was decanted from the plate. The residual solution in wells was removed 
by tapping as before. The plate was washed 5 times with 200 j^ l of IX wash buffer 
per well per wash. The remaining buffer was decanted and tapped after each wash. 
A hundred microliters of enzyme solution (streptavidin-HP conjugate) was pipetted to 
each well. The plate was sealed and incubated with shaking at 450 rpm for 30 min at 
room temperature. After the second incubation, the plate sealer was removed, and 
used enzyme solution was decanted and tapped. The plate was washed with 200 
of IX wash buffer per well for 9 times. The residue was decanted and tapped after 
each wash. One hundred microliters of substrate solution (3, 3', 5, 5'-
tetramethylbenzidine) was added to each well. The plate was covered with the plate 
-96 -
sealer and incubated with shaking at 450 rpm for 15 min at room temperature. Blue 
color was formed in the wells containing insulin. The plate sealer was discarded. 
The enzyme reaction was stopped by adding 100 |LI1 stop solution to each well and the 
solution was mixed completely by shaking the plate by hand. The blue color in the 
wells was turned into yellow after acidification. The absorbance at 450 nm and 595 
nm of each well was read in a plate reader ()j,Quant™, Bio-Tek Instruments, Winooski, 
VT, USA) within 5 min after adding the stop solution. Before reading, the plates 
should be ensured that no air bubbles in any well. The standard curve for sample 
interpretation was graphed by plotting the absorbance at 450 nm on the Y-axis against 
the concentration of rat insulin standards (ng/ml) on the X-axis. This dose-response 
curve suits to the sigmoidal 4-parameter logistic equation. The insulin concentration 
of serum samples was calculated with the computer software having the 4-parameter 
logistic function (KCjunior, Bio-Tek Instruments, Winooski, VT, USA). 
3.2.4.2.2 Measurement of serum leptin 
The concentration of serum leptin was determined by the mouse leptin 
TiterZyme® EIA kit. All the reagents were warmed to room temperature. The 
mouse leptin standard powder was reconstituted with 500 jiil of NF water. Serial 
dilutions (0, 100，200, 400, 800, 1600, 3200 and 6400 pg/ml) from the mouse leptin 
stock solution (12,800 pg/ml) were prepared with assay buffer. The serum samples 
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from mice were diluted with assay buffer by 1.25 to 45 fold, depending on their diet 
group. Labeled antibody conjugate (antibody to moue leptin linked to HP) was 
prepared by transferring the entire content of a bottle of labeled antibody diluent to 
the vial of mouse leptin antibody conjugate. The antibody solution was allowed to 
stand at room temperture for 5 min and vortexed it gently. One hundred microliters 
of the leptin standards and diluted samples were pipetted to the bottom of the 
appropriate wells. The plate was tapped gently to mix the contents and the plate was 
covered with a plate sealer and incubated at 37°C for 1 hr. The sealer was discarded 
and the entire fluid was emptied from the plate. The plate was washed with 200 jil 
of IX wash buffer per well for 20 times. All reagents should be added to the side of 
the wells to avoid contamination. The residual buffer was decanted after each wash. 
At the final wash, the wells were aspirated and the plate was tapped firmly on 
absorbent towels to remove any remaining buffer. The labeled antibody conjugate 
(100 1^ 1) was added into each well, except the blank. The plate was sealed and 
incubated at 37°C for 30 min. The sealer was removed and the used antibody 
solution was decanted. The plate was further washed with 200 |LI1 of IX wash buffer 
to every well for 20 times. The buffer was emptied after each wash and the plate 
was tapped as before at the final wash. The substrate solution was freshly prepared 
by dissolving 2 substrate pellets (tetramethylbenzidine) into 5 ml substrate buffer 
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completely and then mixing with 5.5 ml peroxide solution. The substrate solution 
was mixed well and 100 |LI1 of this solution was added to each well. The plate was 
covered with the plate sealer and incubated at room temperature for 30 min in the 
dark by wrapping with aluminum foil. The plate sealer was discarded. The 
enzyme reaction was stopped by adding 100 jiil stop solution into every well. The 
plate reader (jiQuant™, Bio-Tek Instruments, Winooski, VT, USA) was blanked 
against the blank well and the absorbance at 450 nm of each well was read with 
correction at 595 nm. The standard curve for sample interpretation was graphed by 
plotting OD450 nm against the concentration of mouse leptin standards (pg/ml). This 
curve fits to the sigmoidal 4-parameter logistic equation. The insulin concentration 
of serum samples was calculated by the computer software utilizing the 4-parameter 
logistic function (KCjunior, Bio-Tek Instruments, Winooski, VT, USA). 
3.2.5 Histological studies of liver, scapular brown fat and gonadal 
white fat pads 
The histological changes of liver scapular BF and gonadal WF pads of PPARP 
(+/+) and PPARp (-/-) mice due to high-fat diet treatment were observed. About 1 
cm^ of liver, scapular BF and gonadal WF tissues were removed, fixed in 10% 
formalin (also named 3.7% formaldehyde), dehydrated and embedded in paraffin. 
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Sections of liver, BF and WF were cut out and then stained with Mayer's hematoxylin 
and eosin (H&E) for histological examination. 
3.2.5.1 Materials 
Formalin was purchased from Riedel-de Haen (Seelze, Germany). Mayer's 
hematoxylin was purchased from Polysciences, Inc (Warrington, PA, USA). 
Concentrated HCl, ethanol, eosin, magnesium sulfate (MgSCU) and sodium hydrogen 
carbonate (NaHCOs) were purchased from BDH (Poole, Dorset, England). Paraffin 
and xylene were purchased from Merck & Co, Inc (Whitehouse Station, NJ, USA). 
Permount was purchased from Fisher Scientific (Fair Lawn, NJ, USA). 
3.2.5.2 Methods 
3.2.5.2.1 Fixation, dehydration, embedding in paraffin and sectioning 
After dissection from the mouse carcass, liver, BF and WF samples were fixed in 
10% phosphate-buffered formalin to preserve the general structure of the cell and 
extracellular components for at least 48 hr at room temperature. The samples were 
transferred in 70% ethanol just before processing. The fixed samples were 
dehydrated and then infiltrated with paraffin in a tissue processor (Shandon, Cheshire, 
England). The serial steps of dehydrating the tissue samples were 70% ethanol at 
room temperature for 2 hr, 80% ethanol at room temperature for 2 hr, 95% ethanol at 
room temperature for 2 hr and 100% ethanol at room temperature for 2 hr by 3 times. 
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The specimens were immersed twice in xylene at room temperature for 1 hr to remove 
ethanol in samples prior to infiltration with melted paraffin, as this organ solvent is 
miscible in both ethanol and paraffin. The dehydrated tissues were soaked in 
liquefied paraffin at 60°C for 2 hr by 4 times. Each of the processed samples was 
put in a cast and then embedded in paraffin. When the melted paraffin was cool and 
hardened, the embedded specimen was trimmed into an approximate size of a block. 
The block was then held in a microtome (Jung, Heidelberg, Germany). Liver and 
BF samples were cut in a thickness of 5 jtrni, while WF samples were sliced in a 
thickness of 8 fim. The sections were mounted onto glass slides and dried at 40°C. 
3.2.5.2.2 H&E staining 
The glass slides were transferred into xylene for 1 min by 3 times to remove 
parrffln in samples, and then rinsed through a series of graded ethanol (100%, 95%, 
80% and 70% ethanol) each for 1 min. The rehydrated tissues on the slides were 
dipped with tap water and then stained with Mayer's hematoxylin for 5 min. After 
staining, the slides were washed well with tap water. The sections were rinsed with 
Scott tap water (0.04 M NaHCOs and 0.15 M MgSOq) and then washed well with tap 
water. Excess stain was washed by dipping in acid alcohol (100-fold diluted 
concentrated HCl with 70% alcohol) for 1 sec and then washed with tap water. The 
sections were further stained with eosin for 5 min. Excess stain was removed with 
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tap water and the stained sections were dehydrated through a series of ethanol of 
ascending concentrations (70%, 80% and 95% ethanol) each for 1 min. The sections 
were then rinsed with 100% ethanol for 1 min and then followed by rinsing with 
xylene 3 times for 1 min per wash. The sections were mounted with permount 
mounting medium and protected by a coverslip. Photographs were taken with 
Integrated Biological Imaging System (Axiophot 2 universal microscope, Zeiss, 
Esslingen, Germany; Spot cooled color Digital camera and software-Spot 32, 
Diagnostic Instruments, Sterling Heights, MO, USA; Software-MetaMorph 4.0, 
Universal Imaging Corporation, Sunnyvale, CA, USA). 
3.2.6 Analyses of fecal lipid contents 
The stools collected from PPARp (-/-) males and females under safflower oil 
diets may contain more lipid substances as comparing with those collected from 
PPARp (+/+) mice (Appendix B). Therefore, the fecal lipid contents of PPARp (+/+) 
and PPARp (-/-) mice fed with different diets were investigated and compared. 
3.2.6.1 Materials 
Chloroform and methanol were purchased from Labscan Asia Co. Ltd (Bangkok, 
Thailand). NaCl was obtained from USB Corporation (Cleveland, OH, USA). 
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3.2.6.2 Method 
3.2.6.2.1 Extraction of lipid contents from stools 
The method for fecal lipid extraction was modified from Folch et al., and 
Granlund et al. (Folch et al., 1957; Granlund et al�2000). The stools collected from 
PPARp (+/+) and PPARp (-/-) mice were freeze-dried for at least 48 hr. Each of the 
samples were weighed and regarded as their dry weight. About 250 mg of 
freeze-dried faeces were mixed with 350 ml water in a 50 ml Falcon tube (tube 1). 
Two thousand five hundred microliters of chloroform:methanol (2:1) was added to the 
tube and the feaces were allowed to equilibrate with the solvent for 2 hr. Each of the 
fecal samples was homogenized with a tissue tearor (Dremel®, BioSpec Products, 
Racine, WI, USA) and then made up to 7.5 ml by adding 5 ml chloroform:methano 1 
(2:1). The homogenates were incubated at room temperature overnight with shaking. 
One thousand five hundred microliters of 0.9% NaCl was added to each tube and then 
the samples were vortexed on the highest setting for 2 min. The tubes were 
centrifuged at 2,500 rpm for 5 min. The lower phase (organic lipid phase) of each 
fecal sample was transferred into a new 15 ml Falcon tube (tube 2). The upper phase 
of each fecal sample in tube 1 was re-extracted by adding additional 2 ml 
chloroform:methanol (2:1) and then vortexed for 2 min. Tube 1 was centrifuged at 
2,500 rpm for 5 min. The lipid phase from second extraction was transferred into 
tube 2 and then the entire content in tube 2 was pipetted into a pre-weighed glass tube 
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(initial glass tube weight). The lipid phase of each fecal sample was dried 
completely under nitrogen gas. Each of the glass tubes was weighed (final glass 
tube weight). The fecal l ipid content of each mouse was calculated as followed: 
Fecal l ipid content (% dry weight) = [(final glass tube weight — initial glass tube 
weight)/dry weight]xlOO% 
3.2.7 Statistical analysis 
The number of mice for each group used in experiments is indicated in the figure 
legends. Data are presented as mean 土 SD. For the results of body weight and 
food intake, Mann-Whitney rank sum test was used to calculate P values as the 
normality test was failed. For the others, two way analysis of variance (ANOVA), 
followed by Tukey test, was used to calculate P values when both normality and equal 
variance tests were passed, or Kruskal-Wallis ANOVA on ranks was used i f the 
normality or equal variance test was failed. A l l the statistics was performed using 
SigmaStat software (version 3.11，Systat Software, San Jose, CA, USA). 
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Chapter 3.3 Results 
3.3.1 Confirmation of genotypes by PCR 
The genotypes of all PPARp (+/+) and PPARp (-/-) males and females were 
checked by PCR tail genotyping before feeding, as there was no obvious difference in 
their phenotypes. The sizes of PCR product amplified in both sexes of PPARp (+/+) 
(Figures 3.1 and 3.2) and PPARP (-/-) (Figures 3.3 an 3.4) mice were about 300 and 
1446 bp, respectively, which were matched with the expected sizes. 
3.3.2 PPARP (-/-) mice were more resistant to high fat diet-induced 
obesity 
In order to investigate the effect of PPARp deficiency on high fat diet-induced 
body weight change in vivo, PPARp (-/-) males and females, together with their 
wild-type controls, were fed 22-week feeding of 5 different diets, including low fat 
lard (10% kcal fat as lard), high fat lard (45% kcal fat as lard), low fat safflower oil 
(10% kcal fat as safflower oil), high fat safflower oil (45% kcal fat as safflower oil) 
and regular chow rodent diets. 
On the regular chow diet, a significant lower body weight was observed in male 
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Male PPARp (+/+) 
Regular chow 
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Figure 3.1. Tail-genotyping of male PPARP (+/+) mice. They were randomly 
assigned to 5 different diets, including the diets of regular chow (n =8)，low fat lard 
(n =11), high fat lard (n = 12), low fat safflower oil (n = 12), and high fat safflower 
oil (n = 12). The PCR products of PPARp (+/+) males were resolved on 2% agarose, 
0.5X TBE gels with EB staining. The sizes of PCR products were as expected. M, 
100 bp DNA molecular weight marker. 
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Female PPARp (+/+) 
Regular chow 
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Figure 3.2. Tail-genotyping of female PPARP (+/+) mice. They were randomly 
assigned to 5 different diets, including the diets of regular chow (n =8)，low fat lard 
(n =11), high fat lard (n = 12), low fat safflower oil (n = 10), and high fat safflower 
oil (n = 12). The PCR products of PPARP (+/十）females were resolved on 2% 
agarose, 0.5X TBE gels with EB staining. The sizes of PCR products were as 
expected. M, 100 bp DNA molecular weight marker. 
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Male PPARp (-/-) 
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Figure 3.3. Tail-genotyping of male PPARp (-/-) mice. They were randomly 
assigned to 5 different diets, including the diets of regular chow (n =8), low fat lard 
(n = 12), high fat lard (n = 13), low fat safflower oil (n = 11), and high fat safflower 
oil (n = 13). The PCR products of PPARp (-/-) males were resolved on 1% agarose, 
0.5X TBE gels with EB staining. The sizes of PCR products were as expected. M, 1 
kb DNA molecular weight marker. 
-108-
Female PPARP (-/-) 
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Figure 3.4. Tail-genotyping of female PPARp (-/-) mice. They were randomly 
assigned to 5 different diets, including the diets of regular chow (n =8)，low fat lard 
(n = 12), high fat lard (n 二 12), low fat safflower oil (n = 12), and high fat safflower 
oil (n = 12). The PCR products of PPARp (-/-) females were resolved on 1% agarose, 
0.5X TBE gels with EB staining. The sizes of PCR products were as expected. M, 1 
kb DNA molecular weight marker. 
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PPARp (-/-) at 15 weeks and continued to 5 months when compared with the PPARp 
(+/+) mice (Figure 3.5.1). The body weights of PPARp (+/+) and PPARp (-/-) males 
after the 5-month feeding were increased by 47% and 34% of their original body 
weights, respectively. When feeding with low fat lard diet for 22 weeks, a consistent 
lower increase in body weight was observed at Week 9 in PPARp (-/-) males (Figure 
3.5.2). The body weight gain in male PPARp (+/+) and PPARp (-/-) mice was 60% 
and 41%, respectively. Under high fat lard diet, the body weight difference between 
genotypes was more dramatic. A consistent increase in body weight was observed at 
Week 2 in PPARp (+/+) males (Figure 3.5.3) compared with the PPARp (-/-) mice. 
The body weight gain in wild-type males was about 2 folds (113%), but the PPARP 
(-/-) males still displayed a lower body weight gain (61%). When feeding with low 
fat safflower oil diet for 22 weeks, a consistent increase in body weight was observed 
in PPARp (+/+) and PPARp (-/-) males (Figure 3.5.4). However, a lower increase in 
body weight gain was noted at Week 11 in PPARp (-/-) mice in comparison to their 
PPARP (+/+) counterparts. The body weight gain in male PPARp (+/+) and PPARp 
(-/-) mice was 61% and 44%, respectively. On high fat safflower oil diet, a 
consistent lower body weight was noted in PPARp (-/-) males (Figure 3.5.5). The 
body weights of PPARp (+/+) and PPARp (-/-) males after the 5-month feeding were 
































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































When feeding with regular chow for 22 weeks, a significant lower body weight 
was observed in female pp ARP (-1-) mice at the beginning of the study and continued 
to Week 10 when compared with the PPARP (+1+) mice (Figure 3.6.1). PPARP (-1-) 
females showed similar body weight increase to its wild-type controls at the end of 
study. Under low fat lard diet, a consistent increase in body weight was observed in 
PPARP (+1+) and PPARP (-1-) females (Figure 3.6.2). The body weight gain in 
female PPARP (+1+) and PPARP (-1-) mice was 48% and 31%, respectively. On 
high fat lard diet, a significant increase in body weight was observed at Week 3 in 
PPARP (+1+) females (Figure 3.6.3) compared with the PPARP (-1-) mice. The body 
weight gain in wild-type females was 82%, while that in PPARP (-1-) males was 36%. 
When feeding with low fat safflower oil diet for 22 weeks, a consistent increase in 
body weight was observed in PPARP (+1+) and PPARP (-1-) females (Figure 3.6.4). 
However, a lower increase in body weight gain was noted in female PPARP (-1-) mice 
in comparison to their PPARP (+1+) counterparts. The body weight gain in female 
PPARP (+1+) and PPARP (-1-) mice was 49% and 350/0, respectively. Under high fat 
safflower oil diet, a consistent lower body weight was noted in pp ARP (-1-) females 
throughout 5 months (Figure 3.6.5). The body weights ofPPARP (+1+) and PPARP 



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Overall, these results showed that male and female pp AR~ (-1-) mice were more 
resistant to body weight gain upon long-term high fat feeding, which was contrast 
from an earlier study indicating that PPAR~-null mice increased body weight gain on 
a high fat diet that contains 35% (w/w) fat content (Wang et aI., 2003). 
3.3.3 PPAR(3 (-1-) mice consumed similarly as to PPAR(3 (+1+) 
counterparts 
To find out whether the difference in body weight gain between the PPAR~ (+1+) 
and PPAR~ (-1-) mice was attributed to the difference in food consumption, daily food 
intake of PPAR~ (+1+) and PPAR~ (-1-) mice from both sexes were measured. 
Despite of the lowered body weight gain in PPAR~ (-1-) males on regular chow, their 
food intake was consistently higher than that of the PPAR~ (+1+) male at 19 weeks 
and onwards of feeding (Figure 3.7.1). The male PPAR~ (-1-) mice also consumed 
significantly more food when feeding high fat safflower oil and high fat lard diets at 
Week 12 (Figures 3.7.2 and 3.7.3). However, statistical analysis on food intake of 
pp AR~ (-I -) males under high fat lard diet indicated no overt difference from the 
PPAR(3 (+1+) mice (Figure 3.7.3). in contrast, the male PPARP (-1-) mice consumed 
significantly less energy on low fat lard and safflower oil diets from the beginning of 
















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Interestingly, no significant difference in food intakes between the two genotypes was 
observed at 22 weeks. 
F or the females, the food intake of pp AR~ (-I -) mice were on the average 
lowered than those ofPPAR~ (+1+) mice in all the diet groups (Figures 3.8.1,3.8.2, 
3.8.3, 3.8.4 and 3.8.5). Though the wild-type females consumed significantly more 
calories than PPAR~ (-1-) mice during the early period of treatment, the two 
genotypes were similar in their food consumption toward the end of the 22-week 
feeding period. 
In summary, the leaner body weights observed in pp AR~ (-1-) males and females 
were not due to their lower food consumption. The recent reports have been 
suggested a possible role of PPAR~ in controlling the metabolic rate, as PPAR~ (-1-) 
males had an increased food intake but with a lowered body weight (Peters et aI., 
2000; Akiyama et al., 2004). This suggestion was not totally supported by the 
findings here. 
3.3.4 Effect of high fat diet on organ weights 
To gain insights into the factors contributed to the observed lean phenotypes in 


























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































(BF) tissues were dissected and measured. To account for the difference in body 
weight, the organ weight of each mouse was normalized to by its percentage of body 
weight. 
3.3.4.1 PPARP (-/-) mice were more resistant to high fat diet-induced liver 
hepatomegaly 
PPARp (+/+) males and females exhibited a slight degree of liver enlargement 
and steatosis following 22 weeks fat feeding (Figures 3.9.1 and 3.9.2). Upon feeding 
with high fat lard diet, the liver weight (% body weight) of PPARp (+/+) mice was 
significantly higher than that of PPARp (-/-) mice in both males (Figure 3.9.IB) and 
females (Figure 3.9.2B). The liver weights of PPARp (-/-) males and females were 
about 44% and 71% of those wild-type livers, respectively. In addition, there were 
statistically significant difference in liver weight between PPARp (+/+) and PPARp 
(-/-) mice under high fat safflower oil diets for males and low fat safflower oil diets 
for females. The liver weight analyses showed a genotype-specific hepatomegaly 
toward PPARp (+/+) mice and could be contributed to the heavier body weight in the 
wild-type controls under high fat diet challenge. 
3.3.4.2 PPARP (-/-) mice were resistant to high fat diet-induced increased 
white fat depots 
The PPARp (-/-) mice had smaller gonadal WF depots, which were more 
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Figure 3.9.1. Livers of male PPARP (+/+) and PPARP (-/-) mice challenged with 
different types of diets. (A) External morphology and (B) relative weight of livers 
were observed from male PPARP (+/+) and PPARp (-/-) mice fed regular chow，low 
fat lard, high fat lard, low fat safflower oil and high fat safflower oil diets for 5 
months. The liver values are expressed as percentage of body weight and 
represented as mean ± SD (n ^ 8). ANOVA on ranks was used to compare the 
differences in median values among treatment groups using SigmaStat software. *\p 
< 0.01, indicates significantly different from the liver weight of PPARP (+/+) mice 
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Figure 3.9.2. Livers of female PPARP (+/+) and PPARP (-/-) mice challenged 
with different diets. (A) External morphology and (B) relative weight of livers 
were observed from female PPARP (+/+) and PPARp (-/-) mice fed regular chow, 
low fat lard, high fat lard, low fat safflower oil and high fat safflower oil diets for 5 
months. The liver values are expressed as percentage of body weight and 
represented as mean 士 SD (n ^ 8). ANOVA on ranks was used to compare the 
differences in median values within each diet group using SigmaStat software. **, p 
< 0.01, indicates significantly different from the liver weight of PPARp (+/+) mice 
fed the same diet. NS, no significant difference from that of regular chow-fed mice. 
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pronounced in females than in males (Figures 3.10.1 and 3.10.2). This data was in 
consistent with the previous reports (Peters et al” 2000; Barak et al., 2002). 
However, comparison of the WF tissues from PPARp (-/-) mice to those from PPARp 
(+/+) controls revealed no significant difference between genotypes in males (Figure 
3.10. IB) and females (Figure 3.10.2B). The relative WF weights of wild-type males 
from the 5 different diet groups were similar. High fat lard feeding in PPARp (-/-) 
males, PPARp (+/+) females and PPARp (-/-) females promoted significant increases 
in the WF weight by 161%, 251% and 104%, respectively, when comparing with 
those WF weights of the corresponding strains under regular chow. The male 
PPARp (-/-) mice on high fat safflower oil diet also accumulated more WF mass, 
which were 2.43 folds of the WF weight from PPARp (-/-) males fed with the control 
diet. The changes of WF weight in all PPARp (+/+) and PPARp (-/-) mice were 
diet-dependent, but not genotype-dependent. 
3.3.4.3 PPARP (-/-) mice were resistant to high fat diet-induced increased 
brown fat mass 
Similar to the reproductive WF tissues, the interscapular BF pads in PPARp (-/-) 
males and females were smaller in its external morphology (Figures 3.11.1 and 
3.11.2), but without any statistical difference between genotypes in the two cohorts 
(Figures 3.11. IB and 3.11.2B). The relative BF weight of PPARp (+/+) males under 
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Figure 3.10.1. White fat tissues from male PPARP (+/+) and PPARP (-/-) mice 
fed different diets. (A) External morphology and (B) relative weight of 
reproductive white fat pads (WF) were observed from PPARP (+/+) and PPARP (-/-) 
males under regular chow, low fat lard, high fat lard, low fat safflower oil and high 
fat safflower oil diets for 5 months. The WF values are expressed as percentage of 
body weight and represented as mean 土 SD (n > 8). ANOVA on ranks was used to 
compare the differences in median values within each treatment using SigmaStat 
software. There was no statistically significant difference in WF weight between 
PPARp (+/+) and PPARP (-/-) mice. p < 0.01, indicates significantly different 
from the WF weight of mice fed with regular chow in the same genotype. NS, no 
significant difference from that of regular chow-fed mice. 
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Figure 3.10.2. White adipose tissues from female PPARP (+/+) and PPARP (-/-) 
mice fed different diets. (A) External morphology and (B) relative weight of 
reproductive white fat pads (WF) were observed from PPARp (+/+) and PPARP (-/-) 
females fed regular chow, low fat lard, high fat lard, low fat safflower oil and high 
fat safflower oil diets for 5 months. The WF values are expressed as percentage of 
body weight and represented as mean 士 SD (n > 8). ANOVA on ranks was used to 
compare the differences in median values within each treatment using SigmaStat 
software. There was no statistically significant difference in WF weight between 
PPARp (+/+) and PPARP (-/-) mice. \ p < 0.05; — , < 0.01’ indicates significantly 
different from the WF weight of regular chow-fed mice within the same genotype. 
NS, no significant difference from that of regular chow-fed mice. 
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Figure 3.11.1. Brown fat pads from male PPARp (+/+) and PPARP (-/-) mice 
fed different types of diets. (A) External morphology and (B) relative weight of 
interscapular brown fat pads (BF) were observed from PPARp (+/+) and PPARP (-/-) 
males under regular chow, low fat lard, high fat lard, low fat safflower oil and high 
fat safflower oil diets for 5 months. The BF values are expressed as percentage of 
body weight and represented as mean 土 SD (n > 8). ANOVA on ranks was used to 
compare the differences in median values within each treatment using SigmaStat 
software. There was no statistically significant difference in BF weight between 
PPARP (+/+) and PPARp (-/-) mice. \ p < 0.05; p < 0.01, indicate significantly 
different from the BF weight of mice fed with regular chow of the same genotype. 
NS, no significant difference from that of regular chow-fed mice. 
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Figure 3.11.2. Brown adipose tissues from female PPARP (+/+) and PPARP (-/-) 
mice fed different types of diets. (A) External morphology and (B) relative weight 
of interscapular brown fat pads (BF) were observed from PPARp (+/+) and PPARp 
(-/-) females fed regular chow, low fat lard, high fat lard, low fat safflower oil and 
high fat safflower oil diets for 5 months. The BF values are expressed as percentage 
of body weight and represented as mean 士 SD (n > 8). ANOVA on ranks was used 
to compare the differences in median values within each treatment using SigmaStat 
software. There was no significant difference in the BF weight between PPARP (+/+) 
and PPARP (-/-) mice. \ p < 0.05; 0.01, indicate significantly different from 
that BF weight of the regular chow-fed mice within the same genotype. NS, no 
significant difference from that of regular chow fed-mice. 
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regular chow was significant lower than those fed with diets of low fat lard (1.74 folds 
of the BF weight from wild-type males on control diet), high fat lard (1.81 folds), low 
fat safflower oil (1.97 folds) and high fat safflower oil (1.68 folds), while a significant 
increase in the BF weight was occurred only in PPARP (-/-) males with high fat lard 
diet that was 2.10 folds of the BF weight from PPARp (-/-) males with regular chow. 
When comparing to the PPARp (+/+) females on regular chow, there were 63% and 
95% increases in the BF tissues from the wild-type controls challenged low fat lard 
and high fat lard diets, respectively. The BF tissues dissected from PPARp (-/-) 
females with the 5 different diets displayed no significant difference. In parallel 
with the observations from the reproductive WF pad, the accumulation of BF mass in 
all PPARP (+/+) and PPARp (-/-) mice was also diet-dependent. 
3.3.5 Effect of high fat diet on organ histology 
By using H&E staining, the morphological changes of liver, WF and BF were 
further examined. The liver, WF and BF histology from male and female PPARp 
(-/-) mice and the wild-type controls under regular chow, low fat lard, high fat lard, 
low fat safflower oil and high fat safflower oil diets were monitored at 2 different 
magnification powers: lOX and 40X. The liver histology was focused on the regions 
of central vein (CV), portal vein (PV), and the intermediate area between these two 
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veins at the higher magnification power (40X). 
3.3.5.1 PPARP (-/-) mice were more resistant to high fat diet-induced liver 
steatosis 
Histological analyses revealed PPARp (-/-) mice were less prone to develop fatty 
liver with severe intracellular lipid accumulation. There was no structural 
abnormality in the liver in both PPARp (-/-) males and females (Figures 3.12.1, 
3.12.2.1, 3.12.2.2, 3.12.2.3, 3.13.1, 3.13.2.1’ 3.13.2.2 and 3.13.2.3, panels B, D, F, H, 
J) fed all the 5 diets. On regular chow diet, normal hepatocytes were arranged in a 
series of anastomosing plates with one cell thick in PPARp (-/-) males (Figures 
3.12.2.1, 3.12.2.2 and 3.12.2.3, panel B). The sinusoidal spaces, which are spaces 
between the anastomosing plates, were seen clearly. When challenging with the low 
fat lard (Figures 3.12.2.1, 3.12.2.2 and 3.12.2.3, panel D) and high fat lard (Figures 
3.12.2.1, 3.12.2.2 and 3.12.2.3, panel F) diets, the hepatocytes of PPARp (-/-) males 
contained microvesicles in their cytoplasm. The PPARP (-/-) males with low fat 
safflower oil (Figures 3.12.2.1, 3.12.2.2 and 3.12.2.3, panel H) and high fat safflower 
oil (Figures 3.12.2.1’ 3.12.2.2 and 3.12.2.3, panel J) diets exhibited similar hepatocyte 
morphology as those under regular chow. Normal liver histology was also detected 
in PPARp (-/-) females from all the diet groups (Figures 3.13.2.1，3.13.2.2 and 
3.13.2.3, panels B, D, F, H and J). 
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Figure 3.12.1. Hematoxylin and eosin staining of liver sections from male 
PPARP (+/+) and PPARP (-/-) mice challenged with different diets (overall view, 
lOX). Photomicrographs of paraffin sections (5 jam thick) were taken from livers of 
PPARp (+/+) and PPARP (-/-) males fed regular chow (panels A, B), low fat lard 
(panels C，D), high fat lard (panels E, F), low fat safflower oil (panels G, H), and 
high fat safflower oil diets (panels I，J) for 5 months. The data shown represent 
similar observations in all the livers examined (n ^ 3). Bars, 100 jam. 
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Figure 3,12.2.1. Hematoxylin and eosin staining of liver sections from male 
PPARP (+/+) and PPARP (-/-) mice challenged with different diets (central vein 
region, 40X). Photomicrographs of paraffin sections (5 jam thick) were taken from 
livers of PPARp (+/+) and PPARP (-/-) males fed regular chow (panels A, B), low 
fat lard (panels C, D)，high fat lard (panels E, F), low fat safflower oil (panels G, H), 
and high fat safflower oil diets (panels I, J) for 5 months. The data shown represent 
similar observations in all the livers examined (n ^ 3). CV, central vein. Bars, 100 
|im. 
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Figure 3.12.2.2. Hematoxylin and eosin staining of liver sections from male 
PPARP (+/+) and PPARP (-/-) mice challenged with different diets (intermediate 
zone，40X). Photomicrographs of paraffin sections (5 jam thick) were taken from 
livers of PPARP (+/+) and PPARP (-/-) males fed regular chow (panels A, B), low 
fat lard (panels C, D), high fat lard (panels E, F), low fat safflower oil (panels G, H), 
and high fat safflower oil diets (panels I, J) for 5 months. The data shown represent 
similar observations in all the livers examined (n ^ 3). CV, central vein. Bars, 100 
|am. 
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Figure 3.12.2.3. Hematoxylin and eosin staining of liver sections from male 
PPARP (+/+) and PPARP (-/-) mice challenged with different diets (portal triad 
region, 40X). Photomicrographs of paraffin sections (5 |am thick) were taken from 
livers of PPARp (+/+) and PPARp (-/-) males fed regular chow (panels A, B), low 
fat lard (panels C, D), high fat lard (panels E, F), low fat safflower oil (panels G, H), 
and high fat safflower oil diets (panels I, J) for 5 months. The data shown represent 
similar observations in all the livers examined (n ^ 3). PV, portal vein. Bars, 100 
|am. 
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Figure 3.13.1. Hematoxylin and eosin staining of liver sections from female 
PPARp (+/+) and PPARp (-/-) mice fed with different diets (overall view, lOX). 
Photomicrographs of paraffin sections (5 jam thick) were taken from livers of PPARp 
(+/+) and PPARp (-/-) females challenged with regular chow (panels A, B)，low fat 
lard (panels C, D)，high fat lard (panels E, F), low fat safflower oil (panels G, H), and 
high fat safflower oil diets (panels I, J) for 5 months. The data shown represent 
similar observations in all the livers examined (n ^ 3). Bars, 100 |Lim. 
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Figure 3.13.2.1. Hematoxylin and eosin staining of liver sections from female 
PPARp (+/+) and PPARP (-/-) mice fed with different diets (central vein region, 
40X). Photomicrographs of paraffin sections (5 jam thick) were taken from livers of 
PPARP (+/+) and PPARP (-/-) females challenged with regular chow (panels A, B), 
low fat lard (panels C, D), high fat lard (panels E, F), low fat safflower oil (panels G, 
H), and high fat safflower oil diets (panels I, J) for 5 months. The data shown 
represent similar observations in all the livers examined (n ^ 3). CV, central vein. 
Bars, 100 jam. 
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Figure 3.13.2.2. Hematoxylin and eosin staining of liver sections from female 
PPARP (+/+) and PPARP (-/-) mice fed with different diets (intermediate zone， 
40X). Photomicrographs of paraffin sections (5 jam thick) were taken from livers of 
PPARP (+/+) and PPARP (-/-) females challenged with regular chow (panels A, B), 
low fat lard (panels C, D), high fat lard (panels E, F), low fat safflower oil (panels G, 
H), and high fat safflower oil diets (panels I, J) for 5 months. The data shown 
represent similar observations in all the livers examined (n ^ 3). CV, central vein; 
PV, portal vein. Bars, 100 |im. 
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Figure 3.13.2.3. Hematoxylin and eosin staining of liver sections from female 
PPARp (+/+) and PPARP (-/-) mice fed with different diets (portal triad region， 
40X). Photomicrographs of paraffin sections (5 jam thick) were taken from livers of 
PPARP (+/+) and PPARP (-/-) females challenged with regular chow (panels A, B), 
low fat lard (panels C, D), high fat lard (panels E, F), low fat safflower oil (panels G, 
H), and high fat safflower oil diets (panels I, J) for 5 months. The data shown 
represent similar observations in all the livers examined (n ^ 3). PV, portal vein. 
Bars, 100 jam. 
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In the livers of wild-type males and females, white empty spaces were found that 
were oil droplets deposited in livers (Figures 3.12.1 and 3.13.1, panels A, C, E, G and 
I); especially those fed high fat lard diet. Numerous microvesicular lipid droplets 
were observed in the cytoplasm of hepatocytes from PPARp (+/+) males with control 
diet (Figures 3.12.2.1, 3.12.2.2 and 3.12.2.3, panel A), together with the narrower 
sinusoidal spaces than those PPARp (-/-) males (Figures 3.12.2.1, 3.12.2.2 and 
3.12.2.3, panel B). The extent and size of microvesicular fat droplets in hepatocytes 
were increased when the wild-type males challenged with low fat lard diet (Figures 
3.12.2.1, 3.12.2.2 and 3.12.2.3, panel C). Intracellular lipid accumulation in liver 
was transited from microvesicular to macrovesicular in which small oil droplets fused 
into a single, large lipid vacuole. The macro vacuolar hepatocytes were clearly 
restricted near the periportal zone, whereas the microvesicular hepatocytes were 
concentrated at the centrilobular area. Under high fat lard feeding, PPARp (+/+) 
males developed fatty liver with abundant macrovacuolar lipid droplets inside 
hepatocytes (Figures 3.12.2.1, 3.12.2.2 and 3.12.2.3, panel E). These droplets 
displaced the nuclei to the periphery of the hepatocytes, in which displayed an 
adipocyte-like morphology. The degree of intracellular lipid accumulation in livers 
of PPARP (+/+) males on low fat and high fat safflower oil diets was diminished 
(Figures 3.12.2.1, 3.12.2.2 and 3.12.2.3, panels G and I), when comparing to those 
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liver histology from the lard diets. For the PPARp (+/+) females, their livers showed 
a normal, healthy liver morphology under regular chow (Figures 3.13.2.1, 3.13.2.2 
and 3.13.2.3, panel A). Up on challenging with low fat lard, high fat lard, low fat 
safflower oil and high fat safflower oil diets, fat droplets were accumulated in livers 
as in the wild-type males (Figures 3.13.2.1，3.13.2.2 and 3.13.2.3, panels C, E, G and 
I), in which the macro vesicular oil droplets were concentrated at the portal vein region 
and microvesicules were found near the central vein area. However, the size of l ipid 
vacuoles in the hepatocytes of PPARp (+/+) females was smaller than that of their 
corresponding wild-type males. 
The correlation between severe lipid accumulation and hepatomegaly in the liver 
of wild-type males and females was strongly evocative of hepatic steatosis. 
Interestingly, macrovacuolar oil droplets in the cytoplasm of hepatocytes were 
restricted to the periportal zone, while lipid microvesicules inside the hepatocytes 
were restricted to the centrilobular area. In contrast, livers from PPARp (-/-) mice 
failed to develop fatty liver, even under high fat diet feeding, suggesting that the 
PPARp deficiency protects against diet-induced obesity. 
3.3.5.2 No defect in white adipocyte expansion in PPARP (-/-) mice upon 
high fat diet feeding 
Typical WF adipocyte morphology was observed in the WF histology from all 
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PPARp (+/+) and PPARp (-/-) male (Figures 3.14.1 and 3.14.2) and female (Figures 
3.15.1 and 3.15.2) mice. The WF adipocytes were closely packed together to form a 
polyhedral shape. They filled with a single massive oil droplet, which pushed the 
nucleus to the cell periphery and reduced the cytoplasm to a thin rim around the lipid 
droplets. 
In the PPARp (-/-) males, the WF adipocytes were smaller in size than those 
from PPARp (+/+) males fed with regular chow (Figure 3.14.2, panels A and B) and 
low fat safflower oil diet (Figure 3.14.2, panels G and H). In contrast, the size of 
adipocytes from PPARp (-/-) males under high fat lard diet was bigger than that of 
wild-type males (Figure 3.14.2, panels E and F). 
For PPARp (-/-) females, their adipocyte size was smaller than that of wild-type 
controls when challenged with low fat lard (Figure 3.15.2, panels C and D), high fat 
lard (Figure 3.15.2, panels E and F) and high fat safflower oil diets (Figure 3.15.2.2, 
panels I and J). The difference in adipocyte size was not found between PPARp (+/+) 
and PPARp (-/-) mice fed regular chow (Figure 3.15.2, panels A and B) and low fat 
safflower oil diet (Figure 3.15.2, panels G and H). The size of WF adipocytes from 
PPARp (-/-) females was increased with high fat lard feeding (Figure 3.15.2, panels B 
and F) compared to those with control diet. The adipocyte size was also expanded in 
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Figure 3.14.1. Hematoxylin and eosin staining of white adipose tissue sections 
from male PPARP (+/+) and PPARP (-/-) mice fed with different diets (lOX). 
Photomicrographs of paraffin sections (12 jam thick) were taken from epididymal 
white fat tissues (WF) of PPARP (+/+) and PPARp (-/-) males fed regular chow 
(panels A, B)，low fat lard (panels C, D), high fat lard (panels E, F), low fat safflower 
oil (panels G, H), and high fat safflower oil (panels I, J) diets for 5 months. The data 
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Figure 3.14.2. Hematoxylin and eosin staining of white adipose tissue sections 
from male PPARP (+/+) and PPARp (-/-) mice fed with different diets (40X). 
Photomicrographs of paraffin sections (12 jam thick) were taken from epididymal 
white fat tissues (WF) of PPARp (+/十）and PPARP (-/-) males fed regular chow 
(panels A, B), low fat lard (panels C, D), high fat lard (panels E, F), low fat safflower 
oil (panels G, H), and high fat safflower oil (panels I, J) diets for 5 months. The data 
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Figure 3.15.1. Hematoxylin and eosin staining of white adipose tissue sections 
from female PPARP (+/+) and PPARP (-/-) mice under different diets (lOX). 
Photomicrographs of paraffin sections (12 jam thick) were taken from reproductive 
white fat tissues (WF) of PPARP (+/+) and PPARP (-/-) females fed regular chow 
(panels A, B), low fat lard (panels C, D), high fat lard (panels E, F), low fat safflower 
oil (panels G, H)，and high fat safflower oil (panels I, J) diets for 5 months. The data 
shown represent similar observations in all the WF mass examined (n ^ 3). Bars, 
100 |Lim. 
-157-
Female p p a r p (+/+) p p A R p (-/-) 
I M ,丫 、< 、 . 口 ^ ^ 广、 
R e g u l a r ： - 々 V , , J 
W W 寸 : 
J 、 ？ > 5 ~ ^ , 、 — r — 
‘ ‘ V 、 / D 一 t 
L o w fa t 义 t . 、 \ Y { I 
, , V J 、 ' … 4 人 \ A 
l a r d 着 ’ 、 >• ‘，， 
E 、 ， < F , 〜 、 广 , 
H i g h fa t , \ 厂 \ 、 ' ； , -
, , / V • �,L \ 人，* 
l a r d ‘ 、 、 产 〜 s 广 / 一产 
/ ‘J “ ‘.、 � , / ‘ 
L o w fa t . 产 . ‘ 、 \ : 、 - 、 、 - > k ' - t 
sa f f l ower o i l ’ 乂 * 丄、r 於 ^ ^ ^ v 盧底 
I I 、 , V J , : 、 、 " 今 
H i g h fa t , 乂 广 
sa f f lower o i l ‘ " •’广 乂 - 、 、 \ T 
Figure 3.15.2. Hematoxylin and eosin staining of white adipose tissue sections 
from female PPARP (+/+) and PPARp (-/-) mice under different diets (40X). 
Photomicrographs of paraffin sections (12 jam thick) were taken from reproductive 
white fat pads (WF) of PPARP (+/+) and PPARP (-/-) females fed regular chow 
(panels A, B), low fat lard (panels C, D), high fat lard (panels E, F), low fat safflower 
oil (panels G, H), and high fat safflower oil (panels I, J) diets for 5 months. The data 
shown represent similar observations in all the WF mass examined (n ^ 3). Bars, 
100 jLim. 
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the PPARp (+/+) females on low fat lard (Figures 3.15.2, panels A and C), high fat 
lard (Figure 3.15.2，panels A and E) and high fat safflower oil diets (Figure 3.15.2, 
panels A and I) with repective to those fed with regular chow diet. 
The WF adipocytes size difference between male and female PPARp (+/+) and 
PPARp (-/-) mice was in consistent with their relative WF weight. The higher the 
WF weight, the bigger the WF adipocyte size, and this was due to more triglycerides 
were accumulated inside the fat cells. The observation that high fat lard and 
safflower oil diets could promote adipocyte hypertrophy in PPARp (-/-) males and 
females as well as their wild-type counterparts, suggesting that there was no defect in 
adipocyte differentiation with the ablation of PPARp receptor, and it was consistent 
with the conclusion obtained from the in vitro study. 
3.3.5.3 No defect in brown adipocyte expansion in PPARP (-/-) mice upon 
high fat diet feeding 
The BF histology from both PPARp (+/+) and PPARp (-/-) mice exhibited a 
similar BF adipocyte morphology (Figures 3.16.1，3.16.2, 3.17.1 and 3.17.2). The 
cytoplasm of BF adipocyte contained a spherical, off center nucleus with multiple 
microvesicular oil droplet of varying sizes. Under regular chow control diet, there 
was no difference in the adipocyte size between the two genotypes in males (Figure 
3.16.2, panels A and B) and females (Figure 3.17.2, panels A and B). Their BF 
-159-
m 
Male ppARp (+/+) ppARP (-/-) 
Regular 業有〜、V';.了、| V ) ‘ ' � / � : 
chow ： ^ 义 ： - ？/ 
\ , t J. . r rf , t rH * ‘ 秦:J .IX，, \ 武、u*- , ‘ • ‘‘ 
狄 仏 遍 ， ， … <裤 
Lowfat 弥 … � “ 
l a r d 、 於 M 、 ' I ‘ ： / ^ 时 L二,： 
袋 約 、 \ ： ；〉 
“ < ：、》、卞岁缺、‘ ^ ‘ ‘ — . 
H i g h fa t 場 ： ； : : : 
‘ ： 、 、 为 义 、 y : 〜 、 
Low fat 二:�;�：〜“） 
safflower oil ： 
“ 产 - ‘ X ^  
V、，‘ 、 、 ， 、,_ — 
.、？： ；: iSS^Ul- J �”h ；‘， 
High fat > ^；： yv,；^：^ \ 
safflower oil 广、‘广’\ ‘ ‘ 奴 ^ 、我��；YJ/�二: ^ 
命 • ' 與 ％ 、 ； 、 
Figure 3.16.1. Hematoxylin and eosin staining of brown adipose tissue sections 
from male PPARp (+/+) and PPARp (-/-) mice fed with different diets (lOX). 
Photomicrographs of paraffin sections (5 jam thick) were taken from interscapular 
brown fat tissues (BF) of PPARp (+/+) and PPARP (-/-) males fed regular chow 
(panels A, B)，low fat lard (panels C, D)，high fat lard (panels E, F), low fat safflower 
oil (panels G, H), and high fat safflower oil (panels I, J) diets for 5 months. The data 
shown represent similar observations in all the BF tissues examined (n ^ 3). Bars, 
100 lam. 
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Figure 3.16.2. Hematoxylin and eosin staining of brown adipose tissue sections 
from male PPARP (+/+) and PPARP (-/-) mice under different diets (40X). 
Photomicrographs of paraffin sections (5 |am thick) were taken from interscapular 
brown fat pads (BF) of PPARP (+/+) and PPARp (-/-) males fed regular chow 
(panels A, B), low fat lard (panels C, D), high fat lard (panels E, F), low fat safflower 
oil (panels G, H), and high fat safflower oil (panels I, J) diets for 5 months. The data 
shown represent similar observations in all the BF tissues examined (n ^ 3 ) . Bars, 
100 lam. 
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Figure 3.17.1. Hematoxylin and eosin staining of brown adipose tissue sections 
from female PPARP (+/+) and PPARP (-/-) mice fed with different diets (lOX). 
Photomicrographs of paraffin sections (5 jam thick) were taken from interscapular 
brown fat pads (BF) of PPARP (+/+) and PPARP (-/-) females fed regular chow 
(panels A, B), low fat lard (panels C, D), high fat lard (panels E, F), low fat safflower 
oil (panels G, H), and high fat safflower oil (panels I, J) diets for 5 months. The data 
shown represent similar observations in all the BF mass examined (n ^ 3 ) . Bars, 100 
nm. 
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Figure 3.17.2. Hematoxylin and eosin staining of brown adipose tissue sections 
from female PPARP (+/+) and PPARp (-/-) mice under different diets (40X). 
Photomicrographs of paraffin sections (5 jam thick) were taken from interscapular 
brown fat tissues (BF) of PPARp (+/+) and PPARp (-/-) females fed regular chow 
(panels A, B), low fat lard (panels C, D), high fat lard (panels E, F), low fat safflower 
oil (panels G, H), and high fat safflower oil (panels I，J) diets for 5 months. The data 
shown represent similar observations in all the BF pads examined (n ^ 3). Bars, 100 
jam. 
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adipocytes expanded in size, and their number and size of oi l droplets increased in 
their cytoplasm, when PPARp (+/+) males were fed with low fat lard diet (Figure 
3.16.2, panel C). This expansion of BF adipocyte size was even more prominent in 
the wild-type males fed with high fat lard diet (Figure 3.16.2, panel E). Interestingly, 
the degree of l ipid accumulation in BF adipocytes diminished in PPARp (+/+) males 
on low fat safflower oil (Figure 3.16.2, panel G) and high fat safflower oil diets 
(Figure 3.16.2, panel I) in comparison to those of lard diets. 
In contrast, PPARp (-/-) males reduced fat store in BF adipocytes, relative to 
those wildtype control with low fat lard (Figure 3.16.2, panels C and D), high fat lard 
(Figure 3.16.2, panels E and F)，low fat safflower oil (Figure 3.16.2, panels G and H) 
and high fat safflower oil diets (Figure 3.16.2, panels I and J). There was no obvious 
difference in the BF adipocyte size of PPARp (-/-) females from all of the 5 different 
diets (Figures 3.17.1 and 3.17.2). In general, the size of BF adipocytes was smaller 
and correlated to its relative BF weight in PPARp (-/-) males and females, owing to 
the reduction of lipid accumulation in BF adipocytes. 
3.3.6 Effect on high fat diet on serum cholesterol, triglyceride, glucose, 
insulin and leptin levels 
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To examine whether there way any alternation in energy homeostasis in PPARp 
(-/-) mice that lead to its lean body phenotype, the serum cholesterol, triglyceride, 
insulin, glucose and leptin levels were measured. 
3.3.6.1 PPARP (-/-) mice had a lower serum cholesterol level, but a similar 
triglyceride level as compared to PPARP (+/+) mice upon high fat 
diet feeding 
Both PPARp (-/-) males and females (Figure 3.18) had a significantly lower 
serum cholesterol level fed all of the 5 different diets when compared with the PPARp 
(+/+) controls. In comparison to the PPARp (+/+) males under control diet, there 
were 3.3-, 11.8-, 2.7- and 5.4-fold increases in serum cholesterol levels in the PPARp 
(+/+) controls of low fat lard, high fat lard, low fat safflower oil and high fat safflower 
oil diets, respectively. The serum cholesterol levels of PPARp (+/+) males on high 
fat lard or safflower oil diet were higher than that fed with the respective low fat diet. 
Significant elevation in the serum cholesterol level was observed in wild-type males 
challenged with high fat lard diet, relative to that of high fat safflower oil-fed mice. 
The serum cholesterol level of PPARp (-/-) males with high fat lard and high fat 
safflower oil diets were increased by 4.8- and 5.2-fold, respectively, as comparing to 
that of PPARp (-/-) mice under regular chow diet. On the other hand, there were 4.6-, 
3.4- and 4.6-fold increased in the serum cholesterol levels in the PPARp (+/+) females 
on high fat lard diet, PPARP (+/+) females on high fat safflower oil diet and PPARp 
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Figure 3.18. Effect of different diets on serum cholesterol level in PPARP (+/+) 
and PPARP (-/-) mice. (A) Male and (B) female PPARP (+/+) and PPAR(3 (-/-) 
mice fed regular chow, low fat lard, high fat lard, low fat safflower oil and high fat 
safflower oil diets for 5 months. Serum cholesterol levels (mg/dl) were measured 
and data are expressed as mean 士 SD (n ^ 6). The differences in mean values 
between diets and genotypes were compared by two-way ANOVA using SigmaStat 
software. * , p < 0.05; < 0.01; < 0.001, indicate significantly different 
from that of PPARp (+/+) mice fed the same diet. \p< 0.05; p < 0.01; +++’ p < 
0.001, indicate significantly different from that of the regular chow group within the 
same genotype. NS, no significant difference from that of regular chow-fed mice. 
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(-/-) females on high fat lard diet, respectively, with respective to their corresponding 
chow-fed mice. The serum cholesterol value in PPARp (+/+) females fed with high 
fat lard diet was increased significantly by 30%, relative to that in mice under low fat 
lard diet. 
No statistically significant difference in serum triglyceride level between PPARp 
(+/+) and PPARp (-/-) males and females from all diet groups (Figure 3.19). High 
fat lard-fed PPARp (+/+)，low fat lard-fed PPARp (-/-) and high fat lard-fed PPARp 
(-/-) males had 4.7-, 6.6-and 5.5-fold, respectively, higher levels when compared to 
their corresponding chow-fed mice. The serum triglyceride levels of low fat lard-fed 
PPARp (+/+)，high fat lard-fed PPARp (+/+) and high fat lard-fed PPARP (-/-) 
females were increased by 7.2-, 7.9- and 5.7-fold, respectively, in comparison to their 
corresponding strain under regular chow. 
3.3.6.2 PPARP (-/-) mice were resistant to high fat diet-induced insulin 
resistance 
There was no significant difference in the serum glucose levels observed in both 
male and female PPARp (+/+) and PPARp (-/-) mice challenged with the low fat lard, 
high fat lard, low fat safflower oil or high fat safflower oil diet compared with the 
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Figure 3.19. Effect of different diets on serum triglyceride level in PPARp (+/+) 
and PPARP (-/-) mice. (A) Male and (B) female PPARP (+/+) and PPARp (-/-) 
mice fed regular chow, low fat lard, high fat lard, low fat safflower oil and high fat 
safflower oil diets for 5 months. Serum triglyceride levels (mg/dl) were measured 
and data are expressed as mean 士 SD (n ^ 7). The differences in median values 
among treatment groups were compared by ANOVA on ranks using SigmaStat 
software. There was no statistically significant difference in serum triglyceride level 
between PPARp (+/+) and PPARp (-/-) mice. \ p < 0.05; , p < 0.01, indicate 
significantly different fi.om that serum triglyceride level of the regular chow-fed 
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Figure 3.20. Effect of different diets on serum glucose level in PPARp (+/+) and 
PPARP (-/-) mice. (A) Male and (B) female PPARp (+/+) and PPARP (-/-) mice fed 
regular chow, low fat lard, high fat lard, low fat safflower oil and high fat safflower 
oil diets for 5 months. Serum glucose levels (mg/dl) were measured and data are 
expressed as mean 土 SD (n ^ 7). Two-way ANOVA was used to compare the 
differences in mean values between diet groups and genotypes using SigmaStat 
software. There was no statistically significant difference among the different levels 
of genotype and diet, and interaction between genotype and diet. 
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Similar as serum glucose levels, no statistically significant difference in serum 
insulin levels was found between male and female PPARp (+/+) and PPARp (-/-) 
mice. The serum insulin levels in PPARp (-/-) males and females fed low fat diets 
did not differ significantly from that fed with regular chow diet (Figures 3.21). In 
contrast, there were 6.5-，5.0- and 4.6-fold increases in the serum insulin levels in the 
PPARp (+/+) males under high fat lard and high fat safflower oil diets, and PPARp 
(+/+) females on high fat lard diet, respectively, in comparison to that fed regular 
chow diet. High fat diet treatment increased serum insulin level, but unaltered serum 
glucose level in PPARp (+/+) mice, suggesting that high fat diet-induced insulin 
resistance occurred only in PPARp (+/+) male and female mice. The PPARp 
deficiency might ameliorate insulin sensitivity under high fat dietary challenge. 
3.3.6.3 PPARp (-/-) mice had a similar serum leptin level as PPARP (+/+) 
mice 
There was no statistically significant difference in serum leptin level between 
PPARP (+/+) and PPARp (-/-) mice (Figure 3.22). A significant higher serum leptin 
levels was observed in both male (16.7-fold) and female (3-fold) PPARp (-/-) mice 
fed high fat lard diet with respective to their corresponding regular chow controls. 
Increases in serum leptin level (24.3-fold) was also observed in high fat lard-fed 
PPARP (+/+) females compared to its corresponding regular chow-fed females. 
-170-
A Male 
: 1 2 1 
1 10 - ^ PPARP (+/+) 
S [ = • PPARp (-/-) 二 
1 8 - - J N S 
- -
a 6 - t 
NS • • 
T NS ^ M 
i 2 - T 丄 NS • 丄 T • NS 
Regular Low fat High fat Low fat High fat 
chow lard lard safflower oil safflower oil 
Diet 
B Female 
^ 12 -| 
I 10 J/ • PPARPf+Z” 
S / f I I PPARp (-/-) 
•Z 
I t 
c 2 - T NS 
；= 丁 
I NS NS NS 
Regular Low fat High fat Low fat High fat 
chow lard lard safflower oil safflower oil 
Diet 
Figure 3.21. Effect of different diets on serum insulin level of PPARp (+/+) and 
PPARP (-/-) mice. (A) Male and (B) female PPARP (+/+) and PPARP (-/-) mice fed 
regular chow, low fat lard, high fat lard, low fat safflower oil and high fat safflower 
oil diets for 5 months. Serum insulin levels (ng/ml) were determined and data are 
expressed as mean ± SD (n > 5). The differences in median values among treatment 
groups were compared by ANOVA on ranks using SigmaStat software. There was 
no significant difference in serum insulin level between PPARP (+/+) and PPARp (-
/-) mice. \ p < 0.05, indicates significantly different from that serum insulin level of 
mice fed with regular chow diet within the same genotype. NS, no significant 
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Figure 3.22. Effect of different diets on serum leptin level of PPARP (+/+) and 
PPARP (-/-) mice. (A) Male and (B) female PPARP (+/+) and PPARp (-/-) mice fed 
regular chow, low fat lard, high fat lard, low fat safflower oil and high fat safflower 
oil diets for 5 months. Serum leptin levels (ng/ml) were determined and data are 
expressed as mean 土 SD (n ^ 4). The differences in median values among 
genotypes and diets were compared by ANOVA on ranks using SigmaStat software. 
There was no significant difference in serum leptin level between PPARP (+/+) and 
PPARp (-/-) mice. 0.05，indicates significantly different from the serum leptin 
level from regular chow-fed mice within the same genotype. NS, no significant 
difference from that of regular chow-fed mice. 
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There was no statistically significant difference in serum leptin level in the PPARp 
(+/+) males fed the fat diets. 
3.3.7 No decision made in fecal lipid content of PPARP (+/+) and 
PPARp (-/-) mice 
In Appendix F, stools collected from PPARp (+/+) and PPARp (-/-) mice fed 
with safflower oil diets were observed. Fecal samples from PPARp (-/-) males and 
females under low fat and high fat safflower oil diets were appeared in a paler color 
than those from PPARp (+/+) mice. There were some white matters appeared on the 
surface of stools of PPARp (-/-) mice, which are believed to be fat substances. 
Therefore, lipid content in stools were extracted, dried completely and then weighed. 
The fecal lipid content of PPARp (+/+) and PPARp (-/-) mice fed with high fat lard 
and high fat safflower oil diets was increased, as comparing to those under low fat 
lard and low fat safflower oil diets (Figure 3.23). However, there was no statistically 
significant difference between PPARp (+/+) and PPARP (-/-) mice challenged with all 
levels of diets, as the standard deviation per group was very large. The method used 
in quantitating fecal lipid content was inaccurate. Big errors came from hairs from 
mice, fibers or pigments from diets，or dust in the atmosphere, which are also counted 
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Figure 3.23. Fecal l ipid content of PPARp (+/+) and PPARP (-/-) mice fed wi th 
different types of diets. (A) Male and (B) female PPARp (+/+) and PPARp (•/-) 
mice fed regular chow, low fat lard, high fat lard, low fat safflower oil and high fat 
safflower oil diets for 5 months. Fecal lipid content (% dry weight) were measured 
and data are expressed as mean 士 SD (n ^ 4). Two-way ANOVA was used to 
compare the differences in mean values between diet groups and genotypes using 
SigmaStat software. There was no statistically significant difference among the 
different levels of genotype and diet, and interaction between genotype and diet. 
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the fecal samples. 
Taken together, the PPARp deficiency could prevent hepatic steatosis, alter 
cholesterol metabolism and improve insulin sensitivity under high fat diet treatment. 
PPARp (-/-) males and females were able to develop adipocyte hypertrophy as well as 
its wild-type controls. This further supported that PPARp is not required for 
adipocyte differentiation. These findings from in vivo study indicated PPARp (-/-) 
mice were protected from high fat diet-induced obesity. 
-175 -
Chapter 3.4 Discussion 
The physiological roles of PPARp in regulating lipid homeostasis under normal 
and high fat dietary challenge were explored using a gene knockout approach in the 
present study. Male and female PPARp (-/-) mice were less prone to diet-induced 
obesity following 22 weeks on high fat lard or safflower oil diet, as comparing with 
their wild-type controls. The lean body phenotype in PPARp (-/-) mice was 
primarily due to a dramatically depletion of fat stores in liver, but not reduction in 
adiposity. Consistent with the histological evidence from livers and quantitation of 
their relative weight, significant decreases of hepatic triglyceride and cholesterol 
levels were reported recently by using the same mouse model (Akiyama et al., 2004). 
In contrast, the wild-type animals here showed hepatomegaly and severe lipid 
accumulation in liver that led to the development of steatosis. High fat-induced 
adipocyte hypertrophy was observed, in which the WF adipocytes expanded its size 
similarly in both PPARp (+/+) and PPARp (-/-) mice under high fat feeding. In line 
with those previous reports that adipose tissue-specific PPARp -knockout mice 
displayed no effect on adipose differentiation (Barak et al., 2002; Wang et al., 2003), 
the present in vivo observation further supported conclusion obtained in chapter 2.4 
that PPARp is not required in the process of adipocyte differentiation. PPARp (-/-) 
mice exhibited less fat stores in BF adipocytes, despite the relative BF weight was not 
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differ significantly from that of wild-type animals. As the main source of excessive 
lipid storage in livers and adipose tissues is originated from dietary uptake, analyses 
of food intake and serum value of leptin, an adipocyte-secreted factor that acts to 
suppress appetite (Friedman and Halaas, 1998), revealed that PPARp (-/-) males and 
females did not diminish their feeding behaviors, and even slightly hyperphagic in 
occasion, when comparing with wild-type controls. Inspection of circulating lipids 
in sera from PPARp (-/-) mice showed that the triglyceride level was not altered, but 
the cholesterol concentration was reduced significantly, implying that the disruption 
of PPARp gene could deter cholesterol metabolism. Other plasma parameters, such 
as glucose and insulin, that are related to develop diet-induced obesity and insulin 
resistance, were remained unchangeable in their levels in PPARp (-/-) mice under 
high fat dietary challenge. 
Enhanced energy utilization and reduced lipid absorption should protect against 
high-fat diet induced obesity. However, PPARp (-/-) mice were recently proved to 
have a lower energy expenditures than the control animals, as they consumed less 
oxygen, produced less carbon dioxide and decreased metabolic rate (Lee et al., 2006). 
Besides, PPARp had been suggested to coordinate the regulation of genes involved in 
lipid transport and metabolism during dietary lipid absorption (Desvergne and Wahli, 
1999; Poirier et al, 2001). It up-regulates the expression of liver fatty-acid-binding 
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protein (L-FABP) in the small intestine with the mediation of LCFAs. L-FABP is 
found abundantly in the enterocyte of small intestine, which is responsible for cellular 
LCFA uptake and trafficking (Poirier et al., 2001). It shows a strong affinity for 
polyunsaturated fatty acids that are also natural ligands for PPARp (Forman et al., 
1997; Krey et al., 1997; Xu et al； 1999; Poirier et al” 2001). Thus L-FABP is 
believed to be a cytosolic-nuclear shuttle protein implicated in the ligand activation of 
PPARp. Other putative PPARP target genes expressed in the enterocytes of small 
intestine, such as fatty acid translocase (FAT/CD36) and ACS, facilitates the transport 
of LCFAs into the cell and transforms LCFAs into triglycerides, respectively 
(Desvergne and Wahli, 1999; Poirier et al., 2001). In the present in vivo study, 
preliminary screening of stools collected from PPARp (+/+) and PPARp (-/-) mice fed 
with safflower oil diets showed that the fecal samples were paler in color in PPARp 
(-/-) males and females (Appendix F). There were some white matters appeared on 
the surface of stools, which are believed to be fat substances. This suggested that the 
PPARp deficiency in mice might affect the regulation of intestinal absorption by 
decreasing fat absorption from the dietary intake and leaving the lipid contents in 
stools. However, preliminary analyses of fecal lipid amount did not draw any 
conclusion, as the errors were very large. Another method to quantitate the fecal 
lipid conent is required to demonstrate that PPARp (-/-) mice do not absorb dietary 
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fats more efficient. 
Consistent with the severe lipid accumulation in livers of PPARp (+/+) wild-type 
controls under high fat diet challenge, the potent selective PPARp ligand GW501516 
was shown to stimulate lipid synthesis in livers of genetically obese db/db mice (Lee 
et al., 2006). Activation of PPARp in these obese db/db mice by GW501516 
treatment up-regulated the PPARp target genes implicated in fatty acid/ triglyceride 
synthesis and glucose catabolism in liver, including fatty acid synthase, acetyl-CoA 
carboxylase (3, stearoyl-CoA desaturase 2, ELOVL family 6, acyl-CoA thioesterase 1, 
glycerol-3-phosphate acyltransferase, ATP citrate lyase, malic enzyme and 
phosphogluconate dehydrogenase. These analyses suggested that PPARp promotes 
lipid synthesis in liver. 
On the other hand, treatment of the obese db/db mice with another PPARp 
agonist L-165041 did not affect the serum glucose or triglyceride level, but raised 
total plasma cholesterol level (Berger et al., 1999; Leibowitz et al., 2000), which was 
matched with the same plasma metabolites measured in the present study. This 
demonstrated that PPARp could modulate cholesterol metabolism that could explain 
for the lower serum cholesterol level in obesity resistant PPARp (-/-) mice. Further 
analyses of the serum lipid profiles of L-165041-treated db/db mice by fast protein 
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liquid chromatography shown that the increased cholesterol was primarily associated 
with HDL particles (Leibowitz et al., 2000). GW501516 also elevated HDL 
cholesterol levels in obese monkeys, thus promoted reverse cholesterol transport from 
the peripheral cells to liver (Oliver et al., 2001). The significant higher cholesterol 
concentration in sera of PPARp (+/+) mice, hence, might due to the increase in serum 
HDL level, suggesting that PPARp might control lipid metabolism in a homeostatic 
mechanism. 
In contrast with my present work, another study using the same PPARp (-/-) 
mouse model showed that an elevation in serum triglyceride level in PPARp (-/-) mice 
on a diet containing 35% fat content, as comparing with the control animals (Akiyama 
et al., 2004). However, the results here indicated that the absence of PPARp gene 
does not alter levels of serum triglyceride in mice. Such a difference between these 
two studies may be due to the different types of high fat diet used with distinct fat 
composition and concentration. The other study using transgenic mice that 
over-express a constitutively activated ligand-independent PPARp-VP16 fusion 
protein specifically in adipose tissue were protected from obesity by increasing fatty 
acid oxidation within this adipose depots, thus causing reduced adiposity dramatically 
(Wang et al., 2003). However, it is presently unclear how much this fusion protein 
specifically mimics the roles of PPARp in physiological conditions. 
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Taken together, the present data indicated that the PPARp deficiency in mice 
protects against high fat diet-induced obesity by depleting lipid storage in liver and 
decreasing serum total cholesterol levels, without any change in adiposity. The 
PPARp (-/-) mice were also less prone to high fat diet-induced insulin resistance. In 
combination with the in vitro analysis, the process of adipocyte differentiation in 
MEFs is independent of the presence of PPARp. PPARp controls systemic lipid 
homeostasis, but not peripherally. Therefore, PPARp is a potential drug target 
candidate in the treatment of high fat diet-induced obesity. However, the limitation 
of my present study is the expression of PPARp receptor in PPARp (+/+) and PPARp 
(-/-) MEFs or mice at protein levels did not well clarify. 
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4441 cagaccggcc aggcctca|tg aatgtgcccc aggtag|aagc catccaggac accattctgc 
Xba I 
4501 gggctctaga attccatctg caggtcaacc accctgacag ccagtacctc ttccccaagc 
4561 tgctgcagaa gatggcagac ctgcggcagc tggtcactga gcatgcccag atgatgcagt 
4621 ggctaaagaa gacggagagt gagaccttgc tgcaccccct gctccaggaa atctacaagg 
4681 acatgtacta aggccgcagc ccaggcctcc cctcaggctc tgctgggccc agccacggac 
RP4758 
4741 Itgttcagagg accagcca|ca ggcactggca gtcaagcagc tagagcctac tcacaacact 
4801 ccagacacgt ggcccagact cttcccccaa cacccccacc cccaccaacc cccccattcc 
4861 cccaaccccc ctcccccacc ccgctctccc catggcccgt ttcctgtttc tcctcagcac 
4921 ctcctgttct tgctgtctcc ctagcgccct tgctcccccc ctttgccttc cttctctagc 
4981 atccccctcc tcccagtcct cacatttgtc tgattcacag cagacagccc gttggtacgc 
5041 tcaccagcag cctaaaagca gtggggcctg tgctggccca gtcctgcctc tcctctctat 
5101 ccccttcaaa gacatgagcc atccaaagaa acactacgct ctctctgggc ccagctttcc 
5161 aagaagcctg gcctggacca actgccatcc cagcttgtgg tcaccaccac agggttcctc 
5221 ctccagagag caagtgggca gggagcctgg gccgggagcc atattcccag gctgtctcag 
5281 ccctaggcac accactctct gacacttcct ttcttctcgc cggcgtccta ggtcattgtc 
5341 acagatgacc cttgtgctgc ctaggagatg acccctccag atgtcccctc cagatgcggt 
5401 ccaacggccc cactgaaggg aagggggtag aggcaggccg gaaggagcag cggcacactt 
5461 aggtcccagg gtcagaagct agacagcgag tgggcaggcc ctccatcagc acccctcctc 
- 1 9 0 -
5521 taccctgtag cagcatccag actggcagat cccagtacca ggaactggac catagctgtt 
5581 ctttcttctc ctgggagatg ctggcacacc tgcccccccc ccccccttgc agctgccccg 
5641 gtgtagccat gacactggct cacctctcgg tcaccacaga gtccctccca ttccctcccc 
5701 aaggccactg gggtacagct atggccctgt tcttaggact ggtgatctgt gagcaggcag 
5761 ggatatccta ccaggtcacc cctgccagct cacaggcaga gttgctaggg ttcctctgac 
5821 cctgtcctct ctcccactca cttgtaccag tagctctgtg gccttctctt cttttgcctg 
5881 gctggtcacc tgctcccatc tgctgcttca agtggcttga aacttgctgg gtgctcccat 
5941 actcagcccc agcccggcag atcctgcctc taggcccata ggtgatcagc ccaggctcgg 
6001 ctcctgccaa cacagaatgc tgccagattc cccgctagca cactccctgc ccctcacctc 
6061 tactgatcag gtcttggggt gttccttgtg gggcccaccc aggctgagaa tggagctaca 
6121 tcacccgccc tgcccccacc tgcccagccc cgcccaggtc tggtgctgag gatgcagctc 
6181 ctctcagggt ctgaagtctc caaatctgaa atgtatattt ttgctaggag ccccagcttc 
6241 ccgtgttttt aatataaata gtgtatacag actgacggaa ctttaaataa atgggaatta 
Appendix A. Location of primers for PCR genotyping in exon 8 of the mouse 
PPARP gene. A set of primers (high-lighted in black box) was designed for the 
PCR genotyping of PPARP (+/+) and PPARP (-/-) MEFs. The pair of primers flanks 
the Xba I site (high-lighted in pink) in exon 8 of the mouse PPARp gene (high-lighted 
in yellow). The nucleotide numbers correspond to the published sequence of NCBI 
accession number AJ420922. 
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Appendix B: Locations of the designed primers for RT-PCR and Northern blot 
analysis 
ACS_FP378 
481 acgacgatgt cagaaccatg tacgatggct tccaga|gggg gattcaggtg tcaa|ataatg 
541 gtccttgttt aggttctcgg aagccaaacc agccctatga gtggatttcc tacaaagagg 
601 tggcagaact ggctgagtgc ataggctccg ggctgatcca gaaggggttc aagccttgct 
661 ccgagcagtt catcggcctc ttctctcaaa acagacccga gtgggtgatc gtcgagcaag 
721 gatgcttctc ttactcaatg gtggtcgtcc cgctctatga cacccttgga gctgacgcca 
781 tcacctacat agtgaacaaa gctgaactct ctgtgatttt tgctgacaag ccagaaaaag 
841 ccaaactctt attagaaggt gtagaaaaca agttaacacc atgccttaaa atcatagtca 
901 tcatggactc ctacggcagt gatctggtgg aacgaggcaa gaagtgtggg gtggaaatca 
961 tcagcctcaa agctctggag gaccttggaa gagtgaacag agtgaagccc aagcctccag 
1021 aacccgaaga tcttgcgata atttgtttca caagtggaac tacaggcaac cccaaaggag 
1081 caatgatcac tcaccaaaac attataaacg actgctcagg ttttataaaa gcaacagaga 
1141 gtgcattcat cgcttccaca gatgatgtgc tgatatcttt cttgcctctc gcccatatgt 
12 01 ttgagaccgt tgtagagtgt gtaatgctgt gtcatggagc taagatagga tttttccaag 
1261 gagatatcag gctgcttatg gacgacctca aggtgcttca gcccaccatc ttccctgtgg 
1321 ttcccaggct gctgaaccgg atgttcgaca gaatttttgg acaagcaaac acttccttga 
1381 agcgatggct gttggacttt gcctccaaaa ggaaagaggc ggagcttcgc agtggcatcg 
1441 tcagaaacaa cagcctgtgg gataaactca tcttccacaa gatacagtcg agcctgggtg 
1501 ggaaagtccg gctgatgatc acaggagcag ccccggtgtc tgccacagtg ctgacgtttc 
1561 tgaggacagc gctcggctgc cagttctatg aaggctacgg acagaccgag tgcactgctg 
- 1 9 2 -
1621 gttgctgcct gagcttgccc ggagactgga cggcaggcca tgttggagcc cccatgcctt 
1681 gcaattatgt aaagcttgtg gatgtggaag aaatgaatta cctggcatcc aagggcgagg 
1741 gtgaggtgtg tgtgaaaggg gcaaatgtgt tcaaaggcta cttgaaagac ccagcaagaa 
1801 cagctgaagc cctggataaa gatggctggt tacacacggg ggacattgga aaatggctgc 
1861 caaatggcac cttgaagatt atcgacagga aaaagcacat atttaaacta gcccaaggag 
1921 agtacatagc accagaaaag attgaaaata tctacctgcg gagtgaagcc gtggcccagg 
1981 tgtttgtcca cggagaaagc ttgcaggcct ttctcatagc agttgtggta cccgacgttg 
2041 agagcctacc gtcctgggca cagaagagag gcttacaagg gtccttcgaa gaactgtgca 
2101 ggaacaagga tatcaataaa gctatcctgg acgacttgtt gaaacttggg aaggaagccg 
2161 gtctgaagcc atttgaacag gtcaaaggca ttgctgtgca cccggaatta ttttctattg 
2221 acaacggcct tctgactcca acactgaagg cgaagaggcc agagctacgg aactatttca 
ACS_RP2168 
2281 ggtcgcagjat agatgaactg tacgccajcca tcaagatcta acgtgaggaa ggatacttag 
Appendix B l . Primer design of cDNA amplification of ACS. A set of primers 
(high-lighted in black box) was designed to amplify the cDNA sequences of ACS. 
The nucleotide numbers correspond to the published sequence of NCBI accession 
number NM_007981. 
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GPDH_FP16 
1 gcagcaagca gcacc|atggc tggcaagaaa gtc|tgcattg tcggctctgg caactggggc 
61 tcagccattg ccaagatcgt gggtagcaat gcaggccggc tggcacactt tgacccacgg 
121 gtgaccatgt gggtgtttga ggaagacatc gggggcagaa agctaactga gatcatcaac 
181 actcagcacg agaatgttaa atacctgcca gggcacaagc tgccccccaa tgtggtggcc 
241 atcccagacg tggtccaggc tgcaacaggc gctgacatcc tggtttttgt ggtaccccat 
301 cagttcattg gcaagatctg tgaccagctc aagggccact tgaaggccaa tactattggc 
361 atatctctta ttaagggggt agacgagggc cccaacgggc tgaagctcat ttctgaagtg 
421 attggggagc gccttggcat tcccatgagc gtgctgatgg gggccaacat tgccagcgag 
481 gtggctgagg agaagttctg tgagacgacc atcggctgca aggacccggc ccagggacag 
541 ctcctgaagg acctgatgca gacacccaac tttcgcatca ctgtggtaca agaggtggac 
601 acagtggaga tctgtggggc cttgaagaat atagtggccg ttggggctgg cttctgtgat 
661 gggcttggct tcggtgacaa caccaaggcg gcggtgatcc ggttggggct catggagatg 
721 atcgccttcg ccaagctctt ctgcagtggc actgtgtcct cggccacctt cctggagagc 
781 tgcggggtcg cagacctcat cacgacctgc tatggggggc ggaaccgcaa ggtggcagag 
841 gcctttgctc gaactggaaa gtccattgag cagctggaga aggagatgct aaatgggcag 
G P D H 一R P 9 5 7 
901 aagctacagg ggccccagac agcccgggag ctgcacagc|a ttctccaaca caaggg^ctt 
Appendix B2. Primer design of cDNA amplification of GPDH. A set o f primers 
(high-lighted in black box) was designed to amplify the cDNA sequences of GPDH. 
The nucleotide numbers correspond to the published sequence of N C B I accession 
number NM_010271. 
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BETA-ACTIN_FP2 
241 tgggtgacga gg|cccagagc aagagaggta| tcctgaccct gaagtacccc attgaacatg 
3 01 gcattgttac caactgggac gacatggaga agatctggca ccacaccttc tacaatgagc 
361 tgcgtgtggc ccctgaggag caccctgtgc tgctcaccga ggcccccctg aaccctaagg 
421 ccaaccgtga aaagatgacc cagatcatgt ttgagacctt caacacccca gccatgtacg 
481 tagccatcca ggctgtgctg tccctgtatg cctctggtcg taccacaggc attgtgatgg 
541 actccggaga cggggtcacc cacactgtgc ccatctacga gggctatgct ctccctcacg 
601 ccatcctgcg tctggacctg gctggccggg acctgacaga ctacctcatg aagatcctga 
661 ccgagcgtgg ctacagcttc accaccacag ctgagaggga aatcgtgcgt gacatcaaag 
721 agaagctgtg ctatgttgct ctagacttcg agcaggagat ggccactgcc gcatcctctt 
781 cctccctgga gaagagctat gagctgcctg acggccaggt catcactatt ggcaacgagc 
841 ggttccgatg ccctgaggct cttttccagc cttccttctt gggtatggaa tcctgtggca 
901 tccatgaaac tacattcaat tccatcatga agtgtgacgt tgacatccgt aaagacctct 
961 atgccaacac agtgctgtct ggtggtacca ccatgtaccc aggcattgct gacaggatgc 
1021 agaaggagat tactgctctg gctcctagca ccatgaagat caagatcatt gctcctcctg 
BETA-ACTIN_RP2 
1081 agcgcaa|gta ctctgtgtgg atcgg|tggct ccatcctggc ctcactgtcc accttccagc 
BETA-ACTIN_RP1 
1141 agatgtggat cagcaagcag gjagtacgatg agtccggccjc ctccatcgtg caccgcaagt 
Appendix B3. Primer design of cDNA amplification of p-actin. Primers 
(high-lighted in black box) were designed to amplify the cDNA sequences of p-actin. 
The nucleotide numbers correspond to the published sequence of NCBI accession 
number NM_007393. 
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121 atcaacgacc ccttcattga cctcaactac atggtctaca tgttccagta tgac|tccact| 
GAPDH_FP191 
181 jcacggcaaat tcaacg|gcac agtcaaggcc gagaatggga agcttgtcat caacgggaag 
241 cccatcacca tcttccagga gcgagacccc actaacatca aatggggtga ggccggtgct 
3 01 gagtatgtcg tggagtctac tggtgtcttc accaccatgg agaaggccgg ggcccacttg 
361 aagggtggag ccaaacgggt catcatctcc gccccttctg ccgatgcccc catgtttgtg 
421 atgggtgtga accacgagaa atatgacaac tcactcaaga ttgtcagcaa tgcatcctgc 
481 accaccaact gcttagcccc cctggccaag gtcatccatg acaactttgg cattgtggaa 
541 gggctcatga ccacagtcca tgccatcact gccacccaga agactgtgga tggcccctct 
601 ggaaagctgt ggcgtgatgg ccgtggggct gcccagaaca tcatccctgc atccactggt 
661 gctgccaagg ctgtgggcaa ggtcatccca gagctgaacg ggaagctcac tggcatggcc 
721 ttccgtgttc ctacccccaa tgtgtccgtc gtggatctga cgtgccgcct ggagaaacct 
781 gccaagtatg atgacatcaa gaaggtggtg aagcaggcat ctgagggccc actgaagggc 
841 atcttgggct acactgagga ccaggttgtc tcctgcgact tcaacagcaa ctcccactct 
901 tccaccttcg atgccggggc tggcattgct ctcaatgaca actttgtcaa gctcatttcc 
GAPDH 一 RP1017 
961 tggtatgaca atgaatacgg c|tacagcaac agggtggtgg ^cctcatggc ctacatggcc 
Appendix B4. Primer design of cDNA amplification of GAPDH. A set of 
primers (high-lighted in black box) was designed to amplify the cDNA sequences of 
GAPDH. The nucleotide numbers correspond to the published sequence of NCBI 
accession number BC093508. 
- 1 9 6 -
1 agatggtggc agagctatga ccaggcctgc aggcgccacg ccaagtgggg gtcagtcatg 
61 gaacagccac aggaggagac ccctgaggcc cgggaagagg agaaagagga agtggccatg 
121 ggtgacggag ccccggagct caatggggga ccagaacaca cgcttccttc cagcagctgt 
181 gcagacctct cccagaattc ctccccttcc tccctgctgg accagctgca gatgggctgt 
241 gatggggcct caggcggcag cctcaacatg gaatgtcggg tgtgcgggga caaggcctcg 
301 ggcttccact acggggtcca cgcgtgcgag gggtgcaagg gcttcttccg ccggacaatc 
361 cgcatgaagc tcgagtatga gaagtgcgat cggatctgca agatccagaa gaagaaccgc 
421 aacaagtgtc agtactgccg cttccagaag tgcctggcac tcggcatgtc gcacaacgct 
481 atccgctttg gacggatgcc ggaggccgag aagaggaagc tggtggcggg gctgactgcc 
541 agcgaggggt gccagcacaa cccccagctg gccgacctga aggccttctc taagcacatc 
601 tacaacgcct acctgaaaaa cttcaacatg accaaaaaga aggcccggag catcctcacc 
661 ggcaagtcca gccacaacgc accctttgtc atccacgaca tcgagacact gtggcaggca 
721 gagaagggcc tggtgtggaa acagctggtg aacgggctgc cgccctacaa cgagatcagt 
781 gtgcacgtgt tctaccgctg ccagtccacc acagtggaga cagtccgaga gctcaccgag 
841 ttcgccaaga acatccccaa cttcagcagc ctcttcctca atgaccaggt gaccctcctc 
901 aagtatggcg tgcacgaggc catctttgcc atgctggcct ccatcgtcaa caaagacggg 
961 ctgctggtgg ccaacggcag tggcttcgtc acccacgagt tcttgcgaag tctccgcaag 
1021 cccttcagtg acatcattga gcccaagttc gagtttgctg tcaagttcaa tgcgctggag 
1081 ctcgatgaca gtgacctggc gctcttcatc gcggccatca ttctgtgtgg agaccggcca 
1141 ggcctcatga atgtgcccca ggtagaagcc atccaggaca ccattctgcg ggctctagaa 
1201 ttccatctgc aggtcaacca ccctgacagc cagtacctct tccccaagct gctgcagaag 
1261 atggcagacc tgcggcagct ggtcactgag catgcccaga tgatgcagtg gctaaagaag 
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1321 acggagagtg agaccttgct gcaccccctg ctccaggaaa tctacaagga catgtactaa 
1381 ggccgcagcc caggcctccc ctcaggctct gctgggccca gccacggact gttcagagga 
1441 ccagccacag gcactggcag tcaagcagct agagcctact cacaacactc cagacacgtg 
1501 gcccagactc tcccccaaca cccccacccc caccaacccc cc 
Appendix C. Sequence of the partial PPARP fragment that was subcloned into 
the pDIRECT vector. The length of the PPARp insert is 900 bp (high-lighted in 
yellow). The nucleotide numbers correspond to the published sequence of NCBI 
accession number L28116. 
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PPARp (+/+) PPARp (-A) 
kPa M WT4 WT12 K04 KOI5 
109.5 • I B 
78.9 > 疆 
60.4 JH • 
35.1 . I ^ K 
24.9 - — . im 
Appendix D. Confirmation of PPARP (+/+) and PPARP (-/-) MEF genotypes by 
Western blot analysis. Eighty microliters of nuclear extracts from untreated 
PPARp (+/+) (n=2) and PPARp (-/-) (n=2) MEFs were separated on a SDS-PAGE 
(12%) gel and transferred to a PVDF membrane. Polyclonal antibody from rabbit 
was used to target mouse PPARp on the membrane. Alkaline phosphatase 
conjugated-goat anti-rabbit antibody was used as the secondary antibody. The signal 
was detected by colorimetric method using reagents NBT and BCIP. M, 
BenchMark™ pre-stained protein ladder. 
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\ . D i e t 
Regular Low fat High fat Low fat High fat 
Nutrient^^^ chow lard lard safflower oil safflower oil 
Protein 29% kcal 20% kcal 20% kcal 20% kcal 20% kcal 
Carbohydrate 59% kcal 70% kcal 35% kcal 70% kcal 35% kcal 
Fat 12% kcal 10% kcal 45% kcal 10% kcal 45% kcal 
Total 100% kcal 100% kcal 100% kcal 100% kcal 100% kcal 
Energy 3.04 kcal/g 3.85 kcal/g 4.73 kcal/g 3.85 kcal/g 4.73 kcal/g 
Appendix E. Nutrient composition of different types of diets. The values are 
presented as percentage of kilocalories. 
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PPARP (+/+) mice PPARp (-/-) mice 
Low fat High fat Low fat High fat 
safflower oil safflower oil safflower oil safflower oil 
1 % % 麵 
Appendix F. Appearance of stools collected from PPARP (+/+) and PPARp (-/-) 
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